The present invention relates to aminoquinazoline compounds or the enantiomers or veterinarily acceptable salts thereof which are useful for combating or controlling inver- tebrate pests, in particular arthropod pests and nematodes. The invention also relates to methods for controlling invertebrate pests by using these compounds and to plant propagation material and to agricultural and veterinary compositions comprising said compounds. Invertebrate pests and in particular arthropods and nematodes destroy growing and harvested crops and attack wooden dwelling and commercial structures, causing large economic loss to the food supply and to property. While a large number of pesticidal agents are known, due to the ability of target pests to develop resistance to said agents, there is an ongoing need for new agents for combating invertebrate pests, in particular insects, arachnids and nematodes.

WO 2005/087742 describes quinoline derivatives usable as agents in the control of pests for crop protection, human and animal health, acting as ethanolamine kinase inhibitors.

EP-A-393999 describes quinazolinylsulfonylureidoazines useful as herbicides.

DE-A-19756388 describes substituted 2-aryl-4-amino-quinazolines and their use as cardiovascular agents for treatment of circulatory diseases, blood pressure, angina, pectoris, heart insufficiency, thrombosis or artherosclorosis and to modulate the production of cGMP.

WO 2002/24667 describes 4-amino-quinazolines as glycoprotein IblX antagonists. WO 2004/030672 describes the use of 4-amino-quinazolines as anti cancer agents and PKB inhibitors.

WO 2004/092196 describes among other quinazolines derivatives compounds for modulating protein kinase enzymatic activity.

It is an object of the present invention to provide compounds that have a good pesticidal activity, in particular insecticidal activity, and show a broad activity spectrum against a large number of different invertebrate pests, especially against difficult to control arthropod pests and/or nematodes. It has been found that these objectives can be achieved by aminoquinazoline compounds of the formula I below, by their steroisomers and by their salts and N-oxides, in particular their agriculturally or veterinarily acceptable salts. Therefore, in a first aspect, the invention relates to aminoquinazoline compounds of the formula I and the salts and N-oxides thereof

(I)

wherein

A ¹ , A ² , A ³ and A ⁴ are N, NX or CR ⁴ wherein X is a lone pair or O, with the proviso that at most three of A ¹ , A ² , A ³ and A ⁴ are N or NX;

R ¹ , R ² are selected independently from one another from the group consisting of hy- drogen, CN, NO2, Ci-Cio-alkyl, Cs-Cs-cycloalkyl, C2-Cio-alkenyl, C2-C10- alkynyl,

wherein the carbon atoms of the aforementioned aliphatic and cyclo- aliphatic radicals may be unsubstituted or substituted with one or more

Si(R ¹¹ ) ₂ R ¹² , OR ⁷ , S(0) _m R ⁷ , NR ⁸ R ⁹ , N=C(R ⁶ ) ₂ , C(=0)R ⁶ , C(=S)R ⁶ , C(=NR ⁸ )R ⁶ and a 3-, 4-, 5-, 6- or 7- membered heterocyclic ring,

wherein said heterocyclic ring

is saturated or partially saturated,

comprises 1 , 2 or 3 heteroatoms selected from oxygen, nitrogen and/or sulfur, wherein the nitrogen and/or the sulfur atom(s) may be oxidized,

is unsubstituted or substituted with one to five R ¹⁰ , and

wherein one or two CH2 groups in said heterocyclic ring may be replaced by one or two C=0 groups;

R ³ is selected from the group consisting of hydrogen, halogen, cyano, azido, ni- tro, SCN, SF ₅ , Ci-Cio-alkyl, C ₃ -C ₈ -cycloalkyl, C ₂ -Cio-alkenyl, C ₂ -Cio-alkynyl, wherein the carbon atoms of the aforementioned aliphatic and cyclo- aliphatic radicals may be unsubstituted or substituted with one or more

Si(R ¹¹ ) ₂ R ¹² , OR ⁷ , S(0) _m R ⁷ , N(R ⁸ )R ⁹ , N=C(R ⁶ ) ₂ , C(=0)R ⁶ , C(=S)R ⁶ , C(=NR ⁸ )R ⁶ , phenyl

which may be substituted with 1 , 2, 3, 4 or 5 radicals R ¹⁰ ; and a 3-, 4-, 5-, 6- or 7- membered heterocyclic ring,

wherein said heterocyclic ring

is saturated or partially saturated,

comprises 1 , 2 or 3 heteroatoms or heteroatom groups selected from N, O, S, NO, SO and S0 ₂ ,

is unsubstituted or substituted with one to five radicals R ¹⁰ , and wherein one or two Chb groups in said heterocyclic ring may be replaced by one or two C=0 groups; each R ⁴ is selected independently from the group consisting of hydrogen, halogen, cyano, azido, nitro, SCN, SF ₅ , Ci-Cio-alkyl, Cs-Cs-cycloalkyl, C2-Cio-alkenyl, C2- Cio-alkynyl,

wherein the carbon atoms of the aforementioned aliphatic and cyclo- aliphatic radicals may be unsubstituted or substituted with one or more

Si(R ¹¹ ) ₂ R ¹² , OR ⁷ , S(0) _m R ⁷ , N(R ⁸ )R ⁹ , N=C(R ⁶ ) ₂ , C(=0)R ⁶ , C(=S)R ⁶ , C(=NR ⁸ )R ⁶ , C(=0)N(R ⁸ )R ⁹ , C(=S)N(R ⁸ )R ⁹ , phenyl

which may be substituted with 1 , 2, 3, 4 or 5 radicals R ¹⁰ ;

and a 3-, 4-, 5-, 6- or 7-membered heterocyclic ring,

wherein said heterocyclic ring

is saturated or partially unsaturated or aromatic, comprises 1 , 2 or 3 heteroatoms or heteroatom groups selected from N, O, S, NO, SO and S0 ₂ ,

is unsubstituted or substituted with one to five radicals R ¹⁰ , and wherein one or two CH2 groups in said saturated or partially saturated rings may be replaced by one or two C=0 groups; or two radicals R ⁴ bound on adjacent carbon atoms together form a group selected from -CH2CH2CH2CH2-, -CH=CH-CH=CH-, -N=CH-CH=CH-,

-CH=N-CH=CH-, -N=CH-N=CH-, -OCH2CH2CH2-, -OCH=CHCH ₂ -,

-CH2OCH2CH2-, -OCH2CH2O-, -OCH2OCH2-, -CH2CH2CH2-, -CH=CHCH ₂ -, -CH2CH2O-, -CH=CHO-, -CH2OCH2-, -CH ₂ C(=0)0-, -C(=0)OCH ₂ -, -0(CH ₂ )0- -SCH2CH2CH2-, -SCH=CHCH ₂ -, -CH2SCH2CH2-, -SCH2CH2S-, -SCH2SCH2-, -CH2CH2S-, -CH=CHS-, -CH2SCH2-, -CH ₂ C(=S)S-, -C(=S)SCH ₂ -, -S(CH ₂ )S-, -CH ₂ CH ₂ NR ⁸ -,-CH ₂ CH=N-, -CH=CH-NR ⁸ -, -OCH=N- and -SCH=N-,

wherein in each of the above group,

one to five hydrogen atoms independently of each other may be re- placed by one to five substituents selected from halogen, methyl, ha- lomethyl, hydroxyl, methoxy and halomethoxy, or

one or two CH2 groups of the above groups may be replaced by one or two C=0 groups; R ^5a is selected from the group consisting of hydrogen, halogen, cyano, azido, nitro, SCN, SF ₅ , Ci-Cio-alkyl, C ₃ -C ₈ -cycloalkyl, C ₂ -Cio-alkenyl, C ₂ -Cio-alkynyl,

wherein the carbon atoms of the aforementioned aliphatic and cyclo- aliphatic radicals may be unsubstituted or substituted with one or more

Si(R ¹¹ ) ₂ R ¹² , OR ⁷ , S(0) _m R ⁷ , N(R ⁸ )R ⁹ , N=C(R ⁶ ) ₂ , C(=0)R ⁶ , C(=S)R ⁶ , C(=NR ⁸ )R ⁶ , phenyl

which may be substituted with 1 , 2, 3, 4 or 5 radicals R ¹⁰ ; and a 3-, 4-, 5-, 6- or 7-membered heterocyclic ring,

wherein said heterocyclic ring

is saturated or partially unsaturated or aromatic,

comprises 1 , 2 or 3 heteroatoms or heteroatom groups selected from N, O, S, NO, SO and S0 ₂ ,

is unsubstituted or substituted with one to five radicals R ¹⁰ , and wherein one or two CH2 groups in said saturated or partially saturated rings may be replaced by one or two C=0 groups; or R ^5a may form together with the adjacent carbon atom R ^5b a 5- or 6-membered ring which is at least substituted with one halogen;

R ^5b is selected from the group consisting of Ci-C6-alkyl, C3-C6-cycloalkyl, C1-C6- alkoxy and Ci-C6-cycloalkoxy, wherein each mentioned radical

is at least substituted with one halogen,

may be further partially or fully halogenated, and

may be substituted with one to five radicals R ⁶ ; or R ^5b may form together with the adjacent carbon atom R ^5c or R ^5a a 5- or 6- membered ring which is at least substituted with one halogen; R ^5c is selected from the group consisting of hydrogen, halogen, cyano, azido, nitro, SCN, SF ₅ , Ci-Cio-alkyl, C ₃ -C ₈ -cycloalkyl, C ₂ -Cio-alkenyl, C ₂ -Cio-alkynyl,

wherein the carbon atoms of the aforementioned aliphatic and cyclo- aliphatic radicals may be unsubstituted or substituted with one or more R ⁶ ;

Si(R ¹¹ ) ₂ R ¹² , OR ⁷ , S(0) _m R ⁷ , N(R ⁸ )R ⁹ , N=C(R ⁶ ) ₂ , C(=0)OR ⁷ , C(=S)OR ⁷ ,

C(=NR ⁸ )R ⁶ , C(=0)N(R ⁸ )R ⁹ , C(=S)N(R ⁸ )R ⁹ , phenyl

which may be substituted with 1 , 2, 3, 4 or 5 radicals R ¹⁰ ; and a 3-, 4-, 5-, 6- or 7-membered heterocyclic ring,

wherein said heterocyclic ring

is saturated, partially unsaturated or aromatic,

comprises 1 , 2 or 3 heteroatoms or heteroatom groups selected from

N, O, S, NO, SO and S0 ₂ ,

is unsubstituted or substituted with one to five radicals R ¹⁰ , and wherein one or two CH ₂ groups in said saturated or partially saturated rings may be replaced by one or two C=0 groups; or R ^5c may form together with the adjacent carbon atom R ^5b or R ^5d a 5- or 6- membered ring which is at least substituted with one halogen in case of R ^5b beings involved;

R ^5d is selected from the group consisting of hydrogen, halogen, cyano, azido, nitro, SCN, SF ₅ , Ci-Cio-alkyl, C ₃ -C ₈ -cycloalkyl, C ₂ -Cio-alkenyl, C ₂ -Cio-alkynyl,

wherein the carbon atoms of the aforementioned aliphatic and cyclo- aliphatic radicals may be unsubstituted or substituted with one or more R ⁶ ; Si(R ¹¹ ) ₂ R ¹² , OR ⁷ , S(0) _m R ⁷ , S(0) _m N(R ⁸ )R ⁹ , N(R ⁸ )R ⁹ , N=C(R ⁶ ) ₂ , C(=0)R ⁶ , C(=S)R ⁶ , C(=NR ⁸ )R ⁶ , phenyl

which may be substituted with 1 , 2, 3, 4 or 5 radicals R ¹⁰ ;

and a 3-, 4-, 5-, 6- or 7-membered heterocyclic ring,

wherein said heterocyclic ring

is saturated, partially unsaturated or aromatic,

comprises 1 , 2 or 3 heteroatoms or heteroatom groups selected from N, O, S, NO, SO and S0 ₂ ,

is unsubstituted or substituted with one to five radicals R ¹⁰ , and wherein one or two CH ₂ groups in said saturated or partially saturated rings may be replaced by one or two C=0 groups; or R ^5d may form together with the adjacent carbon atom R ^5c or with R ¹ or R ² a 5- or 6-membered ring; is independently selectedselected independently from the group consisting of hydrogen, halogen, cyano, azido, nitro, SCN, SF ₅ , Ci-C6-alkyl, Ci-C6-alkoxy, Ci- C6-alkylthio, Ci-C6-alkylsulfinyl, Ci-C6-alkylsulfonyl, Cs-Cs-cycloalkyl, C3-C8- cycloalkyl-Ci-C4-alkyl, C2-C6-alkenyl, C2-C6-alkynyl,

wherein the carbon atom of the aforementioned aliphatic and cycloaliphatic radicals may be substituted with one or more R ^c ;

Si(R ¹¹ ) ₂ R ¹² , OR ⁰ , 0(CO)R ^c , 0(CS)R ^c , S(0) _m R°, S(0) _m N(R ⁿ ) ₂ , S(CO)R ^c , S(CS)R ^C , S(C=NR")R ^C , N(R") ₂ , N(R")C(=0)R ^c , N(R")C(=S)R ^C , NS(0) _m R°, N=C(R ^C ) ₂ , C(=0)R ^c , C(=S)R ^C , C(=NR")R ^C , C(=0)N(R ⁿ ) ₂ , C(=S)N(R") ₂ , phenyl

which may be substituted with 1 , 2, 3, 4 or 5 radicals R ¹⁰ ;

and a 3-, 4-, 5-, 6- or 7-membered heterocyclic ring,

wherein said heterocyclic ring

is saturated, partially unsaturated or aromatic,

comprises 1 , 2 or 3 heteroatoms or heteroatom groups selected from

N, O, S, NO, SO and S0 ₂ ,

is unsubstituted or substituted with one to five radicals R ¹⁰ , and wherein one or two CH ₂ groups in said saturated or partially saturated rings may be replaced by one or two C=0 groups; or two vicinally bound radicals R ⁶ together form a group selected from =C(R ^C ) ₂ , =S(0) _m R°, =S(0) _m N(R ⁿ ) ₂ , =NR ⁿ and =NN(R") ₂ ; is independently selectedselected independently from the group consisting of hydrogen, cyano, Ci-C6-alkyl, Ci-C6-alkoxy, Ci-C6-alkylthio, Ci-C6-alkylsulfinyl, Ci-C6-alkylsulfonyl, Cs-Cs-cycloalkyl, C3-Cs-cycloalkyl-Ci-C4-alkyl, C ₂ -C6-alkenyl, C ₂ -C6-alkynyl,

wherein the carbon atom of the aforementioned aliphatic and cycloaliphatic radicals may be substituted with one or more R ^c ;

Si(R ¹¹ ) ₂ R ¹² , OR ⁰ , 0(CO)R ^c , 0(CS)R ^c , S(0) _m R°, S(0) _m N(R ⁿ ) ₂ , S(CO)R ^c , S(CS)R ^C , S(C=NR")R ^C , N(R") ₂ , N(R")C(=0)R ^c , N(R")C(=S)R ^C , NS(0) _m R°, N=C(R ^C ) ₂ , C(=0)R ^c , C(=S)R ^C , C(=NR")R ^C , C(=0)N(R ⁿ ) ₂ , C(=S)N(R") ₂ , phenyl

which may be substituted with 1 , 2, 3, 4 or 5 radicals R ¹⁰ ;

and a 3-, 4-, 5-, 6- or 7-membered heterocyclic ring,

wherein said heterocyclic ring

is saturated, partially unsaturated or aromatic, comprises 1 , 2 or 3 heteroatoms or heteroatom groups selected from N, O, S, NO, SO and S0 ₂ ,

is unsubstituted or substituted with one to five radicals R ¹⁰ , and wherein one or two CH ₂ groups in said saturated or partially satu- rated rings may be replaced by one or two C=0 groups; with the proviso that R ⁷ is not Ci-C6-alkoxy or Ci-C6-haloalkoxy if it is bound to an oxygen atom;

R ⁸ , R ⁹ are selected independently from one another and independently of each occurrence from the group consisting of hydrogen, CN, NO2, Ci-C6-alkyl, Ci-C6-alkoxy, Ci-C6-alkylthio, Ci-C6-alkylsulfinyl, Ci-C6-alkylsulfonyl, Cs-Cs-cycloalkyl, C3-C8- cycloalkyl-Ci-C4-alkyl, C2-C6-alkenyl, C2-C6-alkynyl,

wherein the carbon atom of the aforementioned aliphatic and cycloaliphatic radicals may be substituted with one or more R ^c ;

Si(R ¹¹ ) ₂ R ¹² , OR ⁰ , 0(CO)R ^c , 0(CS)R ^c , S(0) _m R°, S(0) _m N(R ⁿ ) ₂ , S(CO)R ^c , S(CS)R ^C , S(C=NR")R ^C , N(R") ₂ , N(R")C(=0)R ^c , N(R")C(=S)R ^C , NS(0) _m R°, N=C(R ^C ) ₂ ,

C(=0)R ^c , C(=S)R ^C , C(=NR")R ^C , C(=0)N(R ⁿ ) ₂ , C(=S)N(R") ₂ phenyl

which may be substituted with 1 , 2, 3, 4 or 5 radicals R ¹⁰ ; and a 3-, 4-, 5-, 6- or 7-membered heterocyclic ring,

wherein said heterocyclic ring

is saturated, partially unsaturated or aromatic,

comprises 1 , 2 or 3 heteroatoms or heteroatom groups selected from N, O, S, NO, SO and S0 ₂ ,

is unsubstituted or substituted with one to five radicals R ¹⁰ , and wherein one or two CH ₂ groups in said saturated or partially saturated rings may be replaced by one or two C=0 groups;

R ¹⁰ is independently selectedselected independently from the group consisting of halogen, cyano, azido, nitro, SCN, SF ₅ , Ci-C6-alkyl, Ci-C6-alkoxy, Ci-C6-alkylthio,

Ci-C6-alkylsulfinyl, Ci-C6-alkylsulfonyl, Cs-Cs-cycloalkyl, C3-Cs-cycloalkyl-Ci-C4- alkyl, C ₂ -C6-alkenyl, C ₂ -C6-alkynyl,

wherein the carbon atom of the aforementioned aliphatic and cycloaliphatic radicals may be substituted with one or more R ^c ;

Si(R ¹¹ ) ₂ R ¹² , OR ⁰ , 0(CO)R ^c , 0(CS)R ^c , S(0) _m R°, S(0) _m N(R ⁿ ) ₂ , S(CO)R ^c , S(CS)R ^C ,

S(C=NR")R ^C , N(R") ₂ , N(R")C(=0)R ^c , N(R")C(=S)R ^C , NS(0) _m R°, N=C(R ^C ) ₂ ,

C(=0)R ^c , C(=S)R ^C , C(=NR")R ^C , C(=0)N(R ⁿ ) ₂ , C(=S)N(R") ₂ , phenyl which may be substituted with one to five radicals independently selectedselected independently from halogen, cyano, nitro, Ci-C6-alkyl, C1-C6- haloalkyl, Ci-C6-alkoxy and Ci-C6-haloalkoxy;

and a 3-, 4-, 5-, 6- or 7-membered heterocyclic ring,

wherein said heterocyclic ring

is saturated or unsaturated,

comprises 1 , 2 or 3 heteroatoms or heteroatom groups selected from N, O, S, NO, SO and S0 ₂ ,

is unsusbtituted or substituted with one to five radicals independently selectedselected independently from halogen, cyano, nitro, C1-C6- alkyl, Ci-C6-haloalkyl, Ci-C6-alkoxy and Ci-C6-haloalkoxy; or two radicals R ¹⁰ bound on adjacent atoms together form a group selected from -CH2CH2CH2CH2-, -CH=CH-CH=CH-, -N=CH-CH=CH-, -CH=N-CH=CH-, -N=CH-N=CH-, -OCH2CH2CH2-, -OCH=CHCH ₂ -, -CH ₂ OCH ₂ CH ₂ -, -OCH2CH2O-, -OCH ₂ OCH2-,-CH2CH ₂ CH2-, -CH=CHCH ₂ -, -CH2CH2O-, -CH=CHO-, -CH2OCH2-, -CH ₂ C(=0)0-, -C(=0)OCH ₂ -, -0(CH ₂ )0-, -SCH ₂ CH ₂ CH ₂ -, -SCH=CHCH ₂ -, -CH2SCH2CH2-, -SCH2CH2S-, -SCH2SCH2-, -CH2CH2S-, -CH=CHS-, -CH2SCH2-, -CH ₂ C(=S)S-, -C(=S)SCH ₂ -, -S(CH ₂ )S-, -CH ₂ CH ₂ NR ⁸ -, -CH ₂ CH=N-,

-CH=CH-NR ⁸ -, -OCH=N- and -SCH=N-,

wherein in each of the above groups,

one to five hydrogen atoms independently of each other may be replaced by one to five substituents selected from halogen, methyl, ha- lomethyl, hydroxyl, methoxy and halomethoxy, or

one or two or more CH2 groups of the above groups may be replaced by one or two C=0 groups;

R ¹¹ , R ¹² are selected independently of each other and independently of each occurrence from the group consisting of Ci-C4-alkyl, C3-C6-cycloalkyl, Ci-C4-alkoxy-Ci- C4-alkyl, phenyl and benzyl;

R ^c is independently selectedselected independently from the group consisting of hydrogen, halogen, cyano, azido, nitro, SCN, SF ₅ , Ci-C6-alkyl, Ci-C6-haloalkyl, Ci-C6-alkoxy, Ci-C6-haloalkoxy, Ci-C6-alkylthio, Ci-C6-haloalkylthio, C1-C6- alkylsulfinyl, Ci-C6-haloalkylsulfinyl, Ci-C6-alkylsulfonyl, Ci-C6-haloalkylsulfonyl,

Cs-Ce-cycloalkyI, C3-C8-cycloalkyl-Ci-C4-alkyl, Cs-Cs-halocycloalkyl, C2-C6- alkenyl, C2-C6-haloalkenyl, C2-C6-alkynyl, C2-C6-haloalkynyl, phenyl, and a 3-, 4-, 5-, 6- or 7-membered heterocyclic ring,

wherein said heterocyclic ring is saturated, partially unsaturated or aromatic,

comprises 1 , 2 or 3 heteroatoms or heteroatom groups selected from

CO, N , O, S, NO, SO and S0 ₂ ,

is unsubstituted or substituted with one to five radicals, which are se- lected independently of each other from halogen, cyano, nitro, C1-C4- alkyl, Ci-C4-haloalkyl, Ci-C4-alkoxy and Ci-C4-haloalkoxy; is independently selectedselected independently from the group consisting of hydrogen, cyano, Ci-C6-alkyl, Ci-C6-haloalkyl, Ci-C6-alkoxy, Ci-C6-haloalkoxy, Ci-C6-alkylthio, Ci-C6-haloalkylthio, Ci-C6-alkylsulfinyl, Ci-C6-haloalkylsulfinyl, Ci- C6-alkylsulfonyl, Ci-C6-haloalkylsulfonyl, Cs-Cs-cycloalkyl, C3-Cs-cycloalkyl-Ci-C4- alkyl, Cs-Cs-halocycloalkyl, C2-C6-alkenyl, C2-C6-haloalkenyl, C2-C6-alkynyl, C2- C6-haloalkynyl, phenyl, and a 3-, 4-, 5-, 6- or 7-membered heterocyclic ring, wherein said heterocyclic ring

is saturated, partially unsaturated or aromatic,

comprises 1 , 2 or 3 heteroatoms or heteroatom groups selected from

CO, N , O, S, NO, SO and S0 ₂ ,

is unsubstituted or substituted with one to five radicals, which are selected independently of each other from halogen, cyano, nitro, C1-C4- alkyl, Ci-C4-haloalkyl, Ci-C4-alkoxy and Ci-C4-haloalkoxy; with the proviso that R° is not Ci-C6-alkoxy or Ci-C6-haloalkoxy if it is bound to an oxygen atom; is independently selectedselected independently from the group consisting of hydrogen, CN, NO2, Ci-C6-alkyl, Ci-C6-haloalkyl, Ci-C6-alkoxy, Ci-C6-haloalkoxy, Ci-C6-alkylthio, Ci-C6-haloalkylthio, Ci-C6-alkylsulfinyl, Ci-C6-haloalkylsulfinyl, Ci- C6-alkylsulfonyl, Ci-C6-haloalkylsulfonyl, Cs-Cs-cycloalkyl, C3-Cs-cycloalkyl-Ci-C4- alkyl, Cs-Cs-halocycloalkyl, C2-C6-alkenyl, C2-C6-haloalkenyl, C2-C6-alkynyl, C2- C6-haloalkynyl, phenyl, and a 3-, 4-, 5-, 6- or 7-membered saturated heterocyclic ring,

wherein said heterocyclic ring

is saturated, partially unsaturated or aromatic,

comprises 1 , 2 or 3 heteroatoms or heteroatom groups selected from

CO, N, O, S, NO, SO and S0 ₂ ,

is unsubstituted or substituted with one to five radicals, which are selected independently of each other from halogen, cyano, nitro, C1-C4- alkyl, Ci-C4-haloalkyl, Ci-C4-alkoxy and Ci-C4-haloalkoxy; m is independently 0, 1 or 2;

p is 0, 1 , 2, 3 or 4;

or enantiomers or diastereoisomers thereof or their agriculturally or veterinarily acceptable salts.

The present invention also provides a composition comprising at least one compound of the formula I as defined herein and/or an agriculturally acceptable salt thereof and at least one inert solid/ liquid and/or solid carrier The present invention also provides an agricultural composition comprising at least one compound of the formula I as defined herein andr at least one agriculturally acceptable liquid and/or solid carrier.

The present invention also provides a veterinary composition comprising at least one compound of the formula I as defined herein and/or a veterinarily acceptable salt thereof and at least one liquid and/or solid carrier.

The present invention also provides a method for controlling or combating invertebrate pests attack or infestation which method comprises treating the pests, their food sup- ply, their habitat or their breeding ground or a cultivated plant, plant propagation materials (such as seed), soil, area, material or environment in which the pests are growing or may grow, with a pesticidally effective amount of at least one compound of formula I or salt thereof as defined herein. The present invention also relates to plant propagation material, in particular to seed, comprising at least one compound of formula I or an composition comprising a t least one compound of formula I or an agriculturally acceptable salt thereof as defined herein. The present invention further relates to a method for treating or protecting an animal from infestation or infection by parasites which comprises bringing the animal in contact with a parasiticidally effective amount of a compound of the formula I or a veterinarily acceptable salt thereof as defined herein. Bringing the animal in contact with the compound I, its salt or the veterinary composition of the invention means applying or ad- ministering it to the animal.

If used, the term "steroisomers" encompasses both optical isomers, such as

enantiomers or diastereomers, the latter existing due to more than one center of chirality in the molecule, as well as geometrical isomers (cis/trans isomers). Depending on the substitution pattern, the compounds of the formula I may have one or more centers of chirality, in which case they are present as mixtures of enantiomers or diastereomers. The invention provides both the pure enantiomers or diastereomers and their mixtures and the use according to the invention of the pure enantiomers or diastereomers of the compound I or its mixtures. Suitable compounds of the formula I also include all possible geometrical stereoisomers (cis/trans isomers) and mixtures thereof. Cis/trans isomers may be present with respect to an imine group. The compounds of the present invention may be amorphous or may exist in one ore more different crystalline states (polymorphs) which may have a different macroscopic properties such as stability or show different biological properties such as activities. The present invention includes both amorphous and crystalline compounds of the formula I , mixtures of different crystalline states of the respective compound I , as well as amorphous or crystalline salts thereof.

Salts of the compounds of the formula I are preferably agriculturally and veterinarily acceptable salts. They can be formed in a customary method, e.g. by reacting the compound with an acid of the anion in question if the compound of formula I has a ba- sic functionality or by reacting an acidic compound of formula I with a suitable base.

Suitable agriculturally acceptable salts are especially the salts of those cations or the acid addition salts of those acids whose cations and anions, respectively, do not have any adverse effect on the action of the compounds according to the present invention. Suitable cations are in particular the ions of the alkali metals, preferably lithium, sodium and potassium, of the alkaline earth metals, preferably calcium, magnesium and barium, and of the transition metals, preferably manganese, copper, zinc and iron, and also ammonium (NH ⁴⁺ ) and substituted ammonium in which one to four of the hydrogen atoms are replaced by Ci-C4-alkyl, Ci-C4-hydroxyalkyl, Ci-C4-alkoxy, Ci-C4-alkoxy- Ci-C4-alkyl, hydroxy-Ci-C4-alkoxy-Ci-C4-alkyl, phenyl or benzyl. Examples of substituted ammonium ions comprise methylammonium, isopropylammonium, dimethylam- monium, diisopropylammonium, trimethylammonium, tetramethylammonium, tetra- ethylammonium, tetrabutylammonium, 2-hydroxyethylammonium, 2-(2-hydroxy- ethoxy)ethylammonium, bis(2-hydroxyethyl)ammonium, benzyltrimethylammonium and benzl-triethylammonium, furthermore phosphonium ions, sulfonium ions, preferably tri(Ci-C4-alkyl)sulfonium, and sulfoxonium ions, preferably tri(Ci-C4-alkyl)sulfoxonium.

Anions of useful acid addition salts are primarily chloride, bromide, fluoride, hydrogen sulfate, sulfate, dihydrogen phosphate, hydrogen phosphate, phosphate, nitrate, hy- drogen carbonate, carbonate, hexafluorosilicate, hexafluorophosphate, benzoate, and the anions of Ci-C4-alkanoic acids, preferably formate, acetate, propionate and bu- tyrate. They can be formed by reacting a compound of formula I with an acid of the corresponding anion, preferably of hydrochloric acid, hydrobromic acid, sulfuric acid, phosphoric acid or nitric acid.

By the term "veterinarily acceptable salts" is meant salts of those cations or anions which are known and accepted in the art for the formation of salts for veterinary use. Suitable acid addition salts, e.g. formed by compounds of formula I containing a basic nitrogen atom, e.g. an amino group, include salts with inorganic acids, for example hydrochloride, sulphates, phosphates, and nitrates and salts of organic acids for example acetic acid, maleic acid, dimaleic acid, fumaric acid, difumaric acid, methane sulfenic acid, methane sulfonic acid, and succinic acid. The term "invertebrate pest" as used herein encompasses animal populations, such as insects, arachnids and nematodes, which may attack plants, thereby causing substantial damage to the plants attacked, as well as ectoparasites which may infest animals, in particular warm blooded animals such as e.g. mammals or birds, or other higher animals such as reptiles, amphibians or fish, thereby causing substantial damage to the animals infested.

The term "plant propagation material" as used herein includes all the generative parts of the plant such as seeds and vegetative plant material such as cuttings and tubers (e. g. potatoes), which can be used for the multiplication of the plant. This includes seeds, roots, fruits, tubers, bulbs, rhizomes, shoots, sprouts and other parts of plants. Seedlings and young plants, which are to be transplanted after germination or after emergence from soil, may also be included. These plant propagation materials may be treated prophylactically with a plant protection compound either at or before planting or transplanting.

The term "plants" comprises any types of plants including "non-cultivated plants" and in particular "cultivated plants".

The term "non-cultivated plants" refers to any wild type species or related species or related genera of a cultivated plant.

The term "cultivated plants" as used herein includes plants which have been modified by breeding, mutagenesis or genetic engineering. Genetically modified plants are plants, which genetic material has been so modified by the use of recombinant DNA techniques that under natural circumstances cannot readily be obtained by cross breeding, mutations or natural recombination. Typically, one or more genes have been integrated into the genetic material of a genetically modified plant in order to improve certain properties of the plant. Such genetic modifications also include but are not lim- ited to targeted post-transtional modification of protein(s) (oligo- or polypeptides) poly for example by glycosylation or polymer additions such as prenylated, acetylated or farnesylated moieties or PEG moieties (e.g. as disclosed in Biotechnol Prog. 2001 Jul- Aug;17(4):720-8., Protein Eng Des Sel. 2004 Jan;17(1 ):57-66, Nat. Protoc.

2007;2(5):1225-35., Curr. Opin. Chem. Biol. 2006 Oct; 10(5):487-91 . Epub 2006 Aug 28., Biomaterials. 2001 Mar; 22(5):405-17, Bioconjug Chem. 2005 Jan-Feb;16(1 ):1 13- 21 ).

The term "cultivated plants" as used herein further includes plants that have been rendered tolerant to applications of specific classes of herbicides, such as hy- droxy-phenylpyruvate dioxygenase (HPPD) inhibitors; acetolactate synthase (ALS) inhibitors, such as sulfonyl ureas (see e. g. US 6,222,100, WO 01/82685, WO

00/26390, WO 97/41218, WO 98/02526, WO 98/02527, WO 04/106529, WO 05/20673, WO 03/14357, WO 03/13225, WO 03/14356, WO 04/16073) or imidazolinones (see e. g. US 6,222,100, WO 01/82685, WO 00/26390, WO 97/41218, WO 98/02526, WO 98/02527, WO 04/106529, WO 05/20673, WO 03/14357, WO 03/13225, WO 03/14356, WO 04/16073); enolpyruvylshikimate-3-phosphate synthase (EPSPS) inhibitors, such as glyphosate (see e. g. WO 92/00377); glutamine synthetase (GS) inhibitors, such as glufosinate (see e. g. EP-A-0242236, EP-A-242246) or oxynil herbicides (see e. g. US 5,559,024) as a result of conventional methods of breeding or genetic engineering. Several cultivated plants have been rendered tolerant to herbicides by conventional methods of breeding (mutagenesis), for example Clearfield ^® summer rape (Canola) being tolerant to imidazolinones, e. g. imazamox. Genetic engineering methods have been used to render cultivated plants, such as soybean, cotton, corn, beets and rape, tolerant to herbicides, such as glyphosate and glufosinate, some of which are commercially available under the trade names RoundupReady ^® (glyphosate) and LibertyLink ^® (glufosinate).

The term "cultivated plants" as used herein further includes plants that are by the use of recombinant DNA techniques capable to synthesize one or more insecticidal pro- teins, especially those known from the bacterial genus bacillus, particularly from bacillus thuringiensis, such as a-endotoxins, e. g. CrylA(b), CrylA(c), CrylF, CrylF(a2), Cry- IIA(b), CrylllA, CrylllB(bl ) or Cry9c; vegetative insecticidal proteins (VIP), e. g. VIP1 , VIP2, VIP3 or VIP3A; insecticidal proteins of bacteria colonizing nematodes, for example Photorhabdus spp. or Xenorhabdus spp.; toxins produced by animals, such as scorpion toxins, arachnid toxins, wasp toxins, or other insect-specific neurotoxins; toxins produced by fungi, such Streptomycetes toxins, plant lectins, such as pea or barley lectins; agglutinins; proteinase inhibitors, such as trypsin inhibitors, serine protease inhibitors, patatin, cystatin or papain inhibitors; ribosome-inactivating proteins (RIP), such as ricin, maize-RIP, abrin, luffin, saporin or bryodin; steroid metabolism enzymes, such as 3-hydroxysteroid oxidase, ecdysteroid-IDP-glycosyl-transferase, cholesterol oxidases, ecdysone inhibitors or HMG-CoA-reductase; ion channel blockers, such as blockers of sodium or calcium channels; juvenile hormone esterase; diuretic hormone receptors (helicokinin receptors); stilben synthase, bibenzyl synthase, chitinases or glucanases. In the context of the present invention these insecticidal proteins or toxins are to be understood expressly also as pre-toxins, hybrid proteins, truncated or otherwise modified proteins. Hybrid proteins are characterized by a new combination of protein domains, (see, for example WO 02/015701 ). Further examples of such toxins or genetically modified plants capable of synthesizing such toxins are disclosed, for ex- ample, in EP-A 374 753, WO 93/007278, WO 95/34656, EP-A 427 529, EP-A 451 878, WO 03/018810 und WO 03/052073. These insecticidal proteins contained in the genetically modified plants impart to the plants producing these proteins protection from harmful pests from certain taxonomic groups of arthropods insects, particularly to beetles (Coleoptera), flies (Diptera), and butterflies and moths (Lepidoptera) and to plant parasitic nematodes (Nematoda).

The term "cultivated plants" as used herein further includes plants that are by the use of recombinant DNA techniques capable to synthesize one or more proteins to increase the resistance or tolerance of those plants to bacterial, viral or fungal patho- gens. Examples of such proteins are the so-called "pathogenesis-related proteins" (PR proteins, see, for example EP-A 0 392 225), plant disease resistance genes (for example potato cultivars, which express resistance genes acting against Phytophthora in- festans derived from the mexican wild potato Solanum bulbocastanum) or T4-lyso-zym (e. g. potato cultivars capable of synthesizing these proteins with increased resistance against bacteria such as Erwinia amylvora).

The term "cultivated plants" as used herein further includes plants that are by the use of recombinant DNA techniques capable to synthesize one or more proteins to increase the productivity (e. g. bio mass production, grain yield, starch content, oil con- tent or protein content), tolerance to drought, salinity or other growth limiting envi- ron-mental factors or tolerance to pests and fungal, bacterial or viral pathogens of those plants.

The term "cultivated plants" as used herein further includes plants that contain by the use of recombinant DNA techniques a modified amount of substances of content or new substances of content, specifically to improve human or animal nutrition, for example oil crops that produce health-promoting long-chain omega-3 fatty acids or unsaturated omega-9 fatty acids (e. g. Nexera ^® rape).

The term "cultivated plants" as used herein further includes plants that contain by the use of recombinant DNA techniques a modified amount of substances of content or new substances of content, specifically to improve raw material production, for example potatoes that produce increased amounts of amylopectin (e. g. Amflora ^® potato).

The organic moieties mentioned in the above definitions of the variables are - like the term halogen - collective terms for individual listings of the individual group members. The prefix C _n -C _m indicates in each case the possible number of carbon atoms in the group.

The term halogen denotes in each case fluorine, bromine, chlorine or iodine, in particular fluorine, chlorine or bromine.

The term "Ci-Cio-alkyl" as used herein and in the alkyl moieties of alkoxy, alkylthio, alkylsulfinyl, alkylsulfonyl, alkylcarbonyl, alkoxycarbonyl and the like refers to saturated straight-chain or branched hydrocarbon radicals having 1 to 2 ("Ci-C2-alkyl"), 1 to 4 ("Ci-C ₄ -alkyl"), 1 to 6 ("Ci-C ₆ -alkyl"), 1 to 8 ("Ci-C ₈ -alkyl") or 1 to 10 ("Ci-Cio-alkyl") carbon atoms. Ci-C2-alkyl is methyl or ethyl. Ci-C ₄ -alkyl is additionally propyl, isopro- pyl, butyl, 1 -methylpropyl (sec-butyl), 2-methylpropyl (isobutyl) or 1 ,1 -dimethylethyl (tert-butyl). Ci-C6-alkyl is additionally also, for example, pentyl, 1 -methylbutyl, 2- methylbutyl, 3-methylbutyl, 2,2-dimethylpropyl, 1 -ethylpropyl, 1 ,1 -dimethylpropyl, 1 ,2- dimethylpropyl, hexyl, 1 -methylpentyl, 2-methylpentyl, 3-methylpentyl, 4-methylpentyl, 1 ,1 -dimethylbutyl, 1 ,2-dimethylbutyl, 1 ,3-dimethylbutyl, 2,2-dimethylbutyl, 2,3-dime- thylbutyl, 3,3-dimethylbutyl, 1 -ethylbutyl, 2-ethylbutyl, 1 ,1 ,2-trimethylpropyl, 1 ,2,2-tri- methylpropyl, 1 -ethyl-1 -methylpropyl, or 1 -ethyl-2-methylpropyl. Ci-Cs-alkyl is additionally also, for example, heptyl, octyl, 2-ethylhexyl and positional isomers thereof. C1-C10- alkyl is additionally also, for example, nonyl, decyl and positional isomers thereof.

The term "Ci-Cio-haloalkyl" as used herein, which is also expressed as "Ci-Cio-alkyl which is partially or fully halogenated", refers to straight-chain or branched alkyl groups having 1 to 2 ("Ci-C ₂ -haloalkyl"), 1 to 4 ("Ci-C ₄ -haloalkyl"), 1 to 6 ("Ci-C ₆ -haloalkyl"), 1 to 8 ("Ci-Cs-haloalkyl") or 1 to 10 ("Ci-Cio-haloalkyl") carbon atoms (as mentioned above), where some or all of the hydrogen atoms in these groups are replaced by halogen atoms as mentioned above: in particular Ci-C2-haloalkyl, such as chloro- methyl, bromomethyl, dichloromethyl, trichloromethyl, fluoromethyl, difluoromethyl, trifluoromethyl, chlorofluoromethyl, dichlorofluoromethyl, chlorodifluoromethyl, 1 - chloroethyl, 1 -bromoethyl, 1 -fluoroethyl, 2-fluoroethyl, 2,2-difluoroethyl, 2,2,2- trifluoroethyl, 2-chloro-2-fluoroethyl, 2-chloro-2,2-difluoroethyl, 2,2-dichloro-2- fluoroethyl, 2,2,2-trichloroethyl, pentafluoroethyl or 1 ,1 ,1 -trifl uoroprop-2-yl .

"Halomethyl" is methyl in which 1 , 2 or 3 of the hydrogen atoms are replaced by halogen atoms. Examples are bromomethyl, chloromethyl, fluoromethyl, dichloromethyl, trichloromethyl, difluoromethyl, trifluoromethyl, chlorofluoromethyl, dichlorofluoromethyl, chlorodifluoromethyl and the like.

The term "C2-Cio-alkenyl" as used herein and in the alkenyl moiety of alkenyloxy and the like refers to monounsaturated straight-chain or branched hydrocarbon radicals having 2 to 4 ("C ₂ -C ₄ -alkenyl"), 2 to 6 ("C ₂ -C ₆ -alkenyl"), 2 to 8 ("C ₂ -C ₈ -alkenyl"), 3 to 8 ("Cs-Ce-alkenyl"), 2 to 10 ("C ₂ -Cio-alkenyl") or 3 to 10 ("C ₃ -Cio-alkenyl") carbon atoms and a double bond in any position, for example C ₂ -C ₄ -alkenyl, such as ethenyl, 1 - propenyl, 2-propenyl, 1 -methylethenyl, 1 -butenyl, 2-butenyl, 3-butenyl, 1 -methyl-1 - propenyl, 2-methyl-1 -propenyl, 1 -methyl-2-propenyl or 2-methyl-2-propenyl; C ₂ -C6- alkenyl, such as ethenyl, 1 -propenyl, 2-propenyl, 1-methylethenyl, 1 -butenyl, 2-butenyl, 3-butenyl, 1 -methyl-1 -propenyl, 2-methyl-1 -propenyl, 1 -methyl-2-propenyl, 2-methyl-2- propenyl, 1 -pentenyl, 2-pentenyl, 3-pentenyl, 4-pentenyl, 1 -methyl-1 -butenyl,

2- methyl-1 -butenyl, 3-methyl-1 -butenyl, 1 -methyl-2-butenyl, 2-methyl-2-butenyl,

3- methyl-2-butenyl, 1 -methyl-3-butenyl, 2-methyl-3-butenyl, 3-methyl-3-butenyl,

1 ,1 -dimethyl-2-propenyl, 1 ,2-dimethyl-1 -propenyl, 1 ,2-dimethyl-2-propenyl, 1 -ethyl-1 - propenyl, 1 -ethyl-2-propenyl, 1 -hexenyl, 2-hexenyl, 3-hexenyl, 4-hexenyl, 5-hexenyl, 1 - methyl-1 -pentenyl, 2-methyl-1 -pentenyl, 3-methyl-1 -pentenyl, 4-methyl-1 -pentenyl, 1 - methyl-2-pentenyl, 2-methyl-2-pentenyl, 3-methyl-2-pentenyl, 4-methyl-2-pentenyl, 1 - methyl-3-pentenyl, 2-methyl-3-pentenyl, 3-methyl-3-pentenyl, 4-methyl-3-pentenyl, 1 - methyl-4-pentenyl, 2-methyl-4-pentenyl, 3-methyl-4-pentenyl, 4-methyl-4-pentenyl, 1 ,1 - dimethyl-2-butenyl, 1 ,1 -dimethyl-3-butenyl, 1 ,2-dimethyl-1 -butenyl, 1 ,2-dimethyl-2- butenyl, 1 ,2-dimethyl-3-butenyl, 1 ,3-dimethyl-1 -butenyl, 1 ,3-dimethyl-2-butenyl, 1 ,3- dimethyl-3-butenyl, 2,2-dimethyl-3-butenyl, 2,3-dimethyl-1 -butenyl, 2,3-dimethyl-2- butenyl, 2,3-dimethyl-3-butenyl, 3,3-dimethyl-1 -butenyl, 3,3-dimethyl-2-butenyl, 1 -ethyl-1 -butenyl, 1 -ethyl-2-butenyl, 1 -ethyl-3-butenyl, 2-ethyl-1 -butenyl,

2-ethyl-2-butenyl, 2-ethyl-3-butenyl, 1 ,1 ,2-trimethyl-2-propenyl,

1 -ethyl-1 -methyl-2-propenyl, 1 -ethyl-2-methyl-1 -propenyl, 1 -ethyl-2-methyl-2-propenyl and the like, or C ₂ -Cio-alkenyl, such as the radicals mentioned for C ₂ -C6-alkenyl and additionally 1 -heptenyl, 2-heptenyl, 3-heptenyl, 1 -octenyl, 2-octenyl, 3-octenyl, 4- octenyl, 1 -nonenyl, 2-nonenyl, 3-nonenyl, 4-nonenyl, 1 -decenyl, 2-decenyl, 3-decenyl, 4-decenyl, 5-decenyl and the positional isomers thereof.

The term "C2-Cio-haloalkenyl" as used herein, which is also expressed as "C1-C10- alkenyl which is partially or fully halogenated", and the haloalkenyl moieties in haloal- kenyloxy, haloalkenylcarbonyl and the like refers to unsaturated straight-chain or branched hydrocarbon radicals having 2 to 4 ("C2-C4-haloalkenyl"), 2 to 6 ("C2-C6- haloalkenyl"), 2 to 8 ("C ₂ -C ₆ -haloalkenyl") or 2 to 10 ("C ₂ -Cio-haloalkenyl") carbon atoms and a double bond in any position (as mentioned above), where some or all of the hydrogen atoms in these groups are replaced by halogen atoms as mentioned above, in particular fluorine, chlorine and bromine, for example chlorovinyl, chloroallyl and the like.

The term "C2-Cio-alkynyl" as used herein and the alkynyl moieties in alkynyloxy, al- kynylcarbonyl and the like refers to straight-chain or branched hydrocarbon groups having 2 to 4 ("C ₂ -C ₄ -alkynyl"), 2 to 6 ("C ₂ -C ₆ -alkynyl"), 2 to 8 ("C ₂ -C ₈ -alkynyl"), 3 to 8 ("Cs-Ce-alkynyl"), 2 to 10 ("C ₂ -Cio-alkynyl") or 3 to 10 ("C ₃ -C ₈ -alkynyl") carbon atoms and one or two triple bonds in any position, for example C2-C ₄ -alkynyl, such as ethynyl,

1 - propynyl, 2-propynyl, 1 -butynyl, 2-butynyl, 3-butynyl, 1 -methyl-2-propynyl and the like, C2-C6-alkynyl, such as ethynyl, 1 -propynyl, 2-propynyl, 1 -butynyl, 2-butynyl, 3- butynyl, 1 -methyl-2-propynyl, 1 -pentynyl, 2-pentynyl, 3-pentynyl, 4-pentynyl, 1 -methyl-

2- butynyl, 1 -methyl-3-butynyl, 2-methyl-3-butynyl, 3-methyl-1 -butynyl, 1 ,1 -dimethyl-2- propynyl, 1 -ethyl-2-propynyl, 1 -hexynyl, 2-hexynyl, 3-hexynyl, 4-hexynyl, 5-hexynyl, 1 - methyl-2-pentynyl, 1 -methyl-3-pentynyl, 1 -methyl-4-pentynyl, 2-methyl-3-pentynyl, 2- methyl-4-pentynyl, 3-methyl-1 -pentynyl, 3-methyl-4-pentynyl, 4-methyl-1 -pentynyl, 4- methyl-2-pentynyl, 1 ,1 -dimethyl-2-butynyl, 1 ,1 -dimethyl-3-butynyl, 1 ,2-dimethyl-3- butynyl, 2,2-dimethyl-3-butynyl, 3,3-dimethyl-1 -butynyl, 1 -ethyl-2-butynyl, 1 -ethyl-3- butynyl, 2-ethyl-3-butynyl, 1 -ethyl-1 -methyl-2-propynyl and the like; The term "C2-Cio-haloalkynyl" as used herein, which is also expressed as "C1-C10- alkynyl which is partially or fully halogenated", and the haloalkynyl moieties in haloal- kynyloxy, haloalkynylcarbonyl and the like refers to unsaturated straight-chain or branched hydrocarbon radicals having 2 to 4 ("C2-C ₄ -haloalkynyl"), 3 to 4 ("C3-C4- haloalkynyl"), 2 to 6 ("C ₂ -C ₆ -haloalkynyl"), 3 to 6 ("C ₃ -C ₆ -haloalkynyl"), 2 to 8 ("C ₂ -C ₈ - haloalkynyl"), 3 to 8 ("C ₃ -C ₈ -haloalkynyl"), 2 to 10 ("C ₂ -Cio-haloalkynyl") or 3 to 10 ("C ₃ - Cio-haloalkynyl") carbon atoms and one or two triple bonds in any position (as mentioned above), where some or all of the hydrogen atoms in these groups are replaced by halogen atoms as mentioned above, in particular fluorine, chlorine and bromine; The term "Cs-Cs-cycloalkyl" as used herein refers to mono- or bi- or polycyclic saturated hydrocarbon radicals having 3 to 8, in particular 3 to 6 carbon atoms ("C3-C6- cycloalkyl"). Examples of monocyclic radicals having 3 to 6 carbon atoms comprise cyclopropyl, cyclobutyl, cyclopentyl and cyclohexyl. Examples of monocyclic radicals having 3 to 8 carbon atoms comprise cyclopropyl, cyclobutyl, cyclopentyl, cyclohexyl, cycloheptyl and cyclooctyl. Examples of bicyclic radicals having 7 or 8 carbon atoms comprise bicyclo[2.2.1 ]heptyl, bicyclo[3.1 .1]heptyl, bicyclo[2.2.2]octyl and

bicyclo[3.2.1 ]octyl. The term "Cs-Cs-halocycloalkyl" as used herein, which is also expressed as "Cs-Cs- cycloalkyl which is partially or fully halogenated", and the halocycloalkyl moieties in halocycloalkoxy, halocycloalkylcarbonyl and the like refers to mono- or bi- or polycyclic saturated hydrocarbon groups having 3 to 8 ("Cs-Cs-halocycloalkyl" ) or preferably 3 to 6 ("C3-C6-halocycloalkyl") carbon ring members (as mentioned above) in which some or all of the hydrogen atoms are replaced by halogen atoms as mentioned above, in particular fluorine, chlorine and bromine.

The term "C3-Cs-cycloalkyl-Ci-C4-alkyl" refers to a Cs-Cs-cycloalkyl group as defined above which is bound to the remainder of the molecule via a Ci-C4-alkyl group, as defined above. Examples are cyclopropylmethyl, cyclopropylethyl, cyclopropylpropyl, cyclobutylmethyl, cyclobutylethyl, cyclobutylpropyl, cyclopentylmethyl,

cycloppentylethyl, cyclopentylpropyl, cyclohexylmethyl, cyclohexylethyl,

cyclohexylpropyl, and the like. The term "Ci-C2-alkoxy" is a Ci-C2-alkyl group, as defined above, attached via an oxygen atom. The term "Ci-C4-alkoxy" is a Ci-C4-alkyl group, as defined above, attached via an oxygen atom. The term "Ci-C6-alkoxy" is a Ci-C6-alkyl group, as defined above, attached via an oxygen atom. The term "Ci-Cio-alkoxy" is a Ci-Cio-alkyl group, as defined above, attached via an oxygen atom. Ci-C2-alkoxy is methoxy or ethoxy. Ci-C4-alkoxy is additionally, for example, n-propoxy, 1 -methylethoxy

(isopropoxy), butoxy, 1 -methylpropoxy (sec-butoxy), 2-methylpropoxy (isobutoxy) or 1 ,1 -dimethylethoxy (tert-butoxy). Ci-C6-alkoxy is additionally, for example, pentoxy, 1 - methylbutoxy, 2-methylbutoxy, 3-methylbutoxy, 1 ,1 -dimethylpropoxy, 1 ,2- dimethylpropoxy, 2,2-dimethylpropoxy, 1 -ethylpropoxy, hexoxy, 1 -methylpentoxy, 2- methylpentoxy, 3-methylpentoxy, 4-methylpentoxy, 1 ,1 -dimethylbutoxy, 1 ,2- dimethylbutoxy, 1 ,3-dimethylbutoxy, 2,2-dimethylbutoxy, 2,3-dimethylbutoxy,

3,3-dimethylbutoxy, 1 -ethylbutoxy, 2-ethylbutoxy, 1 ,1 ,2-trimethylpropoxy, 1 ,2,2- trimethylpropoxy, 1 -ethyl-1 -methylpropoxy or 1 -ethyl-2-methylpropoxy. Ci-Cs-alkoxy is additionally, for example, heptyloxy, octyloxy, 2-ethylhexyloxy and positional isomers thereof. Ci-Cio-alkoxy is additionally, for example, nonyloxy, decyloxy and positional isomers thereof.

The term "Ci-C2-haloalkoxy" is a Ci-C2-haloalkyl group, as defined above, attached via an oxygen atom. The term "Ci-C4-haloalkoxy" is a Ci-C4-haloalkyl group, as defined above, attached via an oxygen atom. The term "Ci-C6-haloalkoxy" is a Ci-C6-haloalkyl group, as defined above, attached via an oxygen atom. The term "Ci-Cio-haloalkoxy" is a Ci-Cio-haloalkyl group, as defined above, attached via an oxygen atom. C1-C2- Haloalkoxy is, for example, OCH ₂ F, OCHF ₂ , OCF ₃ , OCH ₂ CI, OCHC , OCCI ₃ , chlorofluoromethoxy, dichlorofluoromethoxy, chlorodifluoromethoxy, 2-fluoroethoxy, 2- chloroethoxy, 2-bromoethoxy, 2-iodoethoxy, 2,2-difluoroethoxy, 2,2,2-trifluoroethoxy, 2- chloro-2-fluoroethoxy, 2-chloro-2,2-difluoroethoxy, 2,2-dichloro-2-fluoroethoxy,

2,2,2-trichloroethoxy or OC2F5. Ci-C4-Haloalkoxy is additionally, for example,

2- fluoropropoxy, 3-fluoropropoxy, 2,2-difluoropropoxy, 2,3-difluoropropoxy,

2-chloropropoxy, 3-chloropropoxy, 2,3-dichloropropoxy, 2-bromopropoxy,

3- bromopropoxy, 3,3,3-trifluoropropoxy, 3,3,3-trichloropropoxy, OCH2-C2F5, OCF2- C2F5, 1 -(CH ₂ F)-2-fluoroethoxy, 1 -(CH ₂ CI)-2-chloroethoxy, 1 -(CH ₂ Br)-2-bromoethoxy,

4- fluorobutoxy, 4-chlorobutoxy, 4-bromobutoxy or nonafluorobutoxy. Ci-C6-Haloalkoxy is additionally, for example, 5-fluoropentoxy, 5-chloropentoxy, 5-brompentoxy,

5-iodopentoxy, undecafluoropentoxy, 6-fluorohexoxy, 6-chlorohexoxy, 6-bromohexoxy, 6-iodohexoxy or dodecafluorohexoxy.

The term "Ci-C2-alkylthio" is a Ci-C2-alkyl group, as defined above, attached via a sulfur atom. The term "Ci-C4-alkylthio" is a Ci-C4-alkyl group, as defined above, attached via a sulfur atom. The term "Ci-C6-alkylthio" is a Ci-C6-alkyl group, as defined above, attached via a sulfur atom. The term "Ci-Cio-alkylthio" is a Ci-Cio-alkyl group, as defined above, attached via a sulfur atom. Ci-C2-alkylthio is methylthio or ethylthio. Ci-C4-alkylthio is additionally, for example, n-propylthio, 1 -methylethylthio

(isopropylthio), butylthio, 1 -methylpropylthio (sec-butylthio), 2-methylpropylthio

(isobutylthio) or 1 ,1 -dimethylethylthio (tert-butylthio). Ci-C6-alkylthio is additionally, for example, pentylthio, 1 -methylbutylthio, 2-methylbutylthio, 3-methylbutylthio, 1 ,1 - dimethylpropylthio, 1 ,2-dimethylpropylthio, 2,2-dimethylpropylthio, 1 -ethylpropylthio, hexylthio, 1 -methylpentylthio, 2-methylpentylthio, 3-methylpentylthio, 4- methylpentylthio, 1 ,1 -dimethylbutylthio, 1 ,2-dimethylbutylthio, 1 ,3-dimethylbutylthio, 2,2-dimethylbutylthio, 2,3-dimethylbutylthio, 3,3-dimethylbutylthio, 1 -ethylbutylthio, 2- ethylbutylthio, 1 ,1 ,2-trimethylpropylthio, 1 ,2,2-trimethylpropylthio, 1 -ethyl-1 - methylpropylthio or 1 -ethyl-2-methylpropylthio. Ci-Cs-alkylthio is additionally, for example, heptylthio, octylthio, 2-ethylhexylthio and positional isomers thereof. C1-C10- alkylthio is additionally, for example, nonylthio, decylthio and positional isomers thereof. The term "Ci-C2-haloalkylthio" is a Ci-C2-haloalkyl group, as defined above, attached via a sulfur atom. The term "Ci-C4-haloalkylthio" is a Ci-C4-haloalkyl group, as defined above, attached via a sulfur atom. The term "Ci-C6-haloalkylthio" is a Ci-C6-haloalkyl group, as defined above, attached via a sulfur atom. The term "Ci-Cio-haloalkylthio" is a Ci-Cio-haloalkyl group, as defined above, attached via a sulfur atom. C1-C2- haloalkylthio is, for example, SCH ₂ F, SCHF ₂ , SCF ₃ , SCH ₂ CI, SCHC , SCCI ₃ , chlorofluoromethylthio, dichlorofluoromethylthio, chlorodifluoromethylthio, 2- fluoroethylthio, 2-chloroethylthio, 2-bromoethylthio, 2-iodoethylthio, 2,2- difluoroethylthio, 2,2,2-trifluoroethylthio, 2-chloro-2-fluoroethylthio, 2-chloro-2,2- difluoroethylthio, 2,2-dichloro-2-fluoroethylthio, 2,2,2-trichloroethylthio or SC ₂ F ₅ . C1-C4- Haloalkylthio is additionally, for example, 2-fluoropropylthio, 3-fluoropropylthio, 2,2- difluoropropylthio, 2,3-difluoropropylthio, 2-chloropropylthio, 3-chloropropylthio, 2,3- dichloropropylthio, 2-bromopropylthio, 3-bromopropylthio, 3,3,3-trifluoropropylthio, 3,3,3-trichloropropylthio, SCH2-C2F5, SCF2-C2F5, 1-(CH ₂ F)-2-fluoroethylthio, 1 -(CH ₂ CI)- 2-chloroethylthio, 1 -(CH ₂ Br)-2-bromoethylthio, 4-fluorobutylthio, 4-chlorobutylthio, 4- bromobutylthio or nonafluorobutylthio. Ci-C6-Haloalkylthio is additionally, for example, 5-fluoropentylthio, 5-chloropentylthio, 5-brompentylthio, 5-iodopentylthio,

undecafluoropentylthio, 6-fluorohexylthio, 6-chlorohexylthio, 6-bromohexylthio, 6- iodohexylthio or dodecafluorohexylthio.

The term "Ci-C2-a I kylsu If i nyl " is a Ci-C2-alkyl group, as defined above, attached via a sulfinyl [S(O)] group. The term "Ci-C4-alkylsulfinyl" is a Ci-C4-alkyl group, as defined above, attached via a sulfinyl [S(O)] group. The term "Ci-C6-alkylsulfinyl" is a C1-C6- alkyl group, as defined above, attached via a sulfinyl [S(O)] group. The term "C1-C10- alkylsulfinyl" is a Ci-Cio-alkyl group, as defined above, attached via a sulfinyl [S(O)] group. Ci-C2-Alkylsulfinyl is methylsulfinyl or ethylsulfinyl. Ci-C4-Alkylsulfinyl is additionally, for example, n-propylsulfinyl, 1 -methylethylsulfinyl (isopropylsulfinyl), butylsulfinyl, 1 -methylpropylsulfinyl (sec-butylsulfinyl), 2-methylpropylsulfinyl

(isobutylsulfinyl) or 1 ,1 -dimethylethylsulfinyl (tert-butylsulfinyl). Ci-C6-Alkylsulfinyl is additionally, for example, pentylsulfinyl, 1 -methylbutylsulfinyl, 2-methylbutylsulfinyl, 3- methylbutylsulfinyl, 1 ,1 -dimethylpropylsulfinyl, 1 ,2-dimethylpropylsulfinyl,

2,2-dimethylpropylsulfinyl, 1 -ethylpropylsulfinyl, hexylsulfinyl, 1 -methylpentylsulfinyl, 2- methylpentylsulfinyl, 3-methylpentylsulfinyl, 4-methylpentylsulfinyl, 1 ,1 - dimethylbutylsulfinyl, 1 ,2-dimethylbutylsulfinyl, 1 ,3-dimethylbutylsulfinyl, 2,2- dimethylbutylsulfinyl, 2,3-dimethylbutylsulfinyl, 3,3-dimethylbutylsulfinyl,

1 -ethylbutylsulfinyl, 2-ethylbutylsulfinyl, 1 ,1 ,2-trimethylpropylsulfinyl, 1 ,2,2- trimethylpropylsulfinyl, 1 -ethyl-1 -methylpropylsulfinyl or 1 -ethyl-2-methylpropylsulfinyl. Ci-Ce-Alkylsulfinyl is additionally, for example, heptylsulfinyl, octylsulfinyl, 2- ethylhexylsulfinyl and positional isomers thereof. Ci-Cio-Alkylsulfinyl is additionally, for example, nonylsulfinyl, decylsulfinyl and positional isomers thereof.

The term "Ci-C2-haloalkylsulfinyl" is a Ci-C2-haloalkyl group, as defined above, attached via a sulfinyl [S(O)] group. The term "Ci-C4-haloalkylsulfinyl" is a C1-C4- haloalkyl group, as defined above, attached via a sulfinyl [S(O)] group. The term "Ci- C6-haloalkylsulfinyl" is a Ci-C6-haloalkyl group, as defined above, attached via a sulfinyl [S(O)] group. The term "Ci-Cio-haloalkylsulfinyl" is a Ci-Cio-haloalkyl group, as defined above, attached via a sulfinyl [S(O)] group. Ci-C2-Haloalkylsulfinyl is, for example, S(0)CH ₂ F, S(0)CHF ₂ , S(0)CF ₃ , S(0)CH ₂ CI, S(0)CHCI ₂ , S(0)CCI ₃ , chlorofluoromethylsulfinyl, dichlorofluoromethylsulfinyl, chlorodifluoromethylsulfinyl, 2- fluoroethylsulfinyl, 2-chloroethylsulfinyl, 2-bromoethylsulfinyl, 2-iodoethylsulfinyl, 2,2- d if I uoroethylsulf i nyl , 2,2,2-trifluoroethylsulfinyl, 2-chloro-2-fluoroethylsulfinyl, 2-chloro- 2,2-difluoroethylsulfinyl, 2,2-dichloro-2-fluoroethylsulfinyl, 2,2,2-trichloroethylsulfinyl or S(0)C2F ₅ . Ci-C4-Haloalkylsulfinyl is additionally, for example, 2-fluoropropylsulfinyl, 3- fluoropropylsulfinyl, 2,2-difluoropropylsulfinyl, 2,3-difluoropropylsulfinyl,

2-chloropropylsulfinyl, 3-chloropropylsulfinyl, 2,3-dichloropropylsulfinyl, 2- bromopropylsulfinyl, 3-bromopropylsulfinyl, 3,3,3-trifluoropropylsulfinyl, 3,3,3- trichloropropylsulfinyl, S(0)CH ₂ -C ₂ F ₅ , S(0)CF ₂ -C ₂ F ₅ , 1 -(CH ₂ F)-2-fluoroethylsulfinyl, 1 - (CH ₂ CI)-2-chloroethylsulfinyl, 1 -(CH ₂ Br)-2-bromoethylsulfinyl, 4-fluorobutylsulfinyl, 4- chlorobutylsulfinyl, 4-bromobutylsulfinyl or nonafluorobutylsulfinyl. C1-C6- Haloalkylsulfinyl is additionally, for example, 5-fluoropentylsulfinyl, 5- chloropentylsulfinyl, 5-brompentylsulfinyl, 5-iodopentylsulfinyl,

undecafluoropentylsulfinyl, 6-fluorohexylsulfinyl, 6-chlorohexylsulfinyl, 6- bromohexylsulfinyl, 6-iodohexylsulfinyl or dodecafluorohexylsulfinyl.

The term "Ci-C2-alkylsulfonyl" is a Ci-C2-alkyl group, as defined above, attached via a sulfonyl [S(0)2] group. The term "Ci-C4-alkylsulfonyl" is a Ci-C4-alkyl group, as defined above, attached via a sulfonyl [S(0)2] group. The term "Ci-C6-alkylsulfonyl" is a C1-C6- alkyl group, as defined above, attached via a sulfonyl [S(0)2] group. The term "C1-C10- alkylsulfonyl" is a Ci-Cio-alkyl group, as defined above, attached via a sulfonyl [S(0)2] group. Ci-C2-Alkylsulfonyl is methylsulfonyl or ethylsulfonyl. Ci-C4-Alkylsulfonyl is additionally, for example, n-propylsulfonyl, 1 -methylethylsulfonyl (isopropylsulfonyl), butylsulfonyl, 1 -methylpropylsulfonyl (sec-butylsulfonyl), 2-methylpropylsulfonyl (isobutylsulfonyl) or 1 ,1 -dimethylethylsulfonyl (tert-butylsulfonyl). Ci-C6-Alkylsulfonyl is additionally, for example, pentylsulfonyl, 1 -methylbutylsulfonyl, 2-methylbutylsulfonyl, 3- methylbutylsulfonyl, 1 ,1 -dimethylpropylsulfonyl, 1 ,2-dimethylpropylsulfonyl,

2,2-dimethylpropylsulfonyl, 1 -ethylpropylsulfonyl, hexyl sulfonyl, 1 -methylpentylsulfonyl, 2-methylpentylsulfonyl, 3-methylpentylsulfonyl, 4-methylpentylsulfonyl, 1 ,1 - dimethylbutylsulfonyl, 1 ,2-dimethylbutylsulfonyl, 1 ,3-dimethylbutylsulfonyl, 2,2- dimethylbutylsulfonyl, 2,3-dimethylbutylsulfonyl, 3,3-dimethylbutylsulfonyl,

1 - ethylbutylsulfonyl, 2-ethylbutylsulfonyl, 1 ,1 ,2-trimethylpropylsulfonyl, 1 ,2,2- trimethylpropylsulfonyl, 1 -ethyl-1 -methylpropylsulfonyl or 1 -ethyl-2- methylpropylsulfonyl. d-Cs-Alkylsulfonyl is additionally, for example, heptylsulfonyl, octylsulfonyl, 2-ethylhexylsulfonyl and positional isomers thereof. Ci-Cio-Alkylsulfonyl is additionally, for example, nonylsulfonyl, decylsulfonyl and positional isomers thereof.

The term "Ci-C2-haloalkylsulfonyl" is a Ci-C2-haloalkyl group, as defined above, attached via a sulfonyl [S(0)2] group. The term "Ci-C4-haloalkylsulfonyl" is a Ci-C ₄ - haloalkyl group, as defined above, attached via a sulfonyl [S(0)2] group. The term "Ci- C6-haloalkylsulfonyl" is a Ci-C6-haloalkyl group, as defined above, attached via a sulfonyl [S(0)2] group. The term "Ci-Cio-haloalkylsulfonyl" is a Ci-Cio-haloalkyl group, as defined above, attached via a sulfonyl [S(0)2] group. Ci-C2-Haloalkylsulfonyl is, for example, S(0) ₂ CH ₂ F, S(0) ₂ CHF ₂ , S(0) ₂ CF ₃ , S(0) ₂ CH ₂ CI, S(0) ₂ CHCI ₂ , S(0) ₂ CCI ₃ , chlorofluoromethylsulfonyl, dichlorofluoromethylsulfonyl, chlorodifluoromethylsulfonyl,

2- fluoroethylsulfonyl, 2-chloroethylsulfonyl, 2-bromoethylsulfonyl, 2-iodoethylsulfonyl, 2,2-difluoroethylsulfonyl, 2,2,2-trifluoroethylsulfonyl, 2-chloro-2-fluoroethylsulfonyl, 2- chloro-2,2-difluoroethylsulfonyl, 2,2-dichloro-2-fluoroethylsulfonyl,

2,2,2-trichloroethylsulfonyl or S(0) ₂ C ₂ F ₅ . Ci-C ₄ -Haloalkylsulfonyl is additionally, for example, 2-fluoropropylsulfonyl, 3-fluoropropylsulfonyl, 2,2-difluoropropylsulfonyl, 2,3- difluoropropylsulfonyl, 2-chloropropylsulfonyl, 3-chloropropylsulfonyl, 2,3- dichloropropylsulfonyl, 2-bromopropylsulfonyl, 3-bromopropylsulfonyl, 3,3,3- trifluoropropylsulfonyl, 3,3,3-trichloropropylsulfonyl, S(0) ₂ CH2-C2F ₅ , S(0)2CF2-C ₂ F ₅ , 1 - (CH ₂ F)-2-fluoroethylsulfonyl, 1 -(CH ₂ CI)-2-chloroethylsulfonyl, 1 -(CH ₂ Br)-2- bromoethylsulfonyl, 4-fluorobutylsulfonyl, 4-chlorobutylsulfonyl, 4-bromobutylsulfonyl or nonafluorobutylsulfonyl. Ci-C6-Haloalkylsulfonyl is additionally, for example, 5- fluoropentylsulfonyl, 5-chloropentylsulfonyl, 5-brompentylsulfonyl, 5-iodopentylsulfonyl, undecafluoropentylsulfonyl, 6-fluorohexylsulfonyl, 6-chlorohexylsulfonyl, 6- bromohexylsulfonyl, 6-iodohexylsulfonyl or dodecafluorohexylsulfonyl.

The term "3-, 4-, 5-, 6- or 7-membered saturated, partially unsaturated or aromatic heterocyclic ring containing 1 , 2 or 3 heteroatoms or heteroatom groups (if one or two or at most three heteroatoms of the heterocyclic ring are oxidzed) selected from N, O, S, NO, SO and SO2, as ring members" as used herein refers to monocyclic radicals, the monocyclic radicals being saturated, partially unsaturated or aromatic. The heterocyclic radical may be attached to the remainder of the molecule via a carbon ring member or via a nitrogen ring member. Examples of 3-, 4-, 5-, 6- or 7-membered saturated heterocyclic ring include:

Oxiranyl, aziridinyl, azetidinyl, 2-tetrahydrofuranyl, 3-tetrahydrofuranyl,

2-tetrahydrothienyl, 3-tetrahydrothienyl, 2-pyrrolidinyl, 3-pyrrolidinyl, 3-pyrazolidinyl,

4- pyrazolidinyl, 5-pyrazolidinyl, 2-imidazolidinyl, 4-imidazolidinyl, 2-oxazolidinyl, 4- oxazolidinyl, 5-oxazolidinyl, 3-isoxazolidinyl, 4-isoxazolidinyl, 5-isoxazolidinyl,

2- thiazolidinyl, 4-thiazolidinyl, 5-thiazolidinyl, 3-isothiazolidinyl, 4-isothiazolidinyl,

5- isothiazolidinyl, 1 ,2,4-oxadiazolidin-3-yl, 1 ,2,4-oxadiazolidin-5-yl, 1 ,2,4-thiadiazolidin-

3- yl, 1 ,2,4-thiadiazolidin-5-yl, 1 ,2,4-triazolidin-3-yl, 1 ,3,4-oxadiazolidin-2-yl,

1 ,3,4-thiadiazolidin-2-yl, 1 ,3,4-triazolidin-2-yl, 2-tetrahydropyranyl, 4-tetrahydropyranyl, 1 ,3-dioxan-5-yl, 1 ,4-dioxan-2-yl, 2-piperidinyl, 3-piperidinyl, 4-piperidinyl, 3- hexahydropyridazinyl, 4-hexahydropyridazinyl, 2-hexahydropyrimidinyl, 4- hexahydropyrimidinyl, 5-hexahydropyrimidinyl, 2-piperazinyl, 1 ,3,5-hexahydrotriazin-2- yl and 1 ,2,4-hexahydrotriazin-3-yl, 2-morpholinyl, 3-morpholinyl, 2-thiomorpholinyl, 3- thiomorpholinyl, 1 -oxothiomorpholin-2-yl, 1 -oxothiomorpholin-3-yl, 1 ,1 - dioxothiomorpholin-2-yl, 1 ,1 -dioxothiomorpholin-3-yl, hexahydroazepin-1 -, -2-, -3- or -4- yl, hexahydrooxepinyl, hexahydro-1 ,3-diazepinyl, hexahydro-1 ,4-diazepinyl, hexahydro- 1 ,3-oxazepinyl, hexahydro-1 ,4-oxazepinyl, hexahydro-1 ,3-dioxepinyl, hexahydro-1 ,4- dioxepinyl and the like. Examples of 3-, 4-, 5-, 6- or 7-membered partially unsaturated heterocyclic ring include: 2,3-dihydrofur-2-yl, 2,3-dihydrofur-3-yl, 2,4-dihydrofur-2-yl, 2,4-dihydrofur-3-yl, 2,3- dihydrothien-2-yl, 2,3-dihydrothien-3-yl, 2,4-dihydrothien-2-yl, 2,4-dihydrothien-3-yl, 2- pyrrolin-2-yl, 2-pyrrolin-3-yl, 3-pyrrolin-2-yl, 3-pyrrolin-3-yl, 2-isoxazolin-3-yl, 3- isoxazolin-3-yl, 4-isoxazolin-3-yl, 2-isoxazolin-4-yl, 3-isoxazolin-4-yl, 4-isoxazolin-4-yl, 2-isoxazolin-5-yl, 3-isoxazolin-5-yl, 4-isoxazolin-5-yl, 2-isothiazolin-3-yl, 3-isothiazolin- 3-yl, 4-isothiazolin-3-yl, 2-isothiazolin-4-yl, 3-isothiazolin-4-yl, 4-isothiazolin-4-yl, 2- isothiazolin-5-yl, 3-isothiazolin-5-yl, 4-isothiazolin-5-yl, 2,3-dihydropyrazol-1 -yl, 2,3- dihydropyrazol-2-yl, 2,3-dihydropyrazol-3-yl, 2,3-dihydropyrazol-4-yl, 2,3- dihydropyrazol-5-yl, 3,4-dihydropyrazol-1 -yl, 3,4-dihydropyrazol-3-yl, 3,4- dihydropyrazol-4-yl, 3,4-dihydropyrazol-5-yl, 4,5-dihydropyrazol-1 -yl, 4,5- dihydropyrazol-3-yl, 4,5-dihydropyrazol-4-yl, 4,5-dihydropyrazol-5-yl, 2,3- dihydrooxazol-2-yl, 2,3-dihydrooxazol-3-yl, 2,3-dihydrooxazol-4-yl, 2,3-dihydrooxazol-5- yl, 3,4-dihydrooxazol-2-yl, 3,4-dihydrooxazol-3-yl, 3,4-dihydrooxazol-4-yl, 3,4- dihydrooxazol-5-yl, 3,4-dihydrooxazol-2-yl, 3,4-dihydrooxazol-3-yl, 3,4-dihydrooxazol-4- yl, 2-, 3-, 4-, 5- or 6-di- or tetrahydropyridinyl, 3-di- or tetrahydropyridazinyl, 4-di- or tetrahydropyridazinyl, 2-di- or tetrahydropyrimidinyl, 4-di- or tetrahydropyrimidinyl, 5-di- or tetrahydropyrimidinyl, di- or tetrahydropyrazinyl, 1 ,3, 5-di- or tetrahydrotriazin-2-yl, 1 ,2,4-di- or tetrahydrotriazin-3-yl, 2,3,4,5-tetrahydro[1 H]azepin-1 -, -2-, -3-, -4-, -5-, -6- or -7-yl, 3,4,5,6-tetrahydro[2H]azepin-2-, -3-, -4-, -5-, -6- or -7-yl, 2,3,4,7-tetrahydro[1 H]azepin-1 -, -2-, -3-, -4-, -5-, -6- or -7-yl,

2,3,6,7-tetrahydro[1 H]azepin-1 -, -2-, -3-, -4-, -5-, -6- or -7-yl, tetrahydrooxepinyl, such as 2,3,4,5-tetrahydro[1 H]oxepin-2-, -3-, -4-, -5-, -6- or -7-yl,

2,3,4,7-tetrahydro[1 H]oxepin-2-, -3-, -4-, -5-, -6- or -7-yl, 2,3,6,7-tetrahydro[1 H]oxepin- 2-, -3-, -4-, -5-, -6- or -7-yl, tetrahydro-1 ,3-diazepinyl, tetrahydro-1 ,4-diazepinyl, tetrahydro-1 ,3-oxazepinyl, tetrahydro-1 ,4-oxazepinyl, tetrahydro-1 ,3-dioxepinyl and tetrahydro-1 ,4-dioxepinyl.

3-, 4-, 5-, 6- or 7-membered aromatic heterocyclic ring is 5- or 6-membered aromatic heterocyclic (hetaryl). Examples are: 2-furyl, 3-furyl, 2-thienyl, 3-thienyl, 2-pyrrolyl, 3- pyrrolyl, 3-pyrazolyl, 4-pyrazolyl, 5-pyrazolyl, 2-oxazolyl, 4-oxazolyl, 5-oxazolyl, 2- thiazolyl, 4-thiazolyl, 5-thiazolyl, 2-imidazolyl, 4-imidazolyl, 1 ,3,4-triazol-2-yl, 2-pyridinyl, 3-pyridinyl, 4-pyridinyl, 3-pyridazinyl, 4-pyridazinyl, 2-pyrimidinyl, 4-pyrimidinyl, 5- pyrimidinyl and 2-pyrazinyl.

The remarks made below concerning preferred embodiments of the variables of the compounds of formula I, especially with respect to their substituents A ¹ , A ² , A ³ , A ⁴ , R ¹ . R2, R ³ , R ⁴ , R ^5a , R ^5b , R ^5c , R ^5d , R ⁶ , R ⁷ , R ⁸ , R ⁹ , R ¹⁰ , R ¹¹ , R ¹² , R ^c , R", R°, m, and p the features of the use and method according to the invention and of the composition of the invention are valid both on their own and, in particular, in every possible combination with each other.

The radical A when used in the text is as following defined:

A (I)

wherein # denotes the binding site to the remainder of formula I

and wherein the variables p, R ³ , R ⁴ , A ¹ , A ² , A ³ and A ⁴ are as defined in formula I. As a matter of course, the p radicals R ⁴ replace a hydrogen atom on a carbon ring atom. For instance, if A ¹ , A ² , A ³ or A ⁴ is defined to be CH and if this position is to be substituted by a radical R ⁴ , then A ¹ , A ² , A ³ or A ⁴ is of course a substituted C-R ⁴ . If there is more than one radical R ⁴ , these substituents R ⁴ can be the same or different.

Preferably, at most two of A ¹ , A ² , A ³ and A ⁴ are N.

In a preferred embodiment, A ¹ , A ² , A ³ and A ⁴ are CR ⁴ . In the case that more than one substituent R ⁴ is present in the radical A, the different R ⁴ are selected independently from each other. In case p is 2, the two substituents R ⁴ are preferably bound on the position of A ¹ and A ² . In case p is 1 , the substituent R ⁴ is preferably bound on the position of A ¹ or A ² .

In analogy to the above cited meaning of A, A ³ and A ⁴ are respectively equivalent to A ² and A ¹ and thus have the same definition of preferencies.

Preferably, three of A ¹ , A ² , A ³ and A ⁴ are CH and the remaining radical is a substituted CR ⁴ . Even more preferably, A ² , A ³ , A ⁴ and A ¹ are CH .

In one embodiment,

R ³ is selected from the group consisting of of hydrogen, halogen, cyano, azido, nitro, SCN , SF ₅ , Ci-Cio-alkyl, C ₃ -C ₈ -cycloalkyl, C ₂ -Cio-alkenyl, C ₂ -Cio-alkynyl,

wherein the carbon atoms of the aforementioned aliphatic and cyclo- aliphatic radicals may be unsubstituted or substituted with one or more R ⁶ ; Si(R ^{1 1} ) ₂ R ¹² , OR ⁷ , S(0) _m R ⁷ , N(R ⁸ )R ⁹ , N=C(R ⁶ ) ₂ , C(=0)R ⁶ , C(=S)R ⁶ , C(=N R ⁸ )R ⁶ , phenyl which may be substituted by 1 , 2, 3, 4 or 5 radicals R ¹⁰ ; and

a 3-, 4-, 5-, 6- or 7-membered heterocyclic ring,

wherein said heterocyclic ring

is saturated, partially unsaturated or aromatic,

comprises 1 , 2 or 3 heteroatoms or heteroatom groups selected from N , O, S, NO, SO and S0 ₂ ,

is unsubstituted or substituted by one to five radicals R ¹⁰ and wherein one or two CH ₂ groups in said saturated or partially saturated heterocyclic rings may be replaced by one or two C=0 groups.

In another embodiement, R ³ is selected from the group consisting of hydrogen, halogen, cyano, azido, nitro, SCN, SF ₅ , Ci-C6-alkyl, C3-C6-cycloalkyl, Ci-C6-alkoxy, C1-C6- cycloalkoxy wherein the last four mentioned radicals are preferably at least substituted by one halogen, Si(R ¹¹ ) ₂ R ¹² , OR ⁷ , S(0) _m R ⁷ , N(R ⁸ )R ⁹ , N=C(R ⁶ ) ₂ , C(=0)R ⁶ , C(=S)R ⁶ and C(=NR ⁸ )R ⁶ . Within these embodiements, R ³ is preferably selected from the group consisting of hydrogen, halogen, cyano, nitro, SR ⁷ , Ci-C6-alkyl, C3-C6-cycloalkyl, Ci-C6-alkoxy and C3- C6-cycloalkoxy wherein the four last mentioned group are preferably at least substituted by one halogen and wherein the five last mentioned radicals may be substituted by one to five radicals R ⁶ .

More preferably, R ³ is selected from the group consisting of halogen, cyano, nitro, Ci- C6-alkyl, Ci-C6-alkoxy wherein the two last mentioned radicals are at least substituted by one halogen.

Even more preferably, R ³ is selected from the group consisting of fluorine, chlorine, bromine, iodine, cyano, N0 ₂ , CF ₃ , CHF ₂ , CH ₂ F, CF ₂ CI, CFC , CCI ₃ , OCF ₃ , OCHF ₂ and

More particularly, R ³ is preferably fluorine or chlorine or bromine. In an embodiment,

R ⁴ is selected independently from the group consisting of hydrogen, halogen, cyano, azido, nitro, SCN, SF ₅ , Ci-Cio-alkyl, Cs-Cs-cycloalkyl, C2-Cio-alkenyl, C2-C10- alkynyl, wherein the carbon atoms of the aforementioned aliphatic and cyclo- aliphatic radicals may be unsubstituted or substituted with one or more R ⁶ ;

Si(R ¹¹ ) ₂ R ¹² , OR ⁷ , S(0) _m R ⁷ , N(R ⁸ )R ⁹ , N=C(R ⁶ ) ₂ , C(=0)R ⁶ , C(=S)R ⁶ , C(=NR ⁸ )R ⁶ , C(=0)N(R ⁸ )R ⁹ , C(=S)N(R ⁸ )R ⁹ , phenyl which may be substituted by 1 , 2, 3, 4 or 5 radicals R ¹⁰ ; and

a 3-, 4-, 5-, 6- or 7-membered heterocyclic ring,

wherein said heterocyclic ring

is saturated or partially unsaturated or aromatic,

comprises 1 , 2 or 3 heteroatoms or heteroatom groups selected from N, O, S, NO, SO and S0 ₂

is unsubstituted or substituted by one to five radicals R ¹⁰ and

wherein one or two CH2 groups in said saturated or partially saturated heterocyclic rings may be replaced by one or two C=0 groups; or two radicals R ⁴ bound on adjacent carbon atoms together form a group selected from -CH2CH2CH2CH2-, -CH=CH-CH=CH-, -N=CH-CH=CH-,

-CH=N-CH=CH-, -N=CH-N=CH-, -OCH2CH2CH2-, -OCH=CHCH ₂ -,

-CH2OCH2CH2-, -OCH2CH2O-, -OCH2OCH2-, -CH2CH2CH2-, -CH=CHCH ₂ -,

-CH2CH2O-, -CH=CHO-, -CH2OCH2-, -CH ₂ C(=0)0-, -C(=0)OCH ₂ -, -0(CH ₂ )0-, -SCH2CH2CH2-, -SCH=CHCH ₂ -, -CH2SCH2CH2-, -SCH2CH2S-, -SCH2SCH2-, -CH2CH2S-, -CH=CHS-, -CH2SCH2-, -CH ₂ C(=S)S-, -C(=S)SCH ₂ -, -S(CH ₂ )S-,

-CH ₂ CH ₂ NR ⁸ -,-CH ₂ CH=N-, -CH=CH-NR ⁸ -, -OCH=N- and -SCH=N-, wherein in each of the above groups one to five hydrogen atoms may be replaced by one to five substitu- ents selected from halogen, methyl, halomethyl, hydroxyl, methoxy and halomethoxy or one or two CH2 groups of the above groups may be replaced by one or two C=0 groups.

In another embodiment,

R ⁴ is selected from the group consisting of hydrogen, halogen, cyano, azido, nitro, SCN, SF ₅ , Ci-Cio-alkyl, C ₃ -C ₈ -cycloalkyl, C ₂ -Cio-alkenyl, C ₂ -Cio-alkynyl,

wherein the carbon atoms of the aforementioned aliphatic and cyclo- aliphatic radicals may be unsubstituted or substituted with one or more R ⁶ ; Si(R ¹¹ ) ₂ R ¹² , OR ⁷ , S(0) _m R ⁷ , N(R ⁸ )R ⁹ , N=C(R ⁶ ) ₂ , C(=0)R ⁶ , C(=S)R ⁶ , C(=NR ⁸ )R ⁶ , C(=0)N(R ⁸ )R ⁹ , C(=S)N(R ⁸ )R ⁹ , phenyl,

which may be substituted by 1 , 2, 3, 4 or 5 radicals R ¹⁰ ; and

a 3-, 4-, 5-, 6- or 7-membered heterocyclic ring,

wherein said heterocyclic ring

is saturated or partially unsaturated or aromatic,

comprises 1 , 2 or 3 heteroatoms or heteroatom groups selected from N, O, S, NO, SO and S0 ₂ ,

is unssubstituted or substituted by one to five radicals R ¹⁰ and wherein one or two CH2 groups in said saturated or partially saturated rings may be replaced by one or two C=0 groups.

In a further embodiment,

R ⁴ is selected from the group consisting of hydrogen, halogen, cyano, azido, nitro, SCN, SF ₅ , Ci-Cio-alkyl, C ₃ -C ₈ -cycloalkyl, C ₂ -Cio-alkenyl, C ₂ -Cio-alkynyl,

wherein the carbon atoms of the aforementioned aliphatic and cyclo- aliphatic radicals may be unsubstituted or substituted with one or more R ⁶ ; Si(R ¹¹ ) ₂ R ¹² , OR ⁷ , S(0) _m R ⁷ , N(R ⁸ )R ⁹ , N=C(R ⁶ ) ₂ , C(=0)R ⁶ , C(=S)R ⁶ , C(=NR ⁸ )R ⁶ , C(=0)N(R ⁸ )R ⁹ and C(=S)N(R ⁸ )R ⁹ .

Within these embodiments, R ⁴ is preferably selected from the group consisting of hydrogen, halogen, cyano, nitro, Ci-C6-alkyl, C3-C6-cycloalkyl, Ci-C6-alkoxy and C1-C6- cycloalkoxy wherein the four last mentioned radicals if substituted are preferably substituted by one halogen and wherein the five last mentioned groups may be substituted by one to five radicals R ⁶ . More preferably, R ⁴ is selected from the group consisting of hydrogen, halogen, cyano, nitro, Ci-C6-alkyl and Ci-C6-haloalkyl.

Even more preferably, R ⁴ is selected from the group consisting of hydrogen, fluorine, chlorine, bromine, iodine, CF3 and CHF2.

More particularly, R ⁴ is hydrogen.

Examples of suitable radicals A are the radicals numbered A1a1 to A1a98 which are radicals of the formula A as above depicted wherein A ² , A ³ , A ⁴ are CH, A ¹ is CR ⁴ , and R ⁴ and R ³ are as defined in one row of the following Table B (radicals A1a1 to A1a98)

Table B:

Radical R ³ R ⁴ Radical R ³ R ⁴ Radical R ³ R ⁴ A A A

A1a1 F H A1a22 CHF ₂ F A1a43 F Br

A1a2 CI H A1a23 CH ₂ F F A1a44 CI Br

A1a3 Br H A1a24 CF2CI F A1a45 Br Br

A1a4 I H A1a25 CFCb F A1a46 I Br

A1a5 CN H A1a26 CCIs F A1a47 CN Br

A1a6 N0 ₂ H A1a27 OCHF2 F A1a48 N0 ₂ Br

A1a7 CF ₃ H A1a28 SCFs F A1a49 CF ₃ Br

A1a8 CHF ₂ H A1a29 F CI A1a50 CHF ₂ Br

A1a9 CH ₂ F H A1a30 CI CI A1a51 CH2F Br

A1a10 CF2CI H A1a31 Br CI A1a52 CF2CI Br

A1a11 CFC H A1a32 I CI A1a53 CFCb Br

A1a12 CCIs H A1a33 CN CI A1a54 CCIs Br

A1a13 OCHF2 H A1a34 N0 ₂ CI A1a55 OCHF2 Br

A1a14 SCFs H A1a35 CF ₃ CI A1a56 SCFs Br

A1a15 F F A1a36 CHF ₂ CI A1a57 F CN

A1a16 CI F A1a37 CH2F CI A1a58 CI CN

A1a17 Br F A1a38 CF2CI CI A1a59 Br CN

A1a18 I F A1a39 CFCb CI A1a60 I CN

A1a19 CN F A1a40 CCIs CI A1a61 CN CN

A1a20 N0 ₂ F A1a41 OCHF2 CI A1a62 N0 ₂ CN

A1a21 CF ₃ F A1a42 SCFs CI A1a63 CFs CN Radical R ³ R ⁴ Radical R ³ R ⁴ Radical R ³ R ⁴ A A A

A1a64 CHF ₂ CN A1a76 N0 ₂ Me A1a88 I CFs

A1a65 CH ₂ F CN A1a77 CFs Me A1a89 CN CFs

A1a66 CF2CI CN A1a78 CHF ₂ Me A1a90 N0 ₂ CFs

A1a67 CFC CN A1a79 CH ₂ F Me A1a91 CFs CFs

A1a68 CCIs CN A1a80 CF2CI Me A1a92 CHF ₂ CFs

A1a69 OCHF2 CN A1a81 CFCb Me A1a93 CH ₂ F CFs

A1a70 SCFs CN A1a82 CCIs Me A1a94 CF2CI CFs

A1a71 F Me A1a83 OCHF2 Me A1a95 CFCb CFs

A1a72 CI Me A1a84 SCFs Me A1a96 CCIs CFs

A1a73 Br Me A1a85 F CFs A1a97 OCHF2 CFs

A1a74 I Me A1a86 CI CFs A1a98 SCFs CFs

A1a75 CN Me A1a87 Br CFs

Analog to the above listed Table B, further examples of suitable radicals A are the radicals of the formula A numbered A1a99 to A1a197 wherein A ¹ , A ³ , A ⁴ are CH, A ² is CR ⁴ , and R ⁴ and R ³ for each radical A have the meaning of one line in Table B.

In a particular embodiment of the invention, each example of radical A numbered A1 a1 to A1 a 197 is a preferred radical A in formula I.

In an embodiment,

R ^5a is selected from the group consisting of hydrogen, halogen, cyano, azido, nitro, - SCN, SF ₅ , Ci-Cio-alkyl, C ₃ -C ₈ -cycloalkyl, C ₂ -Cio-alkenyl, C ₂ -Cio-alkynyl,

wherein the carbon atoms of the aforementioned aliphatic and cyclo- aliphatic radicals may be unsubstituted or substituted with one or more R ⁶ , Si(R ¹¹ ) ₂ R ¹² , OR ⁷ , S(0) _m R ⁷ , N(R ⁸ )R ⁹ , N=C(R ⁶ ) ₂ , C(=0)R ⁶ , C(=S)R ⁶ , C(=NR ⁸ )R ⁶ , phenyl,

which may be substituted by 1 , 2, 3, 4 or 5 radicals R ¹⁰ ;

and a 3-, 4-, 5-, 6- or 7-membered heterocyclic ring

wherein said heterocyclic ring

is saturated or partially unsaturated or aromatic,

comprises 1 , 2 or 3 heteroatoms or heteroatom groups selected from

N, O, S, NO, SO and S0 ₂ ,

is unsubstituted or substituted by one to five radicals R ¹⁰ , and wherein one or two CH2 groups in said saturated or partially saturated rings may be by one or two C=0 groups; or R ^5a may form together with the adjacent carbon atom R ^5b a 5- or 6-membered ring which is at least substituted by one halogen.

More preferably,

R ^5a is selected from the group consisting of hydrogen, halogen, cyano, azido, nitro, Ci-Cio-alkyl, Cs-Cs-cycloalkyl, C2-Cio-alkenyl, C2-Cio-alkynyl,

wherein the carbon atoms of the aforementioned aliphatic and cyclo- aliphatic radicals may be unsubstituted or substituted with one or more R ⁶ ; Si(R ¹¹ ) ₂ R ¹² , OR ⁷ , S(0) _m R ⁷ , N(R ⁸ )R ⁹ , N=C(R ⁶ ) ₂ , C(=0)R ⁶ , C(=S)R ⁶ and

C(=NR ⁸ )R ⁶ .

More preferably, R ^5a is selected from the group consisting of hydrogen, halogen, cyano, nitro, SCF3, SOCF3, Ci-C6-alkyl, C3-C6-cycloalkyl, Ci-C6-alkoxy and Ci-Ce- cycloalkoxy wherein the last four mentioned radicals may be substituted by one halo- gen.

More preferably, R ^5a is selected from the group consisting of hydrogen, halogen, cyano, nitro, Ci-C6-alkyl, C3-C6-cycloalkyl, Ci-C6-alkoxy (e.g. OCF3, OCHF2,

OCF2CHF2) and Ci-C6-cycloalkoxy wherein the five last mentioned group may be sub- stituted by halogen.

Even more preferably, R ^5a is selected from the group consisting of hydrogen, halogen, Ci-C6-alkyl and Ci-C6-haloalkyl. Even more preferably, R ^5a is selected from the group consisting of hydrogen, fluorine, chlorine, bromine, iodine, CH ₃ , CF ₃ , CHF ₂ , CH ₂ F, CF ₂ CI, CFCI2 and CCI ₃ .

Even more preferably, R ^5a is selected from the group consisting of hydrogen, fluorine, chlorine, bromine, iodine, CF3 and CHF2.

More particularly, R ^5a is hydrogen. In a embodiment,

R ^5b is selected from the group consisting of Ci-C6-alkyl, C3-C6-cycloalkyl, C1-C6- alkoxy and Ci-C6-cycloalkoxy, wherein each mentioned radical

is at least substituted with one halogen,

may be further partially or fully halogenated and

may be substituted with one to five radicals R ⁶ ; or may form together with the adjacent carbon atom R ^5c or R ^5a a 5- or 6-membered ring which is at least substituted with one halogen.

Within the above embodiment, R ^5b is preferably selected from the group consisting of Ci-C6-alkyl, C3-C6-cycloalkyl, Ci-C6-alkoxy and Ci-C6-cycloalkoxy and wherein each mentioned radical is at least substituted with one halogen.

Within the above embodiments, R ^5b is preferably selected from the group consisting of Ci-C6-haloalkyl and Ci-C6-haloalkoxy.

Even more preferably, R ^5b is selected from the group consisting of CF3, CHF2, CH2F, CF2F3, CF(CF ₃ ) ₂ , COH(CF ₃ ) ₂ , CF2CI, CFCI2, CCIs, OCF3, OCHF2, OCF2CF3,

OCF2CHF2, OCF(CF ₃ ) ₂ ,OCF ₂ CI, OCFC and OCCI ₃ .

Even more preferably, R ^5b is selected from the group consisting of CF3, CHF2, CF2F3 CF(CF ₃ ) ₂ , COH(CF ₃ ) ₂ , CF2CI, CFCI2, CCI3, OCF3, OCHF2, OCF2CF3, OCF2CHF2, OCF(CF ₃ ) ₂ ,OCF ₂ CI, OCFCb and OCCI ₃ .

More particularly, R ^5b is CF3.

Preferably, R ^5c is selected from the group consisting of hydrogen, halogen, Ci-C6-alkyl, C3-C8-cycloalkyl, C2-C6-alkenyl and C2-C6-alkynyl, wherein the last four mentioned groups may be partially or fully halogenated and/or may be substituted with one to five radicals R ⁶ .

More preferably, R ^5c is selected from the group consisting of hydrogen, halogen, Ci- C6-alkyl and Ci-C6-haloalkyl.

More particularly, R ^5c is hydrogen.

Preferably, R ^5d is selected from the group consisting of hydrogen, halogen, Ci-C6-alkyl, C3-C8-cycloalkyl, C2-C6-alkenyl and C2-C6-alkynyl, wherein the last four mentioned groups may be partially or fully halogenated and/or may be substituted with one to five radicals R ⁶ .

More preferably, R ^5d is selected from the group consisting of of hydrogen, halogen, Ci- C6-alkyl and Ci-C6-haloalkyl.

More particularly, R ^5d is hydrogen. In case R ⁶ is a substituent on an alkyl, alkenyl or alkynyl group, it is preferably selected from the group consisting of

hydrogen, halogen, cyano, azido, nitro, SCN, SF ₅ , Ci-C6-alkyl, Ci-C6-alkoxy, Ci- C6-alkylthio, Ci-C6-alkylsulfinyl, Ci-C6-alkylsulfonyl, Cs-Cs-cycloalkyl, C3-C8- cycloalkyl-Ci-C4-alkyl, C2-C6-alkenyl, C2-C6-alkynyl,

wherein the carbon atom of the aforementioned aliphatic and cycloaliphatic radicals may be substituted with one or more R ^c ;

Si(R ¹¹ ) ₂ R ¹² , OR ⁰ , 0(CO)R ^c , 0(CS)R ^c , S(0) _m R°, S(0) _m N(R ⁿ ) ₂ , S(CO)R ^c , S(CS)R ^C , S(C=NR")R ^C , N(R") ₂ , N(R ⁿ )C(=0)R ^c , N(R")C(=S)R ^C , NS(0) _n R°, N=C(R ^C ) ₂ ,

C(=0)R ^c , C(=S)R ^C , C(=NR")R ^C , C(=0)N(R ⁿ ) ₂ , C(=S)N(R") ₂ , phenyl,

which may be substituted by 1 , 2, 3, 4 or 5 radicals R ¹⁰ , and

a 3-, 4-, 5-, 6- or 7-membered heterocyclic ring,

wherein said heterocyclic ring

is saturated or partially unsaturated or aromatic,

comprises 1 , 2 or 3 heteroatoms or heteroatom groups selected from N, O, S, NO, SO and S0 ₂ ,

is unsubstituted or substituted with one to five radicals R ¹⁰ , and wherein one or two CH ₂ groups in said saturated or partially saturated heterocyclic rings may be replaced by one or two C=0 groups.

In case R ⁶ is a substituent on an alkyl, alkenyl or alkynyl group, it is more preferably selected from the group consisting of

halogen, cyano, Cs-Cs-cycloalkyl, Cs-Cs-halocycloalkyl, OR ⁰ , SR°, phenyl,

which may be substituted with 1 , 2, 3, 4 or 5 radicals R ¹⁰ , and

a 3-, 4-, 5-, 6- or 7-membered heterocyclic ring,

wherein said heterocyclic ring

is saturated or partially unsaturated or aromatic,

comprises 1 , 2 or 3 heteroatoms or heteroatom groups selected from N, O, S, NO, SO and S0 ₂ ,

is unsubstituted or substituted with one or more radicals R ¹⁰ ;

wherein R° and R ¹⁰ have one of the meanings given above or in particular one of the preferred meanings given below. In case R ⁶ is a substituent on an alkyl, alkenyl or alkynyl group, it is even more preferably selected from the group consisting of halogen, cyano, C3-C6-cycloalkyl, C3-C6- halocycloalkyl, Ci-C4-alkoxy, Ci-C4-haloalkoxy, Ci-C4-alkylthio, Ci-C4-haloalkylthio, phenyl which may be substituted with 1 , 2, 3, 4 or 5 radicals R ¹⁰ , and a 5- or 6- membered heteroaromatic ring containing 1 , 2 or 3 heteroatoms selected from N, O and S, wherein the heteroaromatic ring may be substituted with one or more radicals R ¹⁰ ;and

wherein R ¹⁰ has one of the meanings given above or in particular one of the preferred meanings given below.

In case R ⁶ is a substituent on an alkyl, alkenyl or alkynyl group, it is in particular selected from the group consisting of halogen and a 5- or 6-membered heteroaromatic ring containing 1 , 2 or 3 heteroatoms selected from N, O and S, wherein the heteroaromatic ring is unsubstituted or substituted with one or more radicals R ¹⁰ ; and wherein R ¹⁰ has one of the meanings given above or in particular one of the preferred meanings given below.

In case R ⁶ is a substituent on a cycloalkyi group, it is preferably selected from the group consisting of halogen, cyano, azido, nitro, SCN, SF ₅ , Ci-C6-alkyl, C1-C6- haloalkyl, Ci-C6-alkoxy-Ci-C6-alkyl, Cs-Cs-cycloalkyl, Cs-Cs-halocycloalkyl, C2-C6- alkenyl, C ₂ -C ₆ -haloalkenyl, C ₂ -C ₆ -alkynyl, C ₂ -C ₆ -haloalkynyl, Si(R ¹¹ ) ₂ R ¹² , OR ⁰ ,

0(CO)R ^c , 0(CS)R ^c , S(0) _m R°, S(0) _m N(R ⁿ ) ₂ , S(CO)R ^c , S(CS)R ^C , S(C=NR")R ^C , N(R") ₂ , N(R")C(=0)R ^c , N(R")C(=S)R ^C , NS(0) _m R°, N=C(R ^C ) ₂ , C(=0)R ^c , C(=S)R ^C , C(=NR")R ^C , C(=0)N(R ⁿ ) ₂ , C(=S)N(R ⁿ ) ₂ , phenyl which may be substituted by 1 , 2, 3, 4 or 5 radicals R ¹⁰ , and a 3-, 4-, 5-, 6- or 7-membered heterocyclic ring, wherein said heterocyclic ring is saturated or partially unsaturated or aromatic, comprises 1 , 2 or 3 heteroatoms or heteroatom groups selected from N, O, S, NO, SO and S0 ₂ and wherein said heterocyclic ring is unsubstituted or substituted with one or more radicals R ¹⁰ ; or two vicinally bound radicals R ⁶ together form a group selected from =C(R ^C ) ₂ , =S(0) _m R°, =S(0) _m N(R") ₂ , =NR ⁿ , and =NN(R") ₂ ; or two radicals R ⁶ , together with the carbon atoms to which they are bound, form a 3-, 4-, 5-, 6-, 7- or 8-membered saturated or partially unsaturated carbocyclic or heterocyc- lie ring containing 1 , 2 or 3 heteroatoms or heteroatom groups selected from N, O, S, NO, SO and S0 ₂ ;

wherein R ^c , R ⁿ , R°, R ¹⁰ , R ¹¹ and R ¹² have one of the meanings given above or in particular one of the preferred meanings given below. In case R ⁶ is a substituent on a cycloalkyi group, it is more preferably selected from the group consisting of halogen, cyano, Ci-C6-alkyl, Ci-C6-haloalkyl, Ci-C6-alkoxy-Ci-C6- alkyl, OR ⁰ , SR°, S(0) _m R°, S(0) _m N(R") ₂ , N(R") ₂ , C(=0)N(R") ₂ , C(=S)N(R") ₂ , C(=0) R° , phenyl which may be substituted by 1 , 2, 3, 4 or 5 radicals R ¹⁰ , and a 3-, 4-, 5-, 6- or 7- membered saturated, partially unsaturated or aromatic heterocyclic ring containing 1 , 2 or 3 heteroatoms or heteroatom groups selected from N, O, S, NO, SO and SO2, as ring members, where the heterocyclic ring may be substituted with one or more radicals R ¹⁰ ;

wherein R ^c , R ⁿ , R° and R ¹⁰ have one of the meanings given above or in particular one of the preferred meanings given below.

In case R ⁶ is a substituent on a cycloalkyl group, it is even more preferably selected from the group consisting of halogen, Ci-C4-alkyl, Ci-C3-haloalkyl, Ci-C4-alkoxy and Ci-C3-haloalkoxy. In particular, R ⁶ as a substituent on a cycloalkyl group is selected from halogen, Ci-C4-alkyl and Ci-C3-haloalkyl.

In case R ⁶ is a substituent on C(=0), C(=S) or C(=NR ⁸ ), it is preferably selected from the group consisting of hydrogen, Ci-C6-alkyl, Ci-C6-haloalkyl, Ci-C6-alkoxy-Ci-C6- alkyl, Cs-Cs-cycloalkyl, Cs-Cs-halocycloalkyl, C2-C6-alkenyl, C2-C6-haloalkenyl, C2-C6- alkynyl, C2-Ce-haloalkynyl, -OR ⁰ , -SR°, -N(R ⁿ ) ₂ , phenyl which may be substituted by 1 , 2, 3, 4 or 5 radicals R ¹⁰ , and a 3-, 4-, 5-, 6- or 7-membered saturated, partially unsaturated or aromatic heterocyclic ring containing 1 , 2 or 3 heteroatoms or heteroatom groups selected from N, O, S, NO, SO and SO2, wherein the heterocyclic ring may be substituted with one or more radicals R ¹⁰ ;

wherein R ^c , R ⁿ , R° and R ¹⁰ have one of the meanings given above or in particular one of the preferred meanings given below.

In case R ⁶ is a substituent on C(=0), C(=S) or C(=NR ⁸ ), it is more preferably selected from the group consisting of Ci-C6-alkyl, Ci-C6-haloalkyl, Cs-Cs-cycloalkyl, C3-C8- halocycloalkyi, Ci-C6-alkoxy, Ci-C6-haloalkoxy, phenyl which may be substituted by 1 , 2, 3, 4 or 5 radicals R ¹⁰ , and a 3-, 4-, 5-, 6- or 7-membered saturated, partially unsaturated or aromatic heterocyclic ring containing 1 , 2 or 3 heteroatoms or heteroatom groups selected from N, O, S, NO, SO and SO2, wherein the heterocyclic ring may be substituted by one or more radicals R ¹⁰ ;

wherein R ¹⁰ has one of the meanings given above or in particular one of the preferred meanings given below.

In case R ⁶ is a substituent on C(=0), C(=S) or C(=NR ⁸ ), it is even more preferably selected from the group consisting of Ci-C4-alkyl, Ci-C4-haloalkyl, C3-C6-cycloalkyl, C3- C6-halocycloalkyl, Ci-C4-alkoxy, Ci-C3-haloalkoxy, phenyl which may be substituted with 1 , 2, 3, 4 or 5 radicals R ¹⁰ , and a 5- or 6-membered heteroaromatic ring containing 1 , 2 or 3 heteroatoms selected from N, O and S, wherein the heteroaromatic ring may be substituted with one or more radicals R ¹⁰ ; wherein R ¹⁰ has one of the meanings given above or in particular one of the preferred meanings given below.

Preferably, each R ⁷ is independently selected from the group consisting of hydrogen, Ci-C6-alkyl, Ci-C6-haloalkyl, Cs-Cs-cycloalkyl, Cs-Cs-halocycloalkyl, Cs-Cs-cycloalkyl- Ci-C4-alkyl, phenyl which may be substituted by 1 , 2, 3, 4 or 5 radicals R ¹⁰ ; and a 3-, 4- , 5-, 6- or 7-membered saturated, partially unsaturated or aromatic heterocyclic ring containing 1 , 2 or 3 heteroatoms or heteroatom groups selected from N, O, S, NO, SO and SO2, wherein the heterocyclic ring is unsubstituted or substituted with. 1 , 2, 3 or 4, preferably 1 or 2, more preferably 1 , radicals R ¹⁰ , wherein R ¹⁰ has one of the meanings given above or in particular one of the preferred meanings given below.

More preferably, each R ⁷ is independently selected from the group consisting of hydrogen, Ci-C6-alkyl, Ci-C6-haloalkyl, phenyl which is unsubstituted or substituted by 1 , 2, 3, 4 or 5 radicals R ¹⁰ ; and a 5- or 6-membered heteroaromatic ring containing 1 , 2 or 3 heteroatoms selected from N, O and S, wherein the heteroaromatic ring may be substituted by one or more radicals R ¹⁰ ; where R ¹⁰ has one of the meanings given above or in particular one of the preferred meanings given below. R ⁸ and R ⁹ are independently of each other and independently of each occurrence preferably selected from the group consisting of hydrogen, Ci-C6-alkyl, Ci-C6-haloalkyl, Cs- Cs-cycloalkyl, C3-Cs-halocycloalkyl, phenyl which may be substituted by 1 , 2, 3, 4 or 5 radicals R ¹⁰ , and a 3-, 4-, 5-, 6- or 7-membered saturated, partially unsaturated or aromatic heterocyclic ring containing 1 , 2 or 3 heteroatoms or heteroatom groups selected from N, O, S, NO, SO and SO2, where the heterocyclic ring may be substituted by one or more radicals R ¹⁰ ; and wherein R ¹⁰ has one of the meanings given above or in particular one of the preferred meanings given below.

R ⁸ and R ⁹ are independently of each other and independently of each occurrence more preferably selected from the group consisting of hydrogen, Ci-C6-alkyl, Ci-C6-haloalkyl, phenyl which may be substituted by 1 , 2, 3, 4 or 5 radicals R ¹⁰ , and a 5- or 6- membered heteroaromatic ring containing 1 , 2 or 3 heteroatoms selected from N, O and S, as ring members, wherein the heteroaromatic ring is unsubstituted or substituted by one or more radicals R ¹⁰ ; and wherein R ¹⁰ has one of the meanings given above or in particular one of the preferred meanings given below.

In particular, R ⁸ and R ⁹ are independently of each other and independently of each occurrence selected from the group consisting of hydrogen and Ci-C4-alkyl. Preferably, each R ¹⁰ is independently selected from the group consisting of halogen, cyano, Ci-Cio-alkyl which may be partially or fully halogenated and/or may be substituted by one or more radicals R ^c , Cs-Cs-cycloalkyl which may be partially or fully halogenated and/or may be substituted by one or more radicals R ^c , OR ⁰ , 0(CO)R ^c , 0(CS)R ^c , S(0) _m R°, S(0) _m N(R") ₂ , N(R") ₂ , C(=0)R ^c , C(=0)N(R") ₂ „ phenyl which may be substituted by 1 , 2, 3, 4 or 5 radicals independently selected from halogen, cyano, ni- tro, Ci-C6-alkyl, Ci-C6-haloalkyl, Ci-C6-alkoxy and Ci-C6-haloalkoxy; and a 3-, 4-, 5-, 6- or 7-membered saturated or unsaturated heterocyclic ring containing 1 , 2 or 3 heteroatoms or heteroatom groups selected from N, O, S, NO, SO and S0 ₂ , as ring members, which may be substituted by one or more radicals independently selected from halogen, cyano, nitro, Ci-C6-alkyl, Ci-C6-haloalkyl, Ci-C6-alkoxy and Ci-C6-haloalkoxy; or two radicals R ¹⁰ bound on adjacent atoms together form a group selected from -CH2CH2CH2CH2-, -CH=CH-CH=CH-, -N=CH-CH=CH-, -CH=N-CH=CH-,

-N=CH-N=CH-, -OCH2CH2CH2-, -OCH=CHCH ₂ -, -CH ₂ OCH ₂ CH ₂ -, -OCH2CH2O-, -OCH ₂ OCH2-,-CH2CH ₂ CH2-, -CH=CHCH ₂ -, -CH2CH2O-, -CH=CHO-, -CH2OCH2-, -CH ₂ C(=0)0-, -C(=0)OCH ₂ -, and -0(CH ₂ )0-, thus forming, together with the atoms to which they are bound, a 5- or 6-membered ring, where the hydrogen atoms of the above groups may be replaced by one or more substituents selected from halogen, methyl, halomethyl, hydroxyl, methoxy and halomethoxy or one or more CH2 groups of the above groups may be replaced by a C=0 group,

where R ^c , R ⁿ and R° have one of the general or in particular one of the preferred meanings given above. More preferably, each R ¹⁰ is independently selected from the group consisting of halogen, cyano, Ci-Cio-alkyl which may be partially or fully halogenated and/or may be substituted by one or more radicals R ^c , -OR ⁿ , -N(R ⁿ ) ₂ , C(=0)R ^c , -C(=0)OR°, phenyl which may be substituted by 1 , 2, 3, 4 or 5 radicals independently selected from halogen, cyano, nitro, Ci-C6-alkyl, Ci-C6-haloalkyl, Ci-C6-alkoxy and Ci- C6-haloalkoxy; and a 3-, 4-, 5-, 6- or 7-membered saturated or unsaturated heterocyclic ring containing 1 , 2 or 3 heteroatoms or heteroatom groups selected from N, O, S, NO, SO and SO2, as ring members, which may be substituted by one or more radicals independently selected from halogen, cyano, nitro, Ci-C6-alkyl, Ci-C6-haloalkyl, C1-C6- alkoxy and Ci-C6-haloalkoxy;

where R ^c , R ⁿ , R° have one of the general or in particular one of the preferred meanings given above.

Even more preferably, each R ¹⁰ is independently selected from the group consisting of halogen, Ci-C4-alkyl, Ci-C4-haloalkyl, Ci-C4-alkoxy and Ci-C4-haloalkoxy. In particular, each R ¹⁰ is independently selected from the group consisting of halogen, Ci-C4-alkyl and Ci-C4-haloalkyl and is specifically halogen, more specifically chlorine.

Preferably, R ¹¹ and R ¹² are, independently of each other and independently of each occurrence, selected from Ci-C4-alkyl and are in particular methyl.

A very preferred embodiment of the invention relates to the compounds of the formula (l-a)

(l-a)

wherein

A has one of the general meaning as defined here above;

A is in particular one of the preferred radical A numbered A1 a1 to A1 a 197 as defined in table B above. R ^5b , R ^5a , R ¹ and R ² have one of the general meaning or one of the preferred meaning as here above defined.

In particular, R ^5b , R ¹ and R ² have the meaning lb numbered Ib1 to Ib1 168 as defined in each line of the following Table C. It is to note that R ¹ and R ² are permutable in the meaning of Ib1009 to Ib1 168.

Table C: lb _R 5b R R ² lb _R 5b R R ²

Ib1 CFs Me Me Ib6 CF2CI Me Me

Ib2 CHF ₂ Me Me Ib7 CFC Me Me

Ib3 CF2CF3 Me Me Ib8 CCIs Me Me

Ib4 CF(CF ₃ ) ₂ Me Me Ib9 OCF3 Me Me

Ib5 COH(CF ₃ ) ₂ Me Me Ib10 OCHF2 Me Me lb _R 5b R R ² lb _R 5b R R ²

Ib307 CF2CF3 Pr Pr Ib344 CCI3 Pr Bu

Ib308 CF(CF ₃ ) ₂ Pr Pr Ib345 OCF3 Pr Bu

Ib309 COH(CF ₃ ) ₂ Pr Pr Ib346 OCHF2 Pr Bu

Ib310 CF2CI Pr Pr Ib347 OCF2CF3 Pr Bu

Ib31 1 CFC Pr Pr Ib348 OCF2CHF2 Pr Bu

Ib312 CCIs Pr Pr Ib349 OCF(CF ₃ ) ₂ Pr Bu

Ib313 OCF3 Pr Pr Ib350 OCF2CI Pr Bu

Ib314 OCHF2 Pr Pr Ib351 OCFCb Pr Bu

Ib315 OCF2CF3 Pr Pr Ib352 OCCI3 Pr Bu

Ib316 OCF2CHF2 Pr Pr Ib353 CF ₃ Pr Pn

Ib317 OCF(CF3)2 Pr Pr Ib354 CHF ₂ Pr Pn

Ib318 OCF2CI Pr Pr Ib355 CF2CF3 Pr Pn

Ib319 OCFC Pr Pr Ib356 CF(CF ₃ ) ₂ Pr Pn

Ib320 OCCIs Pr Pr Ib357 COH(CF ₃ ) ₂ Pr Pn

Ib321 CF ₃ Pr iPr Ib358 CF2CI Pr Pn

Ib322 CHF ₂ Pr iPr Ib359 CFCb Pr Pn

Ib323 CF2CF3 Pr iPr Ib360 CCI3 Pr Pn

Ib324 CF(CF ₃ ) ₂ Pr iPr Ib361 OCF3 Pr Pn

Ib325 COH(CF ₃ ) ₂ Pr iPr Ib362 OCHF2 Pr Pn

Ib326 CF2CI Pr iPr Ib363 OCF2CF3 Pr Pn

Ib327 CFCb Pr iPr Ib364 OCF2CHF2 Pr Pn

Ib328 CCI3 Pr iPr Ib365 OCF(CF ₃ ) ₂ Pr Pn

Ib329 OCF3 Pr iPr Ib366 OCF2CI Pr Pn

Ib330 OCHF2 Pr iPr Ib367 OCFCb Pr Pn

Ib331 OCF2CF3 Pr iPr Ib368 OCCI3 Pr Pn

Ib332 OCF2CHF2 Pr iPr Ib369 CF ₃ Pr Me-cPr

Ib333 OCF(CF ₃ ) ₂ Pr iPr Ib370 CHF ₂ Pr Me-cPr

Ib334 OCF2CI Pr iPr Ib371 CF2CF3 Pr Me-cPr

Ib335 OCFCb Pr iPr Ib372 CF(CF ₃ ) ₂ Pr Me-cPr

Ib336 OCCI3 Pr iPr Ib373 COH(CF ₃ ) ₂ Pr Me-cPr

Ib337 CF ₃ Pr Bu Ib374 CF2CI Pr Me-cPr

Ib338 CHF ₂ Pr Bu Ib375 CFCb Pr Me-cPr

Ib339 CF2CF3 Pr Bu Ib376 CCI3 Pr Me-cPr

Ib340 CF(CF ₃ ) ₂ Pr Bu Ib377 OCF3 Pr Me-cPr

Ib341 COH(CF ₃ ) ₂ Pr Bu Ib378 OCHF2 Pr Me-cPr

Ib342 CF2CI Pr Bu Ib379 OCF2CF3 Pr Me-cPr

Ib343 CFCb Pr Bu Ib380 OCF2CHF2 Pr Me-cPr

Following annotation when used in the text are defined as follows: Me is methyl or -CH3;

Et is ethyl or -CH ₂ CH ₃ ;

Pr is propyl or -(Chb^CHs,

iPr is isopropyl or -CH(CH3)2;

Bu is butyl or (CH ₂ )3CH ₃ ;

Pn is pentyl or (CH ₂ )4CH ₃ ;

Me-cPr is methylcyclopropyl;

Me-CN is cyanomethyl. Examples of compounds of this particular preferred embodiment of such compounds are the compounds l-a given in the following tables 1 to 13.

Table 1 Compounds of the formula l-a and their salts, wherein R ^5c and R ^5d are hy- drogen, R ^5a is H and the remaining variables R ¹ , R ² , R ^5b and A correspond to each combination of the radicals numbered A1 a1 to A1 a197 with each row of Table C numbered Ib1 to Ib1 168.

Table 2 Compounds of the formula l-a and their salts, wherein R ^5c and R ^5d are hy- drogen, R ^5a is F and the remaining variables R ¹ , R ² , R ^5b and A correspond to each combination of the radicals numbered A1 a1 to A1 a197 with each row of Table C numbered Ib1 to Ib1 168.

Table 3 Compounds of the formula l-a and their salts, wherein R ^5c and R ^5d are hy- drogen, R ^5a is CI and the remaining variables R ¹ , R ² , R ^5b and A correspond to each combination of the radicals numbered A1 a1 to A1 a197 with each row of Table C numbered Ib1 to Ib1 168.

Table 4 Compounds of the formula l-a and their salts, wherein R ^5c and R ^5d are hy- drogen, R ^5a is Br and the remaining variables R ¹ , R ² , R ^5b and A correspond to each combination of the radicals numbered A1 a1 to A1 a197 with each row of Table C numbered Ib1 to Ib1 168.

Table 5 Compounds of the formula l-a and their salts, wherein R ^5c and R ^5d are hy- drogen, R ^5a is I and the remaining variables R ¹ , R ² , R ^5b and A correspond to each combination of the radicals numbered A1 a1 to A1 a197 with each row of Table C numbered Ib1 to Ib1 168.

Table 6 Compounds of the formula l-a and their salts, wherein R ^5c and R ^5d are hy- drogen, R ^5a is CN and the remaining variables R ¹ , R ² , R ^5b and A correspond to each combination of the radicals numbered A1 a1 to A1 a197 with each row of Table C numbered Ib1 to Ib1 168.

Table 7 Compounds of the formula l-a and their salts, wherein R ^5c and R ^5d are hy- drogen, R ^5a is NO2 and the remaining variables R ¹ , R ² , R ^5b and A correspond to each combination of the radicals numbered A1 a1 to A1 a197 with each row of Table C numbered Ib1 to Ib1 168. Table 8 Compounds of the formula l-a and their salts, wherein R ^5c and R ^5d are hydrogen, R ^5a is CH3 and the remaining variables R ¹ , R ² , R ^5b and A correspond to each combination of the radicals numbered A1 a1 to A1 a197 with each row of Table C numbered Ib1 to Ib1 168.

Table 9 Compounds of the formula l-a and their salts, wherein R ^5c and R ^5d are hydrogen, R ^5a is CF3 and the remaining variables R ¹ , R ² , R ^5b and A correspond to each combination of the radicals numbered A1 a1 to A1 a197 with each row of Table C numbered Ib1 to Ib1 168.

Table 10 Compounds of the formula l-a and their salts, wherein R ^5c and R ^5d are hydrogen, R ^5a is CHF2 and the remaining variables R ¹ , R ² , R ^5b and A correspond to each combination of the radicals numbered A1 a1 to A1 a197 with each row of Table C numbered Ib1 to Ib1 168.

Table 1 1 Compounds of the formula l-a and their salts, wherein R ^5c and R ^5d are hydrogen, R ^5a is OCF3 and the remaining variables R ¹ , R ² , R ^5b and A correspond to each combination of the radicals numbered A1 a1 to A1 a197 with each row of Table C numbered Ib1 to Ib1 168.

Table 12 Compounds of the formula l-a and their salts, wherein R ^5c and R ^5d are hydrogen, R ^5a is OCHF2 and the remaining variables R ¹ , R ² , R ^5b and A correspond to each combination of the radicals numbered A1 a1 to A1 a197 with each row of Table C numbered Ib1 to Ib1 168.

Table 13 Compounds of the formula l-a and their salts, wherein R ^5c and R ^5d are hydrogen, R ^5a is SCF3 and the remaining variables R ¹ , R ² , R ^5b and A correspond to each combination of the radicals numbered A1 a1 to A1 a197 with each row of Table C numbered Ib1 to Ib1 168.

Each example of the compounds of formula l-a as defined in the tables 1 to 13 constitutes a preferred embodiment of the invention.

Especially preferred embodiment of the invention are the compounds l-a wherein R ^5a , is hydrogen, A ² , A ³ , A ⁴ are CH, and the remaining variables R ¹ , R ² , R ³ , R ⁴ , R ^5b , A ¹ are defined in each row of the following Table D (variables R ¹ , R ² , R ³ , R ⁴ , R ^5b , A ¹ are defined in radical A and lb being respectively defined in table B and C):

Table D: Radical lb Radical lb Radical lb Radical lb A A A A

A1a1 Ib1 A1a8 Ib33 A1a1 Ib81 A1a8 Ib113

A1a2 Ib1 A1a9 Ib33 A1a2 Ib81 A1a9 Ib113

A1a3 Ib1 A1a10 Ib33 A1a3 Ib81 A1a10 Ib113

A1a4 Ib1 A1a11 Ib33 A1a4 Ib81 A1a11 Ib113

A1a5 Ib1 A1a12 Ib33 A1a5 Ib81 A1a12 Ib113

A1a6 Ib1 A1a13 Ib33 A1a6 Ib81 A1a13 Ib113

A1a7 Ib1 A1a14 Ib33 A1a7 Ib81 A1a14 Ib113

A1a8 Ib1 A1a1 Ib49 A1a8 Ib81 A1a1 Ib129

A1a9 Ib1 A1a2 Ib49 A1a9 Ib81 A1a2 Ib129

A1a10 Ib1 A1a3 Ib49 A1a10 Ib81 A1a3 Ib129

A1a11 Ib1 A1a4 Ib49 A1a11 Ib81 A1a4 Ib129

A1a12 Ib1 A1a5 Ib49 A1a12 Ib81 A1a5 Ib129

A1a13 Ib1 A1a6 Ib49 A1a13 Ib81 A1a6 Ib129

A1a14 Ib1 A1a7 Ib49 A1a14 Ib81 A1a7 Ib129

A1a1 Ib17 A1a8 Ib49 A1a1 Ib97 A1a8 Ib129

A1a2 Ib17 A1a9 Ib49 A1a2 Ib97 A1a9 Ib129

A1a3 Ib17 A1a10 Ib49 A1a3 Ib97 A1a10 Ib129

A1a4 Ib17 A1a11 Ib49 A1a4 Ib97 A1a11 Ib129

A1a5 Ib17 A1a12 Ib49 A1a5 Ib97 A1a12 Ib129

A1a6 Ib17 A1a13 Ib49 A1a6 Ib97 A1a13 Ib129

A1a7 Ib17 A1a14 Ib49 A1a7 Ib97 A1a14 Ib129

A1a8 Ib17 A1a1 Ib65 A1a8 Ib97 A1a1 Ib145

A1a9 Ib17 A1a2 Ib65 A1a9 Ib97 A1a2 Ib145

A1a10 Ib17 A1a3 Ib65 A1a10 Ib97 A1a3 Ib145

A1a11 Ib17 A1a4 Ib65 A1a11 Ib97 A1a4 Ib145

A1a12 Ib17 A1a5 Ib65 A1a12 Ib97 A1a5 Ib145

A1a13 Ib17 A1a6 Ib65 A1a13 Ib97 A1a6 Ib145

A1a14 Ib17 A1a7 Ib65 A1a14 Ib97 A1a7 Ib145

A1a1 Ib33 A1a8 Ib65 A1a1 Ib113 A1a8 Ib145

A1a2 Ib33 A1a9 Ib65 A1a2 Ib113 A1a9 Ib145

A1a3 Ib33 A1a10 Ib65 A1a3 Ib113 A1a10 Ib145

A1a4 Ib33 A1a11 Ib65 A1a4 Ib113 A1a11 Ib145

A1a5 Ib33 A1a12 Ib65 A1a5 Ib113 A1a12 Ib145

A1a6 Ib33 A1a13 Ib65 A1a6 Ib113 A1a13 Ib145

A1a7 Ib33 A1a14 Ib65 A1a7 Ib113 A1a14 Ib145 Radical lb Radical lb Radical lb Radical lb A A A A

A1a1 Ib161 A1a9 Ib193 A1a3 Ib241 A1a11 Ib273

A1a2 Ib161 A1a10 Ib193 A1a4 Ib241 A1a12 Ib273

A1a3 Ib161 A1a11 Ib193 A1a5 Ib241 A1a13 Ib273

A1a4 Ib161 A1a12 Ib193 A1a6 Ib241 A1a14 Ib273

A1a5 Ib161 A1a13 Ib193 A1a7 Ib241 A1a1 Ib289

A1a6 Ib161 A1a14 Ib193 A1a8 Ib241 A1a2 Ib289

A1a7 Ib161 A1a1 Ib209 A1a9 Ib241 A1a3 Ib289

A1a8 Ib161 A1a2 Ib209 A1a10 Ib241 A1a4 Ib289

A1a9 Ib161 A1a3 Ib209 A1a11 Ib241 A1a5 Ib289

A1a10 Ib161 A1a4 Ib209 A1a12 Ib241 A1a6 Ib289

A1a11 Ib161 A1a5 Ib209 A1a13 Ib241 A1a7 Ib289

A1a12 Ib161 A1a6 Ib209 A1a14 Ib241 A1a8 Ib289

A1a13 Ib161 A1a7 Ib209 A1a1 Ib257 A1a9 Ib289

A1a14 Ib161 A1a8 Ib209 A1a2 Ib257 A1a10 Ib289

A1a1 Ib177 A1a9 Ib209 A1a3 Ib257 A1a11 Ib289

A1a2 Ib177 A1a10 Ib209 A1a4 Ib257 A1a12 Ib289

A1a3 Ib177 A1a11 Ib209 A1a5 Ib257 A1a13 Ib289

A1a4 Ib177 A1a12 Ib209 A1a6 Ib257 A1a14 Ib289

A1a5 Ib177 A1a13 Ib209 A1a7 Ib257 A1a1 Ib305

A1a6 Ib177 A1a14 Ib209 A1a8 Ib257 A1a2 Ib305

A1a7 Ib177 A1a1 Ib225 A1a9 Ib257 A1a3 Ib305

A1a8 Ib177 A1a2 Ib225 A1a10 Ib257 A1a4 Ib305

A1a9 Ib177 A1a3 Ib225 A1a11 Ib257 A1a5 Ib305

A1a10 Ib177 A1a4 Ib225 A1a12 Ib257 A1a6 Ib305

A1a11 Ib177 A1a5 Ib225 A1a13 Ib257 A1a7 Ib305

A1a12 Ib177 A1a6 Ib225 A1a14 Ib257 A1a8 Ib305

A1a13 Ib177 A1a7 Ib225 A1a1 Ib273 A1a9 Ib305

A1a14 Ib177 A1a8 Ib225 A1a2 Ib273 A1a10 Ib305

A1a1 Ib193 A1a9 Ib225 A1a3 Ib273 A1a11 Ib305

A1a2 Ib193 A1a10 Ib225 A1a4 Ib273 A1a12 Ib305

A1a3 Ib193 A1a11 Ib225 A1a5 Ib273 A1a13 Ib305

A1a4 Ib193 A1a12 Ib225 A1a6 Ib273 A1a14 Ib305

A1a5 Ib193 A1a13 Ib225 A1a7 Ib273 A1a1 Ib321

A1a6 Ib193 A1a14 Ib225 A1a8 Ib273 A1a2 Ib321

A1a7 Ib193 A1a1 Ib241 A1a9 Ib273 A1a3 Ib321

A1a8 Ib193 A1a2 Ib241 A1a10 Ib273 A1a4 Ib321 Radical lb Radical lb Radical lb Radical lb A A A A

A1a5 Ib321 A1a13 Ib353 A1a7 Ib401 A1a1 Ib449

A1a6 Ib321 A1a14 Ib353 A1a8 Ib401 A1a2 Ib449

A1a7 Ib321 A1a1 Ib369 A1a9 Ib401 A1a3 Ib449

A1a8 Ib321 A1a2 Ib369 A1a10 Ib401 A1a4 Ib449

A1a9 Ib321 A1a3 Ib369 A1a11 Ib401 A1a5 Ib449

A1a10 Ib321 A1a4 Ib369 A1a12 Ib401 A1a6 Ib449

A1a11 Ib321 A1a5 Ib369 A1a13 Ib401 A1a7 Ib449

A1a12 Ib321 A1a6 Ib369 A1a14 Ib401 A1a8 Ib449

A1a13 Ib321 A1a7 Ib369 A1a1 Ib417 A1a9 Ib449

A1a14 Ib321 A1a8 Ib369 A1a2 Ib417 A1a10 Ib449

A1a1 Ib337 A1a9 Ib369 A1a3 Ib417 A1a11 Ib449

A1a2 Ib337 A1a10 Ib369 A1a4 Ib417 A1a12 Ib449

A1a3 Ib337 A1a11 Ib369 A1a5 Ib417 A1a13 Ib449

A1a4 Ib337 A1a12 Ib369 A1a6 Ib417 A1a14 Ib449

A1a5 Ib337 A1a13 Ib369 A1a7 Ib417 A1a1 Ib465

A1a6 Ib337 A1a14 Ib369 A1a8 Ib417 A1a2 Ib465

A1a7 Ib337 A1a1 Ib385 A1a9 Ib417 A1a3 Ib465

A1a8 Ib337 A1a2 Ib385 A1a10 Ib417 A1a4 Ib465

A1a9 Ib337 A1a3 Ib385 A1a11 Ib417 A1a5 Ib465

A1a10 Ib337 A1a4 Ib385 A1a12 Ib417 A1a6 Ib465

A1a11 Ib337 A1a5 Ib385 A1a13 Ib417 A1a7 Ib465

A1a12 Ib337 A1a6 Ib385 A1a14 Ib417 A1a8 Ib465

A1a13 Ib337 A1a7 Ib385 A1a1 Ib433 A1a9 Ib465

A1a14 Ib337 A1a8 Ib385 A1a2 Ib433 A1a10 Ib465

A1a1 Ib353 A1a9 Ib385 A1a3 Ib433 A1a11 Ib465

A1a2 Ib353 A1a10 Ib385 A1a4 Ib433 A1a12 Ib465

A1a3 Ib353 A1a11 Ib385 A1a5 Ib433 A1a13 Ib465

A1a4 Ib353 A1a12 Ib385 A1a6 Ib433 A1a14 Ib465

A1a5 Ib353 A1a13 Ib385 A1a7 Ib433 A1a1 Ib481

A1a6 Ib353 A1a14 Ib385 A1a8 Ib433 A1a2 Ib481

A1a7 Ib353 A1a1 Ib401 A1a9 Ib433 A1a3 Ib481

A1a8 Ib353 A1a2 Ib401 A1a10 Ib433 A1a4 Ib481

A1a9 Ib353 A1a3 Ib401 A1a11 Ib433 A1a5 Ib481

A1a10 Ib353 A1a4 Ib401 A1a12 Ib433 A1a6 Ib481

A1a11 Ib353 A1a5 Ib401 A1a13 Ib433 A1a7 Ib481

A1a12 Ib353 A1a6 Ib401 A1a14 Ib433 A1a8 Ib481 Radical lb Radical lb Radical lb Radical lb A A A A

A1a9 Ib481 A1a3 Ib529 A1a11 Ib561 A1a5 Ib609

A1a10 Ib481 A1a4 Ib529 A1a12 Ib561 A1a6 Ib609

A1a11 Ib481 A1a5 Ib529 A1a13 Ib561 A1a7 Ib609

A1a12 Ib481 A1a6 Ib529 A1a14 Ib561 A1a8 Ib609

A1a13 Ib481 A1a7 Ib529 A1a1 Ib577 A1a9 Ib609

A1a14 Ib481 A1a8 Ib529 A1a2 Ib577 A1a10 Ib609

A1a1 Ib497 A1a9 Ib529 A1a3 Ib577 A1a11 Ib609

A1a2 Ib497 A1a10 Ib529 A1a4 Ib577 A1a12 Ib609

A1a3 Ib497 A1a11 Ib529 A1a5 Ib577 A1a13 Ib609

A1a4 Ib497 A1a12 Ib529 A1a6 Ib577 A1a14 Ib609

A1a5 Ib497 A1a13 Ib529 A1a7 Ib577 A1a1 Ib625

A1a6 Ib497 A1a14 Ib529 A1a8 Ib577 A1a2 Ib625

A1a7 Ib497 A1a1 Ib545 A1a9 Ib577 A1a3 Ib625

A1a8 Ib497 A1a2 Ib545 A1a10 Ib577 A1a4 Ib625

A1a9 Ib497 A1a3 Ib545 A1a11 Ib577 A1a5 Ib625

A1a10 Ib497 A1a4 Ib545 A1a12 Ib577 A1a6 Ib625

A1a11 Ib497 A1a5 Ib545 A1a13 Ib577 A1a7 Ib625

A1a12 Ib497 A1a6 Ib545 A1a14 Ib577 A1a8 Ib625

A1a13 Ib497 A1a7 Ib545 A1a1 Ib593 A1a9 Ib625

A1a14 Ib497 A1a8 Ib545 A1a2 Ib593 A1a10 Ib625

A1a1 Ib513 A1a9 Ib545 A1a3 Ib593 A1a11 Ib625

A1a2 Ib513 A1a10 Ib545 A1a4 Ib593 A1a12 Ib625

A1a3 Ib513 A1a11 Ib545 A1a5 Ib593 A1a13 Ib625

A1a4 Ib513 A1a12 Ib545 A1a6 Ib593 A1a14 Ib625

A1a5 Ib513 A1a13 Ib545 A1a7 Ib593 A1a1 Ib641

A1a6 Ib513 A1a14 Ib545 A1a8 Ib593 A1a2 Ib641

A1a7 Ib513 A1a1 Ib561 A1a9 Ib593 A1a3 Ib641

A1a8 Ib513 A1a2 Ib561 A1a10 Ib593 A1a4 Ib641

A1a9 Ib513 A1a3 Ib561 A1a11 Ib593 A1a5 Ib641

A1a10 Ib513 A1a4 Ib561 A1a12 Ib593 A1a6 Ib641

A1a11 Ib513 A1a5 Ib561 A1a13 Ib593 A1a7 Ib641

A1a12 Ib513 A1a6 Ib561 A1a14 Ib593 A1a8 Ib641

A1a13 Ib513 A1a7 Ib561 A1a1 Ib609 A1a9 Ib641

A1a14 Ib513 A1a8 Ib561 A1a2 Ib609 A1a10 Ib641

A1a1 Ib529 A1a9 Ib561 A1a3 Ib609 A1a11 Ib641

A1a2 Ib529 A1a10 Ib561 A1a4 Ib609 A1a12 Ib641 Radical lb Radical lb Radical lb Radical lb A A A A

A1a13 Ib641 A1a7 Ib689 A1a1 Ib737 A1a9 Ib769

A1a14 Ib641 A1a8 Ib689 A1a2 Ib737 A1a10 Ib769

A1a1 Ib657 A1a9 Ib689 A1a3 Ib737 A1a11 Ib769

A1a2 Ib657 A1a10 Ib689 A1a4 Ib737 A1a12 Ib769

A1a3 Ib657 A1a11 Ib689 A1a5 Ib737 A1a13 Ib769

A1a4 Ib657 A1a12 Ib689 A1a6 Ib737 A1a14 Ib769

A1a5 Ib657 A1a13 Ib689 A1a7 Ib737 A1a1 Ib785

A1a6 Ib657 A1a14 Ib689 A1a8 Ib737 A1a2 Ib785

A1a7 Ib657 A1a1 Ib705 A1a9 Ib737 A1a3 Ib785

A1a8 Ib657 A1a2 Ib705 A1a10 Ib737 A1a4 Ib785

A1a9 Ib657 A1a3 Ib705 A1a11 Ib737 A1a5 Ib785

A1a10 Ib657 A1a4 Ib705 A1a12 Ib737 A1a6 Ib785

A1a11 Ib657 A1a5 Ib705 A1a13 Ib737 A1a7 Ib785

A1a12 Ib657 A1a6 Ib705 A1a14 Ib737 A1a8 Ib785

A1a13 Ib657 A1a7 Ib705 A1a1 Ib753 A1a9 Ib785

A1a14 Ib657 A1a8 Ib705 A1a2 Ib753 A1a10 Ib785

A1a1 Ib673 A1a9 Ib705 A1a3 Ib753 A1a11 Ib785

A1a2 Ib673 A1a10 Ib705 A1a4 Ib753 A1a12 Ib785

A1a3 Ib673 A1a11 Ib705 A1a5 Ib753 A1a13 Ib785

A1a4 Ib673 A1a12 Ib705 A1a6 Ib753 A1a14 Ib785

A1a5 Ib673 A1a13 Ib705 A1a7 Ib753 A1a1 Ib801

A1a6 Ib673 A1a14 Ib705 A1a8 Ib753 A1a2 Ib801

A1a7 Ib673 A1a1 Ib721 A1a9 Ib753 A1a3 Ib801

A1a8 Ib673 A1a2 Ib721 A1a10 Ib753 A1a4 Ib801

A1a9 Ib673 A1a3 Ib721 A1a11 Ib753 A1a5 Ib801

A1a10 Ib673 A1a4 Ib721 A1a12 Ib753 A1a6 Ib801

A1a11 Ib673 A1a5 Ib721 A1a13 Ib753 A1a7 Ib801

A1a12 Ib673 A1a6 Ib721 A1a14 Ib753 A1a8 Ib801

A1a13 Ib673 A1a7 Ib721 A1a1 Ib769 A1a9 Ib801

A1a14 Ib673 A1a8 Ib721 A1a2 Ib417 A1a10 Ib801

A1a1 Ib689 A1a9 Ib721 A1a3 Ib769 A1a11 Ib801

A1a2 Ib689 A1a10 Ib721 A1a4 Ib769 A1a12 Ib801

A1a3 Ib689 A1a11 Ib721 A1a5 Ib769 A1a13 Ib801

A1a4 Ib689 A1a12 Ib721 A1a6 Ib769 A1a14 Ib801

A1a5 Ib689 A1a13 Ib721 A1a7 Ib769 A1a1 Ib817

A1a6 Ib689 A1a14 Ib721 A1a8 Ib769 A1a2 Ib817 Radical lb Radical lb Radical lb Radical lb A A A A

A1a3 Ib817 A1a11 Ib849 A1a5 Ib897 A1a13 Ib929

A1a4 Ib817 A1a12 Ib849 A1a6 Ib897 A1a14 Ib929

A1a5 Ib817 A1a13 Ib849 A1a7 Ib897 A1a1 Ib945

A1a6 Ib817 A1a14 Ib849 A1a8 Ib897 A1a2 Ib945

A1a7 Ib817 A1a1 Ib865 A1a9 Ib897 A1a3 Ib945

A1a8 Ib817 A1a2 Ib865 A1a10 Ib897 A1a4 Ib945

A1a9 Ib817 A1a3 Ib865 A1a11 Ib897 A1a5 Ib945

A1a10 Ib817 A1a4 Ib865 A1a12 Ib897 A1a6 Ib945

A1a11 Ib817 A1a5 Ib865 A1a13 Ib897 A1a7 Ib945

A1a12 Ib817 A1a6 Ib865 A1a14 Ib897 A1a8 Ib945

A1a13 Ib817 A1a7 Ib865 A1a1 Ib913 A1a9 Ib945

A1a14 Ib817 A1a8 Ib865 A1a2 Ib913 A1a10 Ib945

A1a1 Ib833 A1a9 Ib865 A1a3 Ib913 A1a11 Ib945

A1a2 Ib833 A1a10 Ib865 A1a4 Ib913 A1a12 Ib945

A1a3 Ib833 A1a11 Ib865 A1a5 Ib913 A1a13 Ib945

A1a4 Ib833 A1a12 Ib865 A1a6 Ib913 A1a14 Ib945

A1a5 Ib833 A1a13 Ib865 A1a7 Ib913 A1a1 Ib961

A1a6 Ib833 A1a14 Ib865 A1a8 Ib913 A1a2 Ib961

A1a7 Ib833 A1a1 Ib881 A1a9 Ib913 A1a3 Ib961

A1a8 Ib833 A1a2 Ib881 A1a10 Ib913 A1a4 Ib961

A1a9 Ib833 A1a3 Ib881 A1a11 Ib913 A1a5 Ib961

A1a10 Ib833 A1a4 Ib881 A1a12 Ib913 A1a6 Ib961

A1a11 Ib833 A1a5 Ib881 A1a13 Ib913 A1a7 Ib961

A1a12 Ib833 A1a6 Ib881 A1a14 Ib913 A1a8 Ib961

A1a13 Ib833 A1a7 Ib881 A1a1 Ib929 A1a9 Ib961

A1a14 Ib833 A1a8 Ib881 A1a2 Ib929 A1a10 Ib961

A1a1 Ib849 A1a9 Ib881 A1a3 Ib929 A1a11 Ib961

A1a2 Ib849 A1a10 Ib881 A1a4 Ib929 A1a12 Ib961

A1a3 Ib849 A1a11 Ib881 A1a5 Ib929 A1a13 Ib961

A1a4 Ib849 A1a12 Ib881 A1a6 Ib929 A1a14 Ib961

A1a5 Ib849 A1a13 Ib881 A1a7 Ib929 A1a1 Ib977

A1a6 Ib849 A1a14 Ib881 A1a8 Ib929 A1a2 Ib977

A1a7 Ib849 A1a1 Ib897 A1a9 Ib929 A1a3 Ib977

A1a8 Ib849 A1a2 Ib897 A1a10 Ib929 A1a4 Ib977

A1a9 Ib849 A1a3 Ib897 A1a11 Ib929 A1a5 Ib977

A1a10 Ib849 A1a4 Ib897 A1a12 Ib929 A1a6 Ib977 Radical lb Radical lb Radical lb Radical lb A A A A

A1a7 Ib977 A1a1 Ib1025 A1a9 Ib1057 A1a3 Ib1105

A1a8 Ib977 A1a2 Ib1025 A1a10 Ib1057 A1a4 Ib1105

A1a9 Ib977 A1a3 Ib1025 A1a11 Ib1057 A1a5 Ib1105

A1a10 Ib977 A1a4 Ib1025 A1a12 Ib1057 A1a6 Ib1105

A1a11 Ib977 A1a5 Ib1025 A1a13 Ib1057 A1a7 Ib1105

A1a12 Ib977 A1a6 Ib1025 A1a14 Ib1057 A1a8 Ib1105

A1a13 Ib977 A1a7 Ib1025 A1a1 Ib1073 A1a9 Ib1105

A1a14 Ib977 A1a8 Ib1025 A1a2 Ib1073 A1a10 Ib1105

A1a1 Ib993 A1a9 Ib1025 A1a3 Ib1073 A1a11 Ib1105

A1a2 Ib993 A1a10 Ib1025 A1a4 Ib1073 A1a12 Ib1105

A1a3 Ib993 A1a11 Ib1025 A1a5 Ib1073 A1a13 Ib1105

A1a4 Ib993 A1a12 Ib1025 A1a6 Ib1073 A1a14 Ib1105

A1a5 Ib993 A1a13 Ib1025 A1a7 Ib1073 A1a1 Ib1121

A1a6 Ib993 A1a14 Ib1025 A1a8 Ib1073 A1a2 Ib1121

A1a7 Ib993 A1a1 Ib1041 A1a9 Ib1073 A1a3 Ib1121

A1a8 Ib993 A1a2 Ib1041 A1a10 Ib1073 A1a4 Ib1121

A1a9 Ib993 A1a3 Ib1041 A1a11 Ib1073 A1a5 Ib1121

A1a10 Ib993 A1a4 Ib1041 A1a12 Ib1073 A1a6 Ib1121

A1a11 Ib993 A1a5 Ib1041 A1a13 Ib1073 A1a7 Ib1121

A1a12 Ib993 A1a6 Ib1041 A1a14 Ib1073 A1a8 Ib1121

A1a13 Ib993 A1a7 Ib1041 A1a1 Ib1089 A1a9 Ib1121

A1a14 Ib993 A1a8 Ib1041 A1a2 Ib1089 A1a10 Ib1121

A1a1 Ib1009 A1a9 Ib1041 A1a3 Ib1089 A1a11 Ib1121

A1a2 Ib1009 A1a10 Ib1041 A1a4 Ib1089 A1a12 Ib1121

A1a3 Ib1009 A1a11 Ib1041 A1a5 Ib1089 A1a13 Ib1121

A1a4 Ib1009 A1a12 Ib1041 A1a6 Ib1089 A1a14 Ib1121

A1a5 Ib1009 A1a13 Ib1041 A1a7 Ib1089 A1a1 Ib1137

A1a6 Ib1009 A1a14 Ib1041 A1a8 Ib1089 A1a2 Ib1137

A1a7 Ib1009 A1a1 Ib1057 A1a9 Ib1089 A1a3 Ib1137

A1a8 Ib1009 A1a2 Ib1057 A1a10 Ib1089 A1a4 Ib1137

A1a9 Ib1009 A1a3 Ib1057 A1a11 Ib1089 A1a5 Ib1137

A1a10 Ib1009 A1a4 Ib1057 A1a12 Ib1089 A1a6 Ib1137

A1a11 Ib1009 A1a5 Ib1057 A1a13 Ib1089 A1a7 Ib1137

A1a12 Ib1009 A1a6 Ib1057 A1a14 Ib1089 A1a8 Ib1137

A1a13 Ib1009 A1a7 Ib1057 A1a1 Ib1105 A1a9 Ib1137

A1a14 Ib1009 A1a8 Ib1057 A1a2 Ib1105 A1a10 Ib1137 Radical lb

A

A1a11 Ib1137

A1a12 Ib1137

A1a13 Ib1137

A1a14 Ib1137

A1a1 Ib1153

A1a2 Ib1153

A1a3 Ib1153

A1a4 Ib1153

A1a5 Ib1153

A1a6 Ib1153

A1a7 Ib1153

A1a8 Ib1153

A1a9 Ib1153

A1a10 Ib1153

A1a11 Ib1153

A1a12 Ib1153

A1a13 Ib1153

A1a14 Ib1153

Compounds of formula I can be prepared according to the following methods and variations described in schemes 1 -5. The variables R ¹ , R ² , R ³ , R ⁴ , R ^5a , R ^5b , R ^5c , R ^5d , A ¹ , A ² , A ³ , A ⁴ , and p are defined as above for formula I.

Compounds of formula I can, for example, be prepared by reaction of amines (or salts thereof) and quinazolines of the formula 4 as described by, for example, An- anthan et al, Bioorg. Med. Chem. Lett. 2002, 12, 2225 and outlined in Scheme 1. Depending on the conditions, bases such as triethylamine or potassium carbonate may be necessary. The reaction can be run in a wide variety of solvents including Tetrahydrofuran (THF), dioxane, and isopropanol or the like. The corresponding quinazolines of the formula 4 containing a leaving group (LG) wherein LG is a fluorine, chlorine, bromine, iodine, thioethers, sulfonates or another suitable leaving group can be prepared from quinazolinones of the formula 3 for example by reaction with a halogenating agent such as phosphorus oxychloride, phosphorus trichloride, phosphorus pentachloride, thionyl chloride, phosphorus tribromide, phosphorus triiodide as described, for example, by Hayakawa, Bioorg. Med. Chem. 2006, 14, 6847. Depending on the conditions solvents such as dioxane, ether, toluene, DMF or the like can be employed. Quinazolinones of the formula 3 can be prepared from anthranilamides of formula 1 and aldehydes of formula 2 in the presence of reagents such as iron chloride (or hydrates thereof), iodine, sodium bisulfite or 2,3- dichloro-4,5-dicyano-1 ,4-benzoquinone as described, for example, by Wang et al, Bull. Chem. Soc. Jpn. 2006, 79, 1426.

Quinazolinones of the formula 3 can also be prepared as outlined in Scheme 2 from arylhalides of the formula 7 and amidines of the formula 8 under copper catalysis as described, for example, by Liu, Angew. Chem. Int. Ed. 2009, 48, 348. Alternatively, quinazolinones of the formula 3 can be prepared from anilines 5 and nitriles 6 under acidic conditions (e.g. hydrochloric acid) as described, for example, by Bogolubsky et al, J. Comb. Chem. 2008, 10, 858 for from amides of the formula 9 under basic conditions (e.g. sodium hydroxide) as described, for example, by Roy et al, J. Org. Chem. 2006, 71 , 382.

Scheme 2:

Aminoquinazolines of the formula (I) can be prepared as outlined in Scheme 3 by a coupling reaction between intermediates of the formula 13 and intermediates of the formula 14 in the presence of metal catalyst derived from, for example, palladium, platinum, iron, copper or nickel where LG or Y are, for example, a fluorine, chlorine, bromine, iodine, triflate, thioether, boronic acid, boronate ester, trifluoroborate, or- ganoborane or organostannane or other suitable leaving group. A phosphine-, amine-, sulfoxide-derived ligand and base such as potassium carbonate or triethylemine may also be required for the reaction as described, for example, by Itoh et al, Adv. Syn. Cat. 2004, 346, 1859. Intermediate of the formula 13 can be prepared from dichloroquinazoline of the formula 12 where LG is an analogous leaving group as described above. In turn the corresponding quinazolines of the formula 12 can be prepared from quinazoline-2,4-diones of the formula 1 1 using a similar method to that used to prepare intermediates of the formula 4. Quinazoline- 2,4-diones of the formula 1 1 can be prepared from anthranilic acids of the formula 10 using reagents such as urea, isocyanate, thioisocyanate as described, for example, by Smits et al, J. Med. Chem. 2008, 7855.

Scheme 3:

Anthranilamides of the formula 1 can be prepared following an analogous route as that described in Scheme 4 [T. Sandmeyer, Helv. Chim. Acta 1919, 2, 234 or S. J. Garden et al, Tetrahedron Lett. 1997, 38(9), 1501] starting from isatoic anhydrides of the formula 18 in one step using a reagent such as ammonia or in two steps using an amine-based nucleophile such an benzylamine, hydroxylamine or azide fol- lowed by reduction with, for example, hydrogen or ammonium formate as described, for example by Klaubert et al, J. Med. Chem. 1981 , 24, 742 and Singh et al, J. Heterocyclic Chem. 1990, 27, 2101 . Isatoic anhydrides of the formula 18 can be synthesized from indole-2,3-diones of the formula 17 by oxidation with e.g. meta-chloroperbenzoic acid [G. M. Coppola, J. Heterocyclic Chem. 1987, 24, 1249], hydrogen peroxide or chromic acid in a solvent such as dichloromethane, acetic acid or water. In turn indole-2,3-diones of the formula 17 can be prepared in a Friedel-Crafts-type reaction from isonitrosoacetanilides of the formula 16 using a protic or Lewis acid such as sulfuric acid or aluminium trichloride. Finally isonitrosoacetanilides of the formula 16 can be prepared from substituted anilines of the formula 15 using chloral and hydroxylamine as reagents.

Scheme 4:

18

Anthranilamides of the formula 1 , bearing strongly electron withdrawing substitu- ents on th e phenyl ring, are accessible through corresponding indole-2,3-diones of the formula 17 which in turn can be prepared following a route as that described by P. Hewawasam et al, Tetrahedron Lett. 1994, 35, 7303 and which is outlined in Scheme 5. lndole-2,3-diones of the formula 17 can be prepared by treatment of oxoacetic acid esters of the formula 20 with acids such as hydrochloric acid, trifluoroacetic acid, and triflic acid in solvents such as THF, water or CH2CI2 as described, for example, by Hamashima et al., J. Am. Chem. Soc. 2005, 127, 10154. In turn oxoacetic acid esters of the formula 20, R ^x being for example ethyl, methyl, can be prepared by exposure of carbamates of the formula 19 to strong carbon bases such as n-, sec-, or t-BuLi followed by reaction of the resultant carbanion with oxoacetic acid diesters. Finally carbamates of the formula 19 can be prepared from anilines of the formula 15 by reaction with di-t-butyldicarbonate. Scheme 5:

19 20

If individual compounds cannot be prepared via the above-described routes, they can be prepared by derivatization of other compounds I or by customary modifica- tions of the synthesis routes described.

The reaction mixtures are worked up in the customary manner, for example by mixing with water, separating the phases, and, if appropriate, purifying the crude products by chromatography, for example on alumina or silica gel. Some of the inter- mediates and end products may be obtained in the form of colorless or pale brown viscous oils, which are freed or purified from volatile components under reduced pressure and at moderately elevated temperature. If the intermediates and end products are obtained as solids, they may be purified by recrystallization or digestion.

The present invention also provides a method for controlling invertebrate pests which method comprises treating the pests, their food supply, their habitat or their breeding ground or a cultivated plant, plant propagation materials (such as seed), soil, area, material or environment in which the pests are growing or may grow, or the materials, cultivated plants, plant propagation materials (such as seed), soils, surfaces or spaces to be protected from pest attack or infestation with a pesticidally effective amount of a compound of formula I or a salt or N-oxide thereof or a composition as defined above. Preferably, the method of the invention serves for protecting plant propagation material (such as seed) and the plant which grows therefrom from invertebrate pest attack or infestation and comprises treating the plant propagation material (such as seed) with a pesticidally effective amount of a compound of formula I or an agriculturally acceptable salt or N-oxide thereof as defined above or with a pesticidally effective amount of an agricultural composition as defined above and below. The method of the invention is not limited to the protection of the "substrate" (plant, plant propagation materials, soil material etc.) which has been treated according to the invention, but also has a preventive effect, thus, for example, according protec- tion to a plant which grows from a treated plant propagation materials (such as seed), the plant itself not having been treated.

In the sense of the present invention, "invertebrate pests" are preferably selected from arthropods and nematodes, more preferably from harmful insects, arachnids and nematodes, and even more preferably from insects, acarids and nematodes. In the sense of the present invention, "invertebrate pests" are most preferably insects.

The invention further provides an agricultural composition for combating such inver- tebrate pests, which comprises such an amount of at least one compound of the general formula I or at least one agriculturally useful salt or N-oxide thereof and at least one inert liquid and/or solid agronomically acceptable carrier that has a pesti- cidal action and, if desired, at least one surfactant. Such a composition may contain a single active compound of the formula I or a salt or N-oxide thereof or a mixture of several active compounds I or their salts according to the present invention. The composition according to the present invention may comprise an individual isomer or mixtures of isomers as well as individual tautomers or mixtures of tautomers.

The compounds of the formula I and the pestidicidal compositions comprising them are effective agents for controlling arthropod pests and nematodes. Invertebrate pests controlled by the compounds of formula I include for example insects from the order of the lepidopterans (Lepidoptera), for example Agrotis ypsi- lon, Agrotis segetum, Alabama argillacea, Anticarsia gemmatalis, Argyresthia con- jugella, Autographa gamma, Bupalus piniarius, Cacoecia murinana, Capua reticu- lana, Cheimatobia brumata, Choristoneura fumiferana, Choristoneura occidentalis, Cirphis unipuncta, Cydia pomonella, Dendrolimus pini, Diaphania nitidalis, Diatraea grandiosella, Earias insulana, Elasmopalpus lignosellus, Eupoecilia ambiguella, Evetria bouliana, Feltia subterranea, Galleria mellonella, Grapholitha funebrana, Grapholitha molesta, Heliothis armigera, Heliothis virescens, Heliothis zea, Hellula undalis, Hibernia defoliaria, Hyphantria cunea, Hyponomeuta malinellus, Keiferia lycopersicella, Lambdina fiscellaria, Laphygma exigua, Leucoptera coffeella, Leu- coptera scitella, Lithocolletis blancardella, Lobesia botrana, Loxostege sticticalis, Lymantria dispar, Lymantria monacha, Lyonetia clerkella, Malacosoma neustria, Mamestra brassicae, Orgyia pseudotsugata, Ostrinia nubilalis, Panolis flammea, Pectinophora gossypiella, Peridroma saucia, Phalera bucephala, Phthorimaea op- erculella, Phyllocnistis citrella, Pieris brassicae, Plathypena scabra, Plutella xylos- tella, Pseudoplusia includens, Rhyacionia frustrana, Scrobipalpula absoluta, Sito- troga cerealella, Sparganothis pilleriana, Spodoptera frugiperda, Spodoptera lit- toralis, Spodoptera litura, Thaumatopoea pityocampa, Tortrix viridana, Trichoplu- siani and Zeiraphera canadensis; beetles (Coleoptera), for example Agrilus sinuatus, Agriotes lineatus, Agriotes ob- scu-rus, Amphimallus solstitialis, Anisandrus dispar, Anthonomus grandis, An- thonomus pomorum, Atomaria linearis, Blastophagus piniperda, Blitophaga undata, Bruchus rufi-manus, Bruchus pisorum, Bruchus lentis, Byctiscus betulae, Cassida nebulosa, Cero-toma trifurcata, Ceuthorrhynchus assimilis, Ceuthorrhynchus napi, Chaetocnema tibi-alis, Conoderus vespertinus, Crioceris asparagi, Diabrotica longicornis, Diabrotica 12 punctata, Diabrotica virgifera, Epilachna varivestis, Epitrix hirtipennis, Eutinobothrus brasiliensis, Hylobius abietis, Hypera brunneipen- nis, Hypera postica, Ips typographus, Lema bilineata, Lema melanopus, Leptino- tarsa decemlineata, Limonius californicus, Lissorhoptrus oryzophilus, Melanotus communis, Meligethes aeneus, Melolontha hip-pocastani, Melolontha melolontha, Oulema oryzae, Ortiorrhynchus sulcatus, Otiorrhyn-chus ovatus, Phaedon coch- leariae, Phyllotreta chrysocephala, Phyllophaga sp., Phyl-lopertha horticola, Phyllotreta nemorum, Phyllotreta striolata, Popillia japonica, Sitona lineatus and Sitophi- lus granaria; dipterans (Diptera), for example Aedes aegypti, Aedes vexans, Anastrepha ludens, Anopheles maculipennis, Ceratitis capitata, Chrysomya bezziana, Chrysomya homi-nivorax, Chrysomya macellaria, Contarinia sorghicola, Cordylobia anthropo- phaga, Culex pipiens, Dacus cucurbitae, Dacus oleae, Dasineura brassicae, Fan- nia canicularis, Gasterophilus intestinalis, Glossina morsitans, Haematobia irritans, Haplodiplosis equestris, Hylemyia platura, Hypoderma lineata, Liriomyza sativae, Liriomyza trifolii, Lucilia caprina, Lucilia cuprina, Lucilia sericata, Lycoria pectoralis, Mayetiola destruc-tor, Musca domestica, Muscina stabulans, Oestrus ovis, Os- cinella frit, Pegomya hyso-cyami, Phorbia antiqua, Phorbia brassicae, Phorbia coarctata, Rhagoletis cerasi, Rhagoletis pomonella, Tabanus bovinus, Tipula ol- eracea and Tipula paludosa; thrips (Thysanoptera), e.g. Dichromothrips corbetti, Frankliniella fusca, Frankliniella occidentalis, Frankliniella tritici, Scirtothrips citri, Thrips oryzae, Thrips palmi and Thrips tabaci; hymenopterans (Hymenoptera), e.g. Athalia rosae, Atta cephalotes, Atta sexdens, Atta texana, Hoplocampa minuta, Hoplocampa testudinea, Monomorium pharaonis, So-lenopsis geminata and Solenopsis invicta; heteropterans (Heteroptera), e.g. Acrosternum hilare, Blissus leucopterus, Cyr- topeltis notatus, Dysdercus cingulatus, Dysdercus intermedius, Eurygaster integri- ceps, Euschistus impictiventris, Leptoglossus phyllopus, Lygus lineolaris, Lygus pratensis, Nezara viridula, Piesma quadrata, Solubea insularis and Thyanta perdi- tor; homopterans (Homoptera), e.g. Acyrthosiphon onobrychis, Adelges laricis,

Aphidula nasturtii, Aphis fabae, Aphis forbesi, Aphis pomi, Aphis gossypii, Aphis grossulariae, Aphis schneideri, Aphis spiraecola, Aphis sambuci, Acyrthosiphon pisum, Aulacorthum solani, Bemisia argentifolii, Bemisia tabaci, Brachycaudus car- dui, Brachycaudus helichrysi, Brachycaudus persicae, Brachycaudus prunicola, Brevicoryne brassicae, Capitophorus horni, Cerosipha gossypii, Chaetosiphon fra- gaefolii, Cryptomyzus ribis, Dreyfusia nordmannianae, Dreyfusia piceae, Dysaphis radicola, Dysaulacorthum pseudosolani, Dysaphis plantaginea, Dysaphis pyri, Em- poasca fabae, Hyalopterus pruni, Hyperomyzus lactucae, Macrosiphum avenae, Macrosiphum euphorbiae, Macrosiphon rosae, Megoura viciae, Melanaphis pyrarius, Metopolophium dirhodum, Myzodes persicae, Myzus ascalonicus, Myzus cerasi, Myzus persicae, Myzus varians, Nasonovia ribis-nigri, Nilaparvata lugens, Pemphigus bursarius, Perkinsiella saccharicida, Phorodon humuli, Psylla mali, Psylla piri, Rhopalomyzus ascalonicus, Rhopalosiphum maidis, Rhopalosiphum padi, Rhopalosiphum insertum, Sappaphis mala, Sappaphis mali, Schizaphis graminum, Schizoneura lanuginosa, Sitobion avenae, Sogatella furcifera Trialeu- rodes vaporariorum, Toxoptera aurantiiand, and Viteus

vitifolii; termites (Isoptera), e.g. Calotermes flavicollis, Leucotermes flavipes, Reticulitermes flavipes, Reticulitermes lucifugus und Termes natalensis; orthopterans (Orthoptera), e.g. Acheta domestica, Blatta orientalis, Blattella ger- manica, Forficula auricularia, Gryllotalpa gryllotalpa, Locusta migratoria, Melano- plus bivittatus, Melanoplus femur-rubrum, Melanoplus mexicanus, Melanoplus san- guinipes, Melano-plus spretus, Nomadacris septemfasciata, Periplaneta america- na, Schistocerca ameri-cana, Schistocerca peregrina, Stauronotus maroccanus and Tachycines asynamorus; arachnoidea, such as arachnids (Acarina), e.g. of the families Argasidae, Ixodidae and Sarcoptidae, such as Amblyomma americanum, Amblyomma variegatum, Ar- gas persicus, Boophilus annulatus, Boophilus decoloratus, Boophilus microplus, Dermacentor silvarum, Hyalomma truncatum, Ixodes ricinus, Ixodes rubicundus, Ornithodorus moubata, Otobius megnini, Dermanyssus gallinae, Psoroptes ovis, Rhipicephalus appendiculatus, Rhipicephalus evertsi, Sarcoptes scabiei, and Erio- phyidae spp. such as Aculus schlechtendali, Phyllocoptrata oleivora and Eriophyes sheldoni; Tarsonemidae spp. such as Phytonemus pallidus and Polyphagotarso- nemus latus; Tenuipalpidae spp. such as Brevipalpus phoenicis; Tetranychidae spp. such as Tetranychus cinnabarinus, Tetranychus kanzawai, Tetranychus paci- ficus, Tetranychus telarius and Tetranychus urticae, Panonychus ulmi, Panonychus citri, and oligonychus pratensis; siphonatera, e.g. Xenopsylla cheopsis, Ceratophyllus spp. The compositions and compounds of formula I are useful for the control of nematodes, especially plant parasitic nematodes such as root knot nematodes, Meloido- gyne hapla,Meloidogyne incognita, Meloidogyne javanica, and other Meloidogyne species; cyst-forming nematodes, Globodera rostochiensis and other Globodera species; Het-erodera avenae, Heterodera glycines, Heterodera schachtii, Heterodera trifolii, and other Heterodera species; Seed gall nematodes, Anguina species; Stem and foliar nematodes, Aphelenchoides species; Sting nematodes, Belonolaimus longi- caudatus and other Belonolaimus species; Pine nematodes, Bursaphelenchus xy- lophilus and other Bursaphelenchus species; Ring nematodes, Criconema species, Criconemella species, Criconemoides species, Mesocriconema species; Stem and bulb nematodes, Ditylenchus destructor, Ditylenchus dipsaci and other Ditylenchus species; Awl nema-todes, Dolichodorus species; Spiral nematodes, Heliocotylen- chus multicinctus and other Helicotylenchus species; Sheath and sheathoid nema- todes, Hemicycliophora species and Hemicriconemoides species; Hirshmanniella species; Lance nematodes, Hoploaimus species; false rootknot nematodes, Na- cobbus species; Needle nematodes, Longidorus elongatus and other Longidorus species; Pin nematodes, Paratylen-chus species; Lesion nematodes, Pratylenchus neglectus, Pratylenchus penetrans, Pratylenchus curvitatus, Pratylenchus goodeyi and other Pratylenchus species; Burrowing nematodes, Radopholus similis and other Radopholus species; Reniform nematodes, Rotylenchus robustus and other Rotylenchus species; Scutellonema species; Stubby root nematodes, Trichodorus primitivus and other Trichodorus species, Paratrichodorus species; Stunt nematodes, Tylenchorhynchus claytoni, Tylenchorhynchus dubius and other Tylenchor- hynchus species; Citrus nematodes, Tylenchulus species; Dagger nematodes, Xi- phinema species; and other plant parasitic nematode species.

In a preferred embodiment of the invention the compounds of formula I are used for controlling insects or arachnids, in particular insects of the orders Lepidoptera, Coleoptera, Thysanoptera and Homoptera and arachnids of the order Acarina. The compounds of the formula I according to the present invention are particularly use- ful for controlling insects of the order Thysanoptera and Homoptera.

The compounds of formula formula I or the pesticidal compositions comprising them may be used to protect growing plants and crops from attack or infestation by invertebrate pests, especially insects, acaridae or arachnids by contacting the plant/crop with a pesticidally effective amount of compounds of formula I. The term "crop" refers both to growing and harvested crops.

The compounds of formula I can be converted into the customary formulations, for example solutions, emulsions, suspensions, dusts, powders, pastes and granules. The use form depends on the particular intended purpose; in each case, it should ensure a fine and even distribution of the compound according to the invention.

The formulations are prepared in a known manner (see e.g. for review US

3,060,084, EP-A 707 445 (for liquid concentrates), Browning, "Agglomeration", Chemical Engi-neering, Dec. 4, 1967, 147-48, Perry's Chemical Engineer's Handbook, 4th Ed., McGraw-Hill, New York, 1963, pages 8-57 and et seq. WO

91/13546, US 4,172,714, US 4,144,050, US 3,920,442, US 5,180,587, US

5,232,701 , US 5,208,030, GB 2,095,558, US 3,299,566, Klingman, Weed Control as a Science, John Wiley and Sons, Inc., New York, 1961 , Hance et al., Weed Control Handbook, 8th Ed., Blackwell Scientific Publications, Oxford, 1989 and Mollet, H., Grubemann, A., Formulation tech-nology, Wiley VCH Verlag GmbH, Weinheim (Germany), 2001 , 2. D. A. Knowles, Chemistry and Technology of Agro- chemical Formulations, Kluwer Academic Publishers, Dordrecht, 1998 (ISBN 0- 7514-0443-8), for example by extending the active compound with auxiliaries suitable for the formulation of agrochemicals, such as solvents and/or carriers, if desired emulsifiers, surfactants and dispersants, preservatives, anti-foaming agents, anti-freezing agents, for seed treatment formulation also optionally colorants and/or binders and/or gelling agents.

Examples of suitable solvents are water, aromatic solvents (for example Solvesso products, xylene), paraffins (for example mineral oil fractions), alcohols (for exam- pie methanol, butanol, pentanol, benzyl alcohol), ketones (for example cyclohexa- none, gamma-butyrolactone), pyrrolidones (N-methylpyrrolidone [NMP], N- octylpyrrolidone [NOP]), acetates (glycol diacetate), glycols, fatty acid dimethyla- mides, fatty acids and fatty acid esters. In principle, solvent mixtures may also be used.

Suitable emulsifiers are non-ionic and anionic emulsifiers (for example poly- oxyethylene fatty alcohol ethers, alkylsulfonates and arylsulfonates).

Examples of dispersants are lignin-sulfite waste liquors and methylcellulose.

Suitable surfactants used are alkali metal, alkaline earth metal and ammonium salts of lignosulfonic acid, naphthalenesulfonic acid, phenolsulfonic acid, dibutyl- naphthalene-sulfonic acid, alkylarylsulfonates, alkyl sulphates, alkylsulfonates, fatty alcohol sulfates, fatty acids and sulphated fatty alcohol glycol ethers, furthermore condensates of sulfonated naphthalene and naphthalene derivatives with formaldehyde, condensates of naphthalene or of naphthalenesulfonic acid with phenol and formaldehyde, polyoxyethylene octylphenol ether, ethoxylated isooctylphenol, octylphenol, nonylphenol, alkylphenol polyglycol ethers, tributylphenyl polyglycol ether, tristearylphenyl polyglycol ether, alkylaryl polyether alcohols, alcohol and fatty alcohol ethylene oxide condensates, ethoxylated castor oil, polyoxyethylene alkyl ethers, ethoxylated polyoxypropyl-ene, lauryl alcohol polyglycol ether acetal, sorbitol esters, lignosulfite waste liquors and methylcellulose.

Substances which are suitable for the preparation of directly sprayable solutions, emulsions, pastes or oil dispersions are mineral oil fractions of medium to high boiling point, such as kerosene or diesel oil, furthermore coal tar oils and oils of vegetable or animal origin, aliphatic, cyclic and aromatic hydrocarbons, for example toluene, xylene, paraffin, tetrahydronaphthalene, alkylated naphthalenes or their derivatives, methanol, etha-nol, propanol, butanol, cyclohexanol, cyclohexanone, isophorone, highly polar solvents, for example dimethyl sulfoxide, N- methylpyrrolidone or water.

Also anti-freezing agents such as glycerin, ethylene glycol, propylene glycol and bactericides such as can be added to the formulation.

Suitable antifoaming agents are for example antifoaming agents based on silicon or magnesium stearate.

A suitable preservative is e.g. dichlorophen.

Seed treatment formulations may additionally comprise binders and optionally color-ants.

Binders can be added to improve the adhesion of the active materials on the seeds after treatment. Suitable binders are block copolymers EO/PO surfactants but also polyvinylalcoholsl, polyvinylpyrrolidones, polyacrylates, polymethacrylates, poly- bute-nes, polyisobutylenes, polystyrene, polyethyleneamines, polyethyleneamides, poly-ethyleneimines (Lupasol ^® , Polymin ^® ), polyethers, polyurethans, polyvinylace- tate, ty-lose and copolymers derived from these polymers.

Optionally, also colorants can be included in the formulation. Suitable colorants or dyes for seed treatment formulations are Rhodamin B, C.I. Pigment Red 1 12, C.I. Solvent Red 1 , pigment blue 15:4, pigment blue 15:3, pigment blue 15:2, pigment blue 15:1 , pigment blue 80, pigment yellow 1 , pigment yellow 13, pigment red 1 12, pigment red 48:2, pigment red 48:1 , pigment red 57:1 , pigment red 53:1 , pigment orange 43, pigment orange 34, pigment orange 5, pigment green 36, pigment green 7, pigment white 6, pigment brown 25, basic violet 10, basic violet 49, acid red 51 , acid red 52, acid red 14, acid blue 9, acid yellow 23, basic red 10, basic red 108.

An example of a gelling agent is carrageen (Satiagel ^® ).

Powders, materials for spreading and dustable products can be prepared by mixing or concomitantly grinding the active substances with a solid carrier. Granules, for example coated granules, impregnated granules and homogeneous granules, can be prepared by binding the active compounds to solid carriers. Examples of solid carriers are mineral earths such as silica gels, silicates, talc, kaolin, attaclay, limestone, lime, chalk, bole, loess, clay, dolomite, diatomaceous earth, calcium sulfate, magnesium sulfate, magnesium oxide, ground synthetic materials, fertilizers, such as, for example, ammonium sulfate, ammonium phosphate, ammonium nitrate, ureas, and products of vegetable origin, such as cereal meal, tree bark meal, wood meal and nutshell meal, cellulose powders and other solid carriers.

In general, the formulations comprise from 0.01 to 95 % by weight, preferably from 0.1 to 90 % by weight, of the active compound(s). In this case, the active com- pound(s) are employed in a purity of from 90 % to 100 by weight, preferably 95 % to 100% % by weight (according to NMR spectrum).

For seed treatment purposes, respective formulations can be diluted 2- to10-fold leading to concentrations in the ready to use preparations of 0.01 to 60 % by weight active compound by weight, preferably 0.1 to 40 % by weight.

The compounds of formula I can be used as such, in the form of their formulations or the use forms prepared therefrom, for example in the form of directly sprayable solutions, powders, suspensions or dispersions, emulsions, oil dispersions, pastes, dustable products, materials for spreading, or granules, by means of spraying, atomizing, dusting, spreading or pouring. The use forms depend entirely on the intended purposes; they are intended to ensure in each case the finest possible distribution of the active compound(s) according to the invention. Aqueous use forms can be prepared from emulsion concentrates, pastes or wetable powders (sprayable powders, oil dispersions) by adding water. To prepare emulsions, pastes or oil dispersions, the substances, as such or dissolved in an oil or solvent, can be homogenized in water by means of a wetting agent, tackifier, dispersant or emulsifier. However, it is also possible to prepare concentrates com- posed of active substance, wetting agent, tackifier, dispersant or emulsifier and, if appropriate, solvent or oil, and such concentrates are suitable for dilution with water. The active compound concentrations in the ready-to-use preparations can be varied within relatively wide ranges. In general, they are from 0.0001 to %10, preferably from 0.01 to 1 % per weight.

The active compound(s) may also be used successfully in the ultra-low-volume process (ULV), it being possible to apply formulations comprising over 95 % by weight of active compound, or even to apply the active compound without additives.

The following are examples of formulations:

1 . Products for dilution with water for foliar applications. For seed treatment purposes, such products may be applied to the seed diluted or undiluted.

A) Water-soluble concentrates (SL, LS)

10 parts by weight of the active compound(s) are dissolved in 90 parts by weight of water or a water-soluble solvent. As an alternative, wetting agents or other auxilia- ries are added. The active compound(s) dissolves upon dilution with water, whereby a formula-tion with 10 % (w/w) of active compound(s) is obtained.

B) Dispersible concentrates (DC) 20 parts by weight of the active compound(s) are dissolved in 70 parts by weight of cyclohexanone with addition of 10 parts by weight of a dispersant, for example polyvinylpyrrolidone. Dilution with water gives a dispersion, whereby a formulation with 20 % (w/w) of active compound(s) is obtained. C) Emulsifiable concentrates (EC)

15 parts by weight of the active compound(s) are dissolved in 7 parts by weight of xy-lene with addition of calcium dodecylbenzenesulfonate and castor oil ethoxylate (in each case 5 parts by weight). Dilution with water gives an emulsion, whereby a formu-lation with 15 % (w/w) of active compound(s) is obtained.

D) Emulsions (EW, EO, ES) 25 parts by weight of the active compound(s) are dissolved in 35 parts by weight of xylene with addition of calcium dodecylbenzenesulfonate and castor oil ethoxylate (in each case 5 parts by weight). This mixture is introduced into 30 parts by weight of wa-ter by means of an emulsifier machine (e.g. Ultraturrax) and made into a homogeneous emulsion. Dilution with water gives an emulsion, whereby a formulation with 25 % (w/w) of active compound(s) is obtained.

E) Suspensions (SC, OD, FS)

In an agitated ball mill, 20 parts by weight of the active compound(s) are comminuted with addition of 10 parts by weight of dispersants, wetting agents and 70 parts by weight of water or of an organic solvent to give a fine active compound(s) suspension. Dilution with water gives a stable suspension of the active compound(s), whereby a formulation with 20 % (w/w) of active compound(s) is obtained.

F) Water-dispersible granules and water-soluble granules (WG, SG)

50 parts by weight of the active compound(s) are ground finely with addition of 50 parts by weight of dispersants and wetting agents and made as water-dispersible or water-soluble granules by means of technical appliances (for example extrusion, spray tower, fluidized bed). Dilution with water gives a stable dispersion or solution of the active compound(s), whereby a formulation with 50 % (w/w) of active compound^) is obtained.

G) Water-dispersible powders and water-soluble powders (WP, SP, SS, WS)

75 parts by weight of the active compound(s) are ground in a rotor-stator mill with addition of 25 parts by weight of dispersants, wetting agents and silica gel. Dilution with water gives a stable dispersion or solution of the active compound(s), whereby a formulation with 75 % (w/w) of active compound(s) is obtained.

H) Gel-Formulation (GF) In an agitated ball mill, 20 parts by weight of the active compound(s) are comminuted with addition of 10 parts by weight of dispersants, 1 part by weight of a gelling agent wetting agents and 70 parts by weight of water or of an organic solvent to give a fine active compound(s) suspension. Dilution with water gives a stable suspension of the active compound(s), whereby a formulation with 20 % (w/w) of active compound(s) is obtained. 2. Products to be applied undiluted for foliar applications. For seed treatment purposes, such products may be applied to the seed diluted or undiluted.

I) Dustable powders (DP, DS) 5 parts by weight of the active compound(s) are ground finely and mixed intimately with 95 parts by weight of finely divided kaolin. This gives a dustable product having 5 % (w/w) of active compound(s)

J) Granules (GR, FG, GG, MG)

0.5 parts by weight of the active compound(s) is ground finely and associated with 95.5 parts by weight of carriers, whereby a formulation with 0.5 % (w/w) of active com-pound(s) is obtained. Current methods are extrusion, spray-drying or the fluid- ized bed. This gives granules to be applied undiluted for foliar use.

K) ULV solutions (UL)

10 parts by weight of the active compound(s) are dissolved in 90 parts by weight of an organic solvent, for example xylene. This gives a product having 10 % (w/w) of active compound(s), which is applied undiluted for foliar use.

The compounds of formula I are also suitable for the treatment of plant propagation materials (such as seed). Conventional seed treatment formulations include for example flowable concentrates FS, solutions LS, powders for dry treatment DS, water dispersible powders for slurry treatment WS, water-soluble powders SS and emulsion ES and EC and gel formulation GF. These formulations can be applied to the seed diluted or undiluted. Application to the seeds is carried out before sowing, either directly on the seeds or after having pre-germinated the latter In a preferred embodiment a FS formulation is used for seed treatment. Typically, a FS formulation may comprise 1 to 800 g/l of active ingredient, 1 to 200 g/l surfactant, 0 to 200 g/l antifreezing agent, 0 to 400 g/l of binder, 0 to 200 g/l of a pigment and up to 1 liter of a solvent, preferably water.

Other preferred FS formulations of compounds of formula I for seed treatment comprise from 0.5 to 80 wt of the active ingredient, from 0.05 to 5 wt of a wetting agent, from 0.5 to 15 wt of a dispersing agent, from 0.1 to 5 wt of a thickener, from 5 to 20 wt of an anti-freeze agent, from 0.1 to 2 wt of an anti-foam agent, from 1 to 20 wt of a pigment and/or a dye, from 0 to 15 wt of a sticker /adhesion agent, from 0 to 75 wt of a filler/vehicle, and from 0.01 to 1 wt of a preservative. Various types of oils, wetting agents, adjuvants, herbicides, fungicides, other pesticides, or bactericides may be added to the active ingredients, if appropriate just immediately prior to use (tank mix). These agents usually are admixed with the agents according to the invention in a weight ratio of 1 :10 to 10:1 . The compounds of formula I are effective through both contact (via soil, glass, wall, bed net, carpet, plant parts or animal parts), and ingestion (bait, or plant part).

For use against ants, termites, wasps, flies, mosquitoes, crickets, or cockroaches, corn-pounds of formula I are preferably used in a bait composition.

The bait can be a liquid, a solid or a semisolid preparation (e.g. a gel). Solid baits can be formed into various shapes and forms suitable to the respective application e.g. granules, blocks, sticks, disks. Liquid baits can be filled into various devices to ensure proper application, e.g. open containers, spraying devices, droplet sources, or evaporation sources. Gels can be based on aqueous or oily matrices and can be formulated to particular necessities in terms of stickiness, moisture retention or aging characteristics.

The bait employed in the composition is a product, which is sufficiently attractive to incite insects such as ants, termites, wasps, flies, mosquitoes, crickets etc. or cockroaches to eat it. The attractiveness can be manipulated by using feeding stimulants or sex pheromones. Food stimulants are chosen, for example, but not exclusively, from animal and/or plant proteins (meat-, fish- or blood meal, insect parts, egg yolk), from fats and oils of animal and/or plant origin, or mono-, oligo- or poly- organosaccharides, especially from sucrose, lactose, fructose, dextrose, glucose, starch, pectin or even molasses or honey. Fresh or decaying parts of fruits, crops, plants, animals, insects or specific parts thereof can also serve as a feeding stimu- lant. Sex pheromones are known to be more insect specific. Specific pheromones are described in the literature and are known to those skilled in the art.

Formulations of compounds of formula I as aerosols (e.g. in spray cans), oil sprays or pump sprays are highly suitable for the non-professional user for controlling pests such as flies, fleas, ticks, mosquitos or cockroaches. Aerosol recipes are preferably corn-posed of the active compound, solvents such as lower alcohols (e.g. methanol, ethanol, propanol, butanol), ketones (e.g. acetone, methyl ethyl ketone), paraffin hydrocar-bons (e.g. kerosenes) having boiling ranges of approxi- mately 50 to 250 °C, dimethyl-formamide, N-methylpyrrolidone, dimethyl sulphox- ide, aromatic hydrocarbons such as toluene, xylene, water, furthermore auxiliaries such as emulsifiers such as sorbitol monooleate, oleyl ethoxylate having 3 to 7 mol of ethylene oxide, fatty alcohol ethoxylate, perfume oils such as ethereal oils, esters of medium fatty acids with lower alcohols, aromatic carbonyl compounds, if appropriate stabilizers such as sodium benzoate, am-photeric surfactants, lower epoxides, triethyl orthoformate and, if required, propellants such as propane, butane, nitrogen, compressed air, dimethyl ether, carbon dioxide, nitrous oxide, or mixtures of these gases. The oil spray formulations differ from the aerosol recipes in that no propellants are used.

The compounds of formula I and their respective compositions can also be used in mosquito and fumigating coils, smoke cartridges, vaporizer plates or long-term va- porizers and also in moth papers, moth pads or other heat-independent vaporizer systems.

Methods to control infectious diseases transmitted by insects (e.g. malaria, dengue and yellow fever, lymphatic filariasis, and leishmaniasis) with compounds of for- mula I and its respective compositions also comprise treating surfaces of huts and houses, air spraying and impregnation of curtains, tents, clothing items, bed nets, tsetse-fly trap or the like. Insecticidal compositions for application to fibers, fabric, knitgoods, non-wovens, netting material or foils and tarpaulins preferably comprise a mixture including the insecticide, optionally a repellent and at least one binder. Suitable repellents for example are Ν,Ν-diethyl-meta-toluamide (DEET), N,N- diethylphenylacetamide (DEPA), 1 -(3-cyclohexan-1 -yl-carbonyl)-2-methylpiperine, (2-hydroxymethylcyclohexyl) acetic acid lactone, 2-ethyl-1 ,3-hexandiol, indalone, Methylneodecanamide (MNDA), a pyrethroid not used for insect control such as {(+/-)-3-allyl-2-methyl-4-oxocyclopent-2-

(+)-enyl-(+)-trans-chrysantemate (Esbiothrin), a repellent derived from or identical with plant extracts like limonene, eugenol, (+)-Eucamalol (1 ), (-)-l -epi-eucamalol or crude plant extracts from plants like Eucalyptus maculata, Vitex rotundifolia, Cym- bopogan martinii, Cymbopogan citratus (lemon grass), Cymopogan nartdus (citro- nella). Suitable binders are selected for example from polymers and copolymers of vinyl esters of aliphatic acids (such as such as vinyl acetate and vinyl versatate), acrylic and methacrylic esters of alcohols, such as butyl acrylate, 2- ethylhexylacrylate, and methyl acrylate, mono- and diethylenically unsaturated hydrocarbons, such as styrene, and aliphatic diens, such as butadiene.

The impregnation of curtains and bednets is done in general by dipping the textile ma-terial into emulsions or dispersions of the active compounds of formula I or spraying them onto the nets.

Methods which can be employed for treating the seed are, in principle, all suitable seed treatment and especially seed dressing techniques known in the art, such as seed coating (e.g. seed pelleting), seed dusting and seed imbibition (e.g. seed soaking). Here, "seed treatment" refers to all methods that bring seeds and the compounds of formula I into contact with each other, and "seed dressing" to methods of seed treatment which provide the seeds with an amount of the compounds of formula I, i.e. which generate a seed comprising the compound of formula I. In principle, the treatment can be applied to the seed at any time from the harvest of the seed to the sowing of the seed. The seed can be treated immediately before, or during, the planting of the seed, for example using the "planter's box" method. However, the treatment may also be carried out several weeks or months, for example up to 12 months, before planting the seed, for example in the form of a seed dressing treatment, without a substantially reduced efficacy being observed.

Expediently, the treatment is applied to unsown seed. As used herein, the term "unsown seed" is meant to include seed at any period from the harvest of the seed to the sowing of the seed in the ground for the purpose of germination and growth of the plant.

Specifically, a procedure is followed in the treatment in which the seed is mixed, in a suitable device, for example a mixing device for solid or solid/liquid mixing part- ners, with the desired amount of seed treatment formulations, either as such or after previ-ous dilution with water, until the composition is distributed uniformly on the seed. If ap-propriate, this is followed by a drying step. The compounds of formula I , or the enantiomers, diastereomers or veterinarily acceptable salts thereof are in particular also suitable for being used for combating parasites in and on animals.

An object of the present invention is therefore also to provide new methods to con- trol parasites in and on animals. Another object of the invention is to provide safer pesticides for animals. Another object of the invention is further to provide pesticides for animals that may be used in lower doses than existing pesticides. And another object of the invention is to provide pesticides for animals, which provide a long residual control of the parasites.

The invention also relates to compositions containing a parasiticidally effective amount of compounds of formula I or the enantiomers or veterinarily acceptable salts thereof and an acceptable carrier, for combating parasites in and on animals. The present invention also provides a method for treating, controlling, preventing and protecting animals against infestation and infection by parasites, which comprises orally, topically or parenterally administering or applying to the animals a parasiticidally effective amount of a compound of formula I or the enantiomers or veterinarily acceptable salts thereof or a composition comprising it.

The present invention also provides a non-therapeutic method for treating, controlling, preventing and protecting animals against infestation and infection by parasites, which comprises applying to a locus a parasiticidally effective amount of a compound of formula I or the enantiomers or veterinarily acceptable salts thereof or a composition comprising it.

The invention also provides a process for the preparation of a composition for treating, controlling, preventing or protecting animals against infestation or infection by parasites which comprises including a parasiticidally effective amount of a com- pound of formula I or the enantiomers or veterinarily acceptable salts thereof in a composition comprising it. The invention relates further to the use of compounds of formula I for treating, controlling, preventing or protecting animals against infestation or infection by parasites.

The invention relates also to the use of a compound of formula I, or a composition comprising it, for the manufacture of a medicament for the therapeutic treatment of animals against infections or infestions by parasites.

Activity of compounds against agricultural pests does not suggest their suitability for control of endo- and ectoparasites in and on animals which requires, for exam- pie, low, non-emetic dosages in the case of oral application, metabolic compatibility with the animal, low toxicity, and a safe handling.

Surprisingly it has now been found that compounds of formula I are suitable for combating endo- and ectoparasites in and on animals. The compounds of formula I or the enantiomers or veterinarily acceptable salts thereof and compositions comprising them are suitable for systemic and/or non-systemic control of ecto- and/or endoparasites. They are active against all or some stages of development.

Compounds of formula I or the enantiomers or veterinarily acceptable salts thereof and compositions comprising them are preferably used for controlling and preventing infestations and infections animals including warm-blooded animals (including humans) and fish. They are for example suitable for controlling and preventing infestations and infections in mammals such as cattle, sheep, swine, camels, deer, horses, pigs, poultry, rabbits, goats, dogs and cats, water buffalo, donkeys, fallow deer and reindeer, and also in fur-bearing animals such as mink, chinchilla and raccoon, birds such as hens, geese, turkeys and ducks and fish such as fresh- and salt-water fish such as trout, carp and eels.

Compounds of formula I or the enantiomers or veterinarily acceptable salts thereof and compositions comprising them are preferably used for controlling and preventing infestations and infections in domestic animals, such as dogs or cats.

Infestations in warm-blooded animals and fish include, but are not limited to, lice, biting lice, ticks, nasal bots, keds, biting flies, muscoid flies, flies, myiasitic fly lar- vae, chiggers, gnats, mosquitoes and fleas.

The compounds of formula I are especially useful for combating ectoparasites.

The compounds of formula I are especially useful for combating endoparasites. The compounds of formula I are especially useful for combating parasites of the following orders and species, respectively: fleas (Siphonaptera), e.g. Ctenocephalides felis, Ctenocephalides canis, Xenop- sylla cheopis, Pulex irritans, Tunga penetrans, and Nosopsyllus fasciatus, cockroaches (Blattaria - Blattodea), e.g. Blattella germanica, Blattella asahinae, Periplaneta americana, Periplaneta japonica, Periplaneta brunnea, Periplaneta fuligginosa, Periplaneta australasiae, and Blatta orientalis, flies, mosquitoes (Diptera), e.g. Aedes aegypti, Aedes albopictus, Aedes vexans, Anastrepha ludens, Anopheles maculipennis, Anopheles crucians, Anopheles al- bimanus, Anopheles gambiae, Anopheles freeborni, Anopheles leucosphyrus, Anopheles minimus, Anopheles quadrimaculatus, Calliphora vicina, Chrysomya bezziana, Chrysomya hominivorax, Chrysomya macellaria, Chrysops discalis, Chrysops silacea, Chrysops atlanticus, Cochliomyia hominivorax, Cordylobia an- thropophaga, Culicoides furens, Culex pipiens, Culex nigripalpus, Culex quinque- fasciatus, Culex tarsalis, Culiseta inornata, Culiseta melanura, Dermatobia hominis, Fannia canicularis, Gasterophilus intestinalis, Glossina morsitans, Glossina pal- palis, Glossina fuscipes, Glossina tachinoides, Haematobia irritans, Haplodiplosis equestris, Hippelates spp., Hypoderma lineata, Leptoconops torrens, Lucilia ca- prina, Lucilia cuprina, Lucilia sericata, Lycoria pectoralis, Mansonia spp., Musca domestica, Muscina stabulans, Oestrus ovis, Phlebotomus argentipes, Psorophora columbiae, Psorophora discolor, Prosimulium mixtum, Sarcophaga haemorrhoi- dalis, Sarcophaga sp., Simulium vittatum, Stomoxys calcitrans, Tabanus bovinus, Tabanus atratus, Tabanus lineola, and Tabanus similis, lice (Phthiraptera), e.g. Pediculus humanus capitis, Pediculus humanus corporis, Pthirus pubis, Haematopinus eurysternus, Haematopinus suis, Linognathus vituli, Bovicola bovis, Menopon gallinae, Menacanthus stramineus and Solenopotes capillatus. ticks and parasitic mites (Parasitiformes): ticks (Ixodida), e.g. Ixodes scapularis, Ixodes holocyclus, Ixodes pacificus, Rhiphicephalus sanguineus, Dermacentor andersoni, Dermacentor variabilis, Amblyomma americanum, Ambryomma macula- turn, Ornithodorus hermsi, Ornithodorus turicata and parasitic mites (Mesostig- mata), e.g. Ornithonyssus bacoti and Dermanyssus gallinae, Actinedida (Prostigmata) und Acaridida (Astigmata) e.g. Acarapis spp., Cheyletiella spp., Ornithocheyletia spp., Myobia spp., Psorergates spp., Demodex spp., Trom- bicula spp., Listrophorus spp., Acarus spp., Tyrophagus spp., Caloglyphus spp., Hypodectes spp., Pterolichus spp., Psoroptes spp., Chorioptes spp., Otodectes spp., Sarcoptes spp., Notoedres spp.,Knemidocoptes spp., Cytodites spp., and Laminosioptes spp,

Bugs (Heteropterida): Cimex lectularius, Cimex hemipterus, Reduvius senilis, Tria- toma spp., Rhodnius ssp., Panstrongylus ssp. and Arilus critatus,

Anoplurida, e.g. Haematopinus spp., Linognathus spp., Pediculus spp., Phtirus spp., and Solenopotes spp,

Mallophagida (suborders Arnblycerina and Ischnocerina), e.g. Trimenopon spp., Menopon spp., Trinoton spp., Bovicola spp., Werneckiella spp., Lepikentron spp., Trichodectes spp., and Felicola spp,

Roundworms Nematoda: Wipeworms and Trichinosis (Trichosyringida), e.g. Trichinellidae (Trichinella spp.), (Trichuridae) Trichuris spp., Capillaria spp,

Rhabditida, e.g. Rhabditis spp, Strongyloides spp., Helicephalobus spp, Strongylida, e.g. Strongylus spp., Ancylostoma spp., Necator americanus,

Bunostomum spp. (Hookworm), Trichostrongylus spp., Haemonchus contortus., Ostertagia spp. , Cooperia spp., Nematodirus spp., Dictyocaulus spp., Cy- athostoma spp., Oesophagostomum spp., Stephanurus dentatus, Ollulanus spp., Chabertia spp., Stephanurus dentatus , Syngamus trachea, Ancylostoma spp., Uncinaria spp., Globocephalus spp., Necator spp., Metastrongylus spp., Muellerius capillaris, Protostrongylus spp., Angiostrongylus spp., Parelaphostrongylus spp. Aleurostrongylus abstrusus, and Dioctophyma renale,

Intestinal roundworms (Ascaridida), e.g. Ascaris lumbricoides, Ascaris suum, As- caridia galli, Parascaris equorum, Enterobius vermicularis (Threadworm), Toxocara canis, Toxascaris leonine, Skrjabinema spp., and Oxyuris equi,

Camallanida, e.g. Dracunculus medinensis (guinea worm) Spirurida, e.g. Thelazia spp. Wuchereria spp., Brugia spp., Onchocerca spp., Diro- filari spp. a, Dipetalonema spp., Setaria spp., Elaeophora spp., Spirocerca lupi, and Habronema spp.,

Thorny headed worms (Acanthocephala), e.g. Acanthocephalus spp., Macracan- thorhynchus hirudinaceus and Oncicola spp,

Planarians (Plathelminthes):

Flukes (Trematoda), e.g. Faciola spp., Fascioloides magna, Paragonimus spp., Dicrocoelium spp., Fasciolopsis buski, Clonorchis sinensis, Schistosoma spp., Trichobilharzia spp., Alaria alata, Paragonimus spp., and Nanocyetes spp,

Cercomeromorpha, in particular Cestoda (Tapeworms), e.g. Diphyllobothrium spp., Tenia spp., Echinococcus spp., Dipylidium caninum, Multiceps spp., Hymenolepis spp., Mesocestoides spp., Vampirolepis spp., Moniezia spp., Anoplocephala spp., Sirometra spp., Anoplocephala spp., and Hymenolepis spp.

Applications The present invention relates to the therapeutic and the non-therapeutic use of compounds of formula I for controlling and/or combating parasites in and/or on animals.

The compounds of formula I may be used to protect the animals from attack or infestation by parasites by contacting them with a parasitically effective amount of compounds of formula I. As such, "contacting" includes both direct contact

(applying the compounds/compositions directly on the parasite, including the application directly on the animal or excluding the application directly on the animal, e.g. at it's locus for the latter) and indirect contact (applying the

compounds/compositions to the locus of the parasite). The contact of the parasite through application to its locus is an example of a non-therapeutic use of compounds of formula I.

"Locus" as defined above means the habitat, food supply, breeding ground, area, material or environment in which a parasite is growing or may grow outside of the animal. The compounds of the invention can also be applied preventively to places at which occurrence of the pests or parasites is expected. The compounds of formula I can be effective through both contact (via soil, glass, wall, bed net, carpet, blankets or animal parts) and ingestion (e.g. baits).

The administration can be carried out prophylactically, therapeutically or non- therapeutically.

Administration of the active compounds is carried out directly or in the form of suitable preparations, orally, topically/dermally or parenterally. In general, "parasiticidally effective amount" means the amount of active ingredient needed to achieve an observable effect on growth, including the effects of necrosis, death, retardation, prevention, and removal, destruction, or otherwise diminishing the occurrence and activity of the target organism. The parasiticidally effective amount can vary for the various compounds/compositions used in the invention. A parasiticidally effective amount of the compositions will also vary according to the prevailing conditions such as desired parasiticidal effect and duration, target species, mode of application, and the like.

Generally it is favorable to apply the compounds of formula I in total amounts of 0.5 mg/kg to 100 mg/kg per day, preferably 1 mg/kg to 50 mg/kg per day.

Formulations

For oral administration to warm-blooded animals, the formula I compounds may be formulated as animal feeds, animal feed premixes, animal feed concentrates, pills, solutions, pastes, suspensions, drenches, gels, tablets, boluses and capsules. In addition, the formula I compounds may be administered to the animals in their drinking water. For oral administration, the dosage form chosen should provide the animal with 0.01 mg/kg to 100 mg/kg of animal body weight per day of the formula I compound, preferably with 0.5 mg/kg to 100 mg/kg of animal body weight per day.

Alternatively, the formula I compounds may be administered to animals parenterally, for example, by intraruminal, intramuscular, intravenous or subcutaneous injection. The formula I compounds may be dispersed or dissolved in a physiologi- cally acceptable carrier for subcutaneous injection. Alternatively, the formula I compounds may be formulated into an implant for subcutaneous administration. In addition the formula I compound may be transdermally administered to animals. For parenteral administration, the dosage form chosen should provide the animal with 0.01 mg/kg to 100 mg/kg of animal body weight per day of the formula I compound.

The formula I compounds may also be applied topically to the animals in the form of dips, dusts, powders, collars, medallions, sprays, shampoos, spot-on and pour- on formulations and in ointments or oil-in-water or water-in-oil emulsions. For topical application, dips and sprays usually contain 0.5 ppm to 5,000 ppm and preferably 1 ppm to 3,000 ppm of the formula I compound. In addition, the formula I compounds may be formulated as ear tags for animals, particularly quadrupeds such as cattle and sheep.

Suitable preparations are:

- Solutions such as oral solutions, concentrates for oral administration after dilu- tion, solutions for use on the skin or in body cavities, pouring-on formulations, gels;

- Emulsions and suspensions for oral or dermal administration; semi-solid preparations; - Formulations in which the active compound is processed in an ointment base or in an oil-in-water or water-in-oil emulsion base;

- Solid preparations such as powders, premixes or concentrates, granules, pellets, tablets, boluses, capsules; aerosols and inhalants, and active compound- containing shaped articles.

Compositions suitable for injection are prepared by dissolving the active ingredient in a suitable solvent and optionally adding further ingredients such as acids, bases, buffer salts, preservatives, and solubilizers. The solutions are filtered and filled ster- ile.

Suitable solvents are physiologically tolerable solvents such as water, alkanols such as ethanol, butanol, benzyl alcohol, glycerol, propylene glycol, polyethylene glycols, N-methyl-pyrrolidone, 2-pyrrolidone, and mixtures thereof.

The active compounds can optionally be dissolved in physiologically tolerable vegetable or synthetic oils which are suitable for injection.

Suitable solubilizers are solvents which promote the dissolution of the active com- pound in the main solvent or prevent its precipitation. Examples are polyvinylpyrrolidone, polyvinyl alcohol, polyoxyethylated castor oil, and polyoxyethylated sorbi- tan ester. Suitable preservatives are benzyl alcohol, trichlorobutanol, p-hydroxybenzoic acid esters, and n-butanol.

Oral solutions are administered directly. Concentrates are administered orally after prior dilution to the use concentration. Oral solutions and concentrates are pre- pared according to the state of the art and as described above for injection solutions, sterile procedures not being necessary.

Solutions for use on the skin are trickled on, spread on, rubbed in, sprinkled on or sprayed on.

Solutions for use on the skin are prepared according to the state of the art and according to what is described above for injection solutions, sterile procedures not being necessary. Further suitable solvents are polypropylene glycol, phenyl ethanol, phenoxy etha- nol, ester such as ethyl or butyl acetate, benzyl benzoate, ethers such as alkylene- glycol alkylether, e.g. dipropylenglycol monomethylether, ketons such as acetone, methylethylketone, aromatic hydrocarbons, vegetable and synthetic oils, dimethyl- formamide, dimethylacetamide, transcutol, solketal, propylencarbonate, and mix- tures thereof.

It may be advantageous to add thickeners during preparation. Suitable thickeners are inorganic thickeners such as bentonites, colloidal silicic acid, aluminium monostearate, organic thickeners such as cellulose derivatives, polyvinyl alcohols and their copolymers, acrylates and methacrylates.

Gels are applied to or spread on the skin or introduced into body cavities. Gels are prepared by treating solutions which have been prepared as described in the case of the injection solutions with sufficient thickener that a clear material having an ointment-like consistency results. The thickeners employed are the thickeners given above.

Pour-on formulations are poured or sprayed onto limited areas of the skin, the active compound penetrating the skin and acting systemically. Pour-on formulations are prepared by dissolving, suspending or emulsifying the active compound in suitable skin-compatible solvents or solvent mixtures. If appropriate, other auxiliaries such as colorants, bioabsorption-promoting substances, antioxidants, light stabilizers, adhesives are added.

Suitable solvents which are: water, alkanols, glycols, polyethylene glycols, polypropylene glycols, glycerol, aromatic alcohols such as benzyl alcohol, phenylethanol, phenoxyethanol, esters such as ethyl acetate, butyl acetate, benzyl benzoate, ethers such as alkylene glycol alkyl ethers such as dipropylene glycol monomethyl ether, diethylene glycol mono-butyl ether, ketones such as acetone, methyl ethyl ketone, cyclic carbonates such as propylene carbonate, ethylene carbonate, aromatic and/or aliphatic hydrocarbons, vegetable or synthetic oils, DMF, dimethy- lacetamide, n-alkylpyrrolidones such as methylpyrrolidone, n-butylpyrrolidone or n- octylpyrrolidone, N-methylpyrrolidone, 2-pyrrolidone, 2,2-dimethyl-4-oxy- methylene-1 ,3-diox- olane and glycerol formal.

Suitable colorants are all colorants permitted for use on animals and which can be dissolved or suspended.

Suitable absorption-promoting substances are, for example, DMSO, spreading oils such as isopropyl myristate, dipropylene glycol pelargonate, silicone oils and copolymers thereof with polyethers, fatty acid esters, triglycerides, fatty alcohols. Suitable antioxidants are sulfites or metabisulfites such as potassium metabisulfite, ascorbic acid, butylhydroxytoluene, butylhydroxyanisole, tocopherol.

Suitable light stabilizers are, for example, novantisolic acid. Suitable adhesives are, for example, cellulose derivatives, starch derivatives, poly- acrylates, natural polymers such as alginates, gelatin.

Emulsions can be administered orally, dermally or as injections. Emulsions are either of the water-in-oil type or of the oil-in-water type.

They are prepared by dissolving the active compound either in the hydrophobic or in the hydrophilic phase and homogenizing this with the solvent of the other phase with the aid of suitable emulsifiers and, if appropriate, other auxiliaries such as col- orants, absorption-promoting substances, preservatives, antioxidants, light stabilizers, viscosity-enhancing substances.

Suitable hydrophobic phases (oils) are:

liquid paraffins, silicone oils, natural vegetable oils such as sesame oil, almond oil, castor oil, synthetic triglycerides such as caprylic/capric biglyceride, triglyceride mixture with vegetable fatty acids of the chain length Cs-Ci2 or other specially selected natural fatty acids, partial glyceride mixtures of saturated or unsaturated fatty acids possibly also containing hydroxyl groups, mono- and diglycerides of the Cs- Cio fatty acids,

fatty acid esters such as ethyl stearate, di-n-butyryl adipate, hexyl laurate, dipropyl- ene glycol perlargonate, esters of a branched fatty acid of medium chain length with saturated fatty alcohols of chain length C16-C18, isopropyl myristate, isopropyl palmitate, caprylic/capric acid esters of saturated fatty alcohols of chain length C12- C18, isopropyl stearate, oleyl oleate, decyl oleate, ethyl oleate, ethyl lactate, waxy fatty acid esters such as synthetic duck coccygeal gland fat, dibutyl phthalate, diisopropyl adipate, and ester mixtures related to the latter, fatty alcohols such as isotridecyl alcohol, 2-octyldodecanol, cetylstearyl alcohol, oleyl alcohol, and fatty acids such as oleic acid and mixtures thereof.

Suitable hydrophilic phases are: water, alcohols such as propylene glycol, glycerol, sorbitol and mixtures thereof.

Suitable emulsifiers are:

non-ionic surfactants, e.g. polyethoxylated castor oil, polyethoxylated sorbitan monooleate, sorbitan monostearate, glycerol monostearate, polyoxyethyl stearate, alkylphenol polyglycol ether;

ampholytic surfactants such as di-sodium N-lauryl-p-iminodipropionate or lecithin; anionic surfactants, such as sodium lauryl sulfate, fatty alcohol ether sulfates, mono/dialkyl polyglycol ether orthophosphoric acid ester monoethanolamine salt; cation-active surfactants, such as cetyltrimethylammonium chloride.

Suitable further auxiliaries are: substances which enhance the viscosity and stabilize the emulsion, such as carboxymethylcellulose, methylcellulose and other cellu- lose and starch derivatives, polyacrylates, alginates, gelatin, gum arabic, polyvinylpyrrolidone, polyvinyl alcohol, copolymers of methyl vinyl ether and maleic anhydride, polyethylene glycols, waxes, colloidal silicic acid or mixtures of the substances mentioned. Suspensions can be administered orally or topically/dermally. They are prepared by suspending the active compound in a suspending agent, if appropriate with addition of other auxiliaries such as wetting agents, colorants, bioabsorption-promoting substances, preservatives, antioxidants, light stabilizers.

Liquid suspending agents are all homogeneous solvents and solvent mixtures.

Suitable wetting agents (dispersants) are the emulsifiers given above. Other auxiliaries which may be mentioned are those given above.

Semi-solid preparations can be administered orally or topically/dermally. They differ from the suspensions and emulsions described above only by their higher viscosity. For the production of solid preparations, the active compound is mixed with suitable excipients, if appropriate with addition of auxiliaries, and brought into the desired form.

Suitable excipients are all physiologically tolerable solid inert substances. Those used are inorganic and organic substances. Inorganic substances are, for example, sodium chloride, carbonates such as calcium carbonate, hydrogencarbonates, aluminium oxides, titanium oxide, silicic acids, argillaceous earths, precipitated or colloidal silica, or phosphates. Organic substances are, for example, sugar, cellulose, foodstuffs and feeds such as milk powder, animal meal, grain meals and shreds, starches.

Suitable auxiliaries are preservatives, antioxidants, and/or colorants which have been mentioned above. Other suitable auxiliaries are lubricants and glidants such as magnesium stearate, stearic acid, talc, bentonites, disintegration-promoting substances such as starch or crosslinked polyvinylpyrrolidone, binders such as starch, gelatin or linear polyvinylpyrrolidone, and dry binders such as microcrystalline cellulose. The compositions which can be used in the invention can comprise generally from about 0.001 to 95% of the compound of formula I.

Ready-to-use preparations contain the compounds acting against parasites, pref- erably ectoparasites, in concentrations of 10 ppm to 80 per cent by weight, preferably from 0.1 to 65 per cent by weight, more preferably from 1 to 50 per cent by weight, most preferably from 5 to 40 per cent by weight. Preparations which are diluted before use contain the compounds acting against ectoparasites in concentrations of 0.5 to 90 per cent by weight, preferably of 1 to 50 per cent by weight.

Furthermore, the preparations comprise the compounds of formula I against endoparasites in concentrations of 10 ppm to 2 per cent by weight, preferably of 0.05 to 0.9 per cent by weight, very particularly preferably of 0.005 to 0.25 per cent by weight.

The compositions comprising the compounds of formula I can be applied orally, parenterally or topically, respectively dermally. For example, optionally the topical application is conducted in the form of compound-containing shaped articles such as collars, medallions, ear tags, bands for fixing at body parts, and adhesive strips and foils. Generally it is favorable to apply solid formulations which release compounds of formula I in total amounts of 10 mg/kg to 300 mg/kg, preferably 20 mg/kg to 200 mg/kg, most preferably 25 mg/kg to 160 mg/kg body weight of the treated animal in the course of three weeks. For the preparation of the shaped articles, thermoplastic and flexible plastics as well as elastomers and thermoplastic elastomers are used. Suitable plastics and elastomers are polyvinyl resins, polyurethane, polyacrylate, epoxy resins, cellulose, cellulose derivatives, polyamides and polyester which are sufficiently compatible with the compounds of formula I. A detailed list of plastics and elastomers as well as preparation procedures for the shaped articles is given e.g. in WO 03/086075.

The active compounds can be applied solely or in a mixture with synergists or with other active compounds which act against pathogenic endo- and ectoparasites. For example, the active compounds of formula I can be applied in mixtures with synthetic coccidiosis compounds, polyetherantibiotics as Amprolium, Robenidin, Toltrazuril, Monensin, Salinomycin, Maduramicin, Lasalocid, Narasin or Sem- duramicin or with other pesticides which are described in the list M below.

Compositions to be used according to this invention for agricultural or veterinary purposes may also contain other active ingredients, for example other pesticides, insecticides, herbicides, fungicides, bactericides, fertilizers such as ammonium nitrate, urea, potash, and super-phosphate, phytotoxicants and plant growth regulators, safeners and nematicides. These additional ingredients may be used sequen- tially or in combination with the above-described compositions, if appropriate also added only immediately prior to use (tank mix). For example, the plant(s) may be sprayed with a composition of this invention either before or after being treated with other active ingredients. These agents can be admixed with the agents used according to the invention in a weight ratio of 1 :10 to 10:1. Mixing the compounds of formula I or the compositions comprising them in the use form as pesticides with other pesticides frequently results in a broader pesticidal spectrum of action. The following list M of pesticides together with which the compounds according to the invention can be used and with which potential synergistic effects might be produced, is intended to illustrate the possible combinations, but not to impose any limitation: M.1. Organo(thio)phosphate compounds: acephate, azamethiphos, azinphos-ethyl, azinphos-methyl, chlorethoxyfos, chlorfenvinphos, chlormephos, chlorpyrifos, chlorpyrifos-methyl, coumaphos, cyanophos, demeton-S-methyl, diazinon, dichlor- vos/ DDVP, dicrotophos, dimethoate, dimethylvinphos, disulfoton, EPN, ethion, ethoprophos, famphur, fenamiphos, fenitrothion, fenthion, flupyrazophos, fosthi- azate, heptenophos, isoxathion, malathion, mecarbam, methamidophos, methi- dathion, mevinphos, monocrotophos, naled, omethoate, oxydemeton-methyl, para- thion, parathion-methyl, phenthoate, phorate, phosalone, phosmet, phosphamidon, phoxim, pirimiphos-methyl, profenofos, propetamphos, prothiofos, pyraclofos, pyri- daphenthion, quinalphos, sulfotep, tebupirimfos, temephos, terbufos, tetrachlorvin- phos, thiometon, triazophos, trichlorfon, vamidothion;

M.2. Carbamate compounds: aldicarb, alanycarb, bendiocarb, benfuracarb, buto- carboxim, butoxycarboxim, carbaryl, carbofuran, carbosulfan, ethiofencarb, feno- bucarb, formetanate, furathiocarb, isoprocarb, methiocarb, methomyl, metolcarb, oxamyl, pirimicarb, propoxur, thiodicarb, thiofanox, trimethacarb, XMC, xylylcarb, triazamate; M.3. Pyrethroid compounds: acrinathrin, allethrin, d-cis-trans allethrin, d-trans al- lethrin, bifenthrin, bioallethrin, bioallethrin S-cylclopentenyl, bioresmethrin, cyclo- prothrin, cyfluthrin, beta-cyfluthrin, cyhalothrin, lambda-cyhalothrin, gamma- cyhalothrin, cypermethrin, alpha-cypermethrin, beta-cypermethrin, theta- cypermethrin, zeta-cypermethrin, cyphenothrin, deltamethrin, empenthrin, esfen- valerate, etofenprox, fenpropathrin, fenvalerate, flucythrinate, flumethrin, tau- fluvalinate, halfenprox, imiprothrin, metofluthrin, permethrin, phenothrin, prallethrin, profluthrin, pyrethrin (pyrethrum), resmethrin, silafluofen, tefluthrin, tetramethrin, tralomethrin, transfluthrin;

M.4. Juvenile hormone mimics: hydroprene, kinoprene, methoprene, fenoxycarb, pyriproxyfen;

M.5. Nicotinic receptor agonists/antagonists compounds: acetamiprid, bensultap, cartap hydrochloride, clothianidin, dinotefuran, imidacloprid, thiamethoxam, niten- pyram, nicotine, spinosad (allosteric agonist), spinetoram (allosteric agonist), thia- cloprid, thiocyclam, thiosultap-sodium and AKD1022.

M.6. GABA gated chloride channel antagonist compounds: chlordane, endosulfan, gamma-HCH (lindane); ethiprole, fipronil, pyrafluprole, pyriprole

M.7. Chloride channel activators: abamectin, emamectin benzoate, milbemectin, lepimectin; M.8. METI I compounds: fenazaquin, fenpyroximate, pyrimidifen, pyridaben, te- bufenpyrad, tolfenpyrad, flufenerim, rotenone;

M.9. METI II and III compounds: acequinocyl, fluacyprim, hydramethylnon; M.10. Uncouplers of oxidative phosphorylation: chlorfenapyr, DNOC;

M.1 1. Inhibitors of oxidative phosphorylation: azocyclotin, cyhexatin, diafenthiuron, fenbutatin oxide, propargite, tetradifon; M.12. Moulting disruptors: cyromazine, chromafenozide, halofenozide, methoxy- fenozide, tebufenozide; M.13. Synergists: piperonyl butoxide, tribufos;

M.14. Sodium channel blocker compounds: indoxacarb, metaflumizone; M.15. Fumigants: methyl bromide, chloropicrin sulfuryl fluoride; M.16. Selective feeding blockers: crylotie, pymetrozine, flonicamid; M.17. Mite growth inhibitors: clofentezine, hexythiazox, etoxazole;

M.18. Chitin synthesis inhibitors: buprofezin, bistrifluron, chlorfluazuron, diflubenzuron, flucycloxuron, flufenoxuron, hexaflumuron, lufenuron, novaluron, noviflumuron, teflubenzuron, triflumuron; M.19. Lipid biosynthesis inhibitors: spirodiclofen, spiromesifen, spirotetramat;

M.20. Octapaminergic agonists: amitraz;

M.21 . Ryanodine receptor modulators: flubendiamide,(R)-,(S)- 3- Chlor-N1 -{2- methyl-4-[1 ,2,2,2 - tetrafluor-1 -(trifluormethyl)ethyl]phenyl}-N2-(1 -methyl-2- methylsulfonylethyl)phthalamid (M21 .1 )

M.22. Isoxazoline compounds: 4-[5-(3,5-Dichloro-phenyl)-5-trifluoromethyl-4,5- dihydro-isoxazol-3-yl]-2-methyl-N-pyridin-2-ylmethyl-benzami de (M22.1 ),

4-[5-(3,5-Dichloro-phenyl)-5-trifluoromethyl-4,5-dihydro- isoxazol-3-yl]-2-methyl-N- (2,2,2-trifluoro-ethyl)-benzamide (M22.2), 4-[5-(3,5-Dichloro-phenyl)-5- trifluoromethyl-4,5-dihydro-isoxazol-3-yl]-2-methyl-N-[(2,2, 2-trifluoro- ethylcarbamoyl)-methyl]-benzamide (M22.3),4-[5-(3,5-Dichloro-phenyl)-5- trifluoromethyl-4,5-dihydro-isoxazol-3-yl]-naphthalene-1 -carboxylic acid [(2,2,2- trifluoro-ethylcarbamoyl)-methyl]-amide (M22.4)and 4-[5-(3,5-Dichlorophenyl)-5- trifluoromethyl-4,5-dihydro-isoxazol-3-yl]-N-[(methoxyimino) methyl]-2- methylbenzamide (M22.5);

M.23. Anthranilamide compounds: chloranthraniliprole, cyantraniliprole,

5-Bromo-2-(3-chloro-pyridin-2-yl)-2H-pyrazole-3-carboxyli c acid [4-cyano-2-(1 - cyclopropyl-ethylcarbamoyl)-6-methyl-phenyl]-amide (M23.1 ), 5-Bromo-2-(3-chloro- pyridin-2-yl)-2H-pyrazole-3-carboxylic acid [2-chloro-4-cyano-6-(1 -cyclopropyl- ethylcarbamoyl)-phenyl]-amide (M23.2), 5-Bromo-2-(3-chloro-pyridin-2-yl)-2H- pyrazole-3-carboxylic acid [2-bromo-4-cyano-6-(1 -cyclopropyl-ethylcarbamoyl)- phenyl]-amide(M23.3), 5-Bromo-2-(3-chloro-pyridin-2-yl)-2H-pyrazole-3-carboxylic acid [2-bromo-4-chloro-6-(1 -cyclopropyl-ethylcarbamoyl)-phenyl]-amide(M23.4), 5-Bromo-2-(3-chloro-pyridin-2-yl)-2H-pyrazole-3-carboxylic acid [2,4-dichloro-6-(1 - cyclopropyl-ethylcarbamoyl)-phenyl]-amide (M23.5), 5-Bromo-2-(3-chloro-pyridin-2- yl)-2H-pyrazole-3-carboxylic acid [4-chloro-2-(1 -cyclopropyl-ethylcarbamoyl)-6- methyl-phenyl]-amide (M23.6), N'-(2-{[5-Bromo-2-(3-chloro-pyridin-2-yl)-2H- pyrazole-3-carbonyl]-amino}-5-chloro-3-methyl-benzoyl)-hydra zinecarboxylic acid methyl ester (M23.7), N'-(2-{[5-Bromo-2-(3-chloro-pyridin-2-yl)-2H-pyrazole-3- carbonyl]-amino}-5-chloro-3-methyl-benzoyl)-N'-methyl-hydraz inecarboxylic acid methyl ester (M23.8),

N'-(2-{[5-Bromo-2-(3-chloro-pyridin-2-yl)-2H-pyrazole-3-carb onyl]-amino}-5-chloro-

3- methyl-benzoyl)-N,N'-dimethyl-hydrazinecarboxylic acid methyl ester (M23.9), N'-(3,5-Dibromo-2-{[5-bromo-2-(3-chloro-pyridin-2-yl)-2H-pyr azole-3-carbonyl]- amino}-benzoyl)-hydrazinecarboxylic acid methyl ester (M23.10), N'-(3,5-Dibromo- 2-{[5-bromo-2-(3-chloro-pyridin-2-yl)-2H-pyrazole-3-carbonyl ]-amino}-benzoyl)-N'- methyl-hydrazinecarboxylic acid methyl ester (M23.1 1 ) and N'-(3,5-Dibromo-2-{[5- bromo-2-(3-chloro-pyridin-2-yl)-2H-pyrazole-3-carbonyl]-amin o}-benzoyl)-N,N'- dimethyl-hydrazinecarboxylic acid methyl ester (M23.12);

M.24. Malononitrile compounds: 2-(2,2,3,3,4,4,5,5-octafluoropentyl)-2-(3,3,3- trifluoro-propyl)malononitrile (CF ₂ H-CF2-CF2-CF2-CH2-C(CN)2-CH2-CH2-CF3) (M24.1 ) and 2-(2,2,3,3,4,4,5,5-octafluoropentyl)-2-(3,3,4,4,4-pentafluor obutyl)- malonodinitrile (CF2H-CF2-CF2-CF2-CH2-C(CN)2-CH2-CH2-CF2-CF ₃ ) (M24.2);

M.25. Microbial disruptors: Bacillus thuringiensis subsp. Israelensi, Bacillus sphaericus, Bacillus thuringiensis subsp. Aizawai, Bacillus thuringiensis subsp. Kurstaki, Bacillus thuringiensis subsp. Tenebrionis;

M.26. Aminofuranone compounds:

4- {[(6-Bromopyrid-3-yl)methyl](2-fluoroethyl)amino}furan-2(5H) -on (M26.1 ), 4-{[(6-Fluoropyrid-3-yl)methyl](2,2-difluoroethyl)amino}fura n-2(5H)-on (M26.2), 4-{[(2-Chloro1 ,3-thiazolo-5-yl)methyl](2-fluoroethyl)amino}furan-2(5H)-on (M26.3), 4-{[(6-Chloropyrid-3-yl)methyl](2-fluoroethyl)amino}furan-2( 5H)-on (M26.4),

4-{[(6-Chloropyrid-3-yl)methyl](2,2-difluoroethyl)amino}f uran-2(5H)-on (M26.5), 4-{[(6-Chloro-5-fluoropyrid-3-yl)methyl](methyl)amino}furan- 2(5H)-on (M26.6), 4-{[(5,6-Dichloropyrid-3-yl)methyl](2-fluoroethyl)amino}fura n-2(5H)-on (M26.7), 4-{[(6-Chloro-5-fluoropynd-3-yl)methyl](cyclopropyl)amino}fu ran-2(5H)-on (M26.8), 4-{[(6-Chloropyrid-3-yl)methyl](cyclopropyl)amino}furan-2(5H )-on (M26.9) and 4-{[(6-Chloropyrid-3-yl)methyl](methyl)amino}furan-2(5H)-on (M26.10);

M.27. Various compounds: aluminium phosphide, amidoflumet, benclothiaz, benzoximate, bifenazate, borax, bromopropylate, cyanide, cyenopyrafen, cyflumetofen, chinomethionate, dicofol, fluoroacetate, phosphine, pyridalyl, pyrifluquinazon, sulfur, organic sulfur compounds, tartar emetic, sulfoxaflor, N-R'- 2,2-dihalo-1 -R"cyclo-propanecarboxamide-2-(2,6-dichloro-a ,a ,a -trifluoro-p- tolyl)hydrazone or N-R'-2,2-di(R"')propionamide-2-(2,6-dichloro-a ,a ,a -trifluoro-p- tolyl)-hydrazone, wherein R' is methyl or ethyl, halo is chloro or bromo, R" is hydrogen or methyl and R'" is methyl or ethyl, 4-But-2-ynyloxy-6-(3,5-dimethyl- piperidin-1 -yl)-2-fluoro-pyrimidine (M27.1 ), Cyclopropaneacetic acid, 1 ,1 '- [(3S,4R,4aR,6S,6aS, 12R, 12aS, 12bS)-4-[[(2-cyclopropylacetyl)oxy]methyl]-

1 ,3,4,4a,5,6,6a,12,12a,12b-decahydro-12-hydroxy-4,6a,12b-trim ethyl-1 1 -oxo-9-(3- pyridinyl)-2H,1 1 H-naphtho[2,1 -b]pyrano[3,4-e]pyran-3,6-diyl] ester(M27.2) and 8- (2-Cyclopropylmethoxy-4-trifluoromethyl-phenoxy)-3-(6-triflu oromethyl-pyridazin-3- yl)-3-aza-bicyclo[3.2.1 ]octane(M27.3).

The commercially available compounds of the group M may be found in The Pesticide Manual, 14th Edition, British Crop Protection Council (2006).

Paraoxon and their preparation have been described in Farm Chemicals Hand- book, Volume 88, Meister Publishing Company, 2001. Flupyrazofos has been described in Pesticide Science 54, 1988, p.237-243 and in US 4822779. AKD 1022 and its preparation have been described in US 6300348. The anthranilamides M23.1 to M23.6 have been described in WO 2008/72743 and WO 200872783, those M23.7 to M23.12 in WO2007/043677. The phthalamide M 21.1 is known from WO 2007/101540. The alkynylether compound M27.1 is described e.g. in JP

2006131529. Organic sulfur compounds have been described in WO 2007060839. The isoxazoline compounds M 22.1 to M 22.5 have been described in e.g.

WO2005/085216, WO 2007/079162 and WO 2007/026965. The aminofuranone compounds M 26.1 to M 26.10 have been described eg. in WO 2007/1 15644. The pyripyropene derivative M 27.2 has been described in WO 2008/66153 and WO 2008/108491. The pyridazin compound M 27.3 has been described in JP

2008/1 15155. Malononitrile compounds as those (M24.1 ) and (M24.2) have been described in WO 02/089579, WO 02/090320, WO 02/090321 , WO 04/006677, WO 05/068423, WO 05/068432 and WO 05/063694.

The following list of active substances, in conjunction with which the compounds according to the invention can be used, is intended to illustrate the possible combinations but does not limit them. Fungicidal mixing partners are in particular those selected from the follwing groups:

F.I) Respiration Inhibitors

F.I-1 ) Inhibitors of complex III at Qo site (e.g. strobilurins)

strobilurins: azoxystrobin, dimoxystrobin, enestroburin, fluoxastrobin, kresoxim- methyl, metominostrobin, orysastrobin, picoxystrobin, pyraclostrobin, pyrame- tostrobin, pyraoxystrobin, pyribencarb, trifloxystrobin, methyl (2-chloro-5 [1 -(3- methylbenzyloxyimino)ethyl]benzyl)carbamate and 2 (2-(3-(2,6-dichlorophenyl)-1 - methyl-allylideneaminooxymethyl)-phenyl)-2-methoxyimino-N methyl-acetamide; oxazolidinediones and imidazolinones: famoxadone, fenamidone;

F.I-2) Inhibitors of complex II (e.g. carboxamides):

carboxanilides: benodanil, bixafen, boscalid, carboxin, fenfuram, fenhexamid, flu- opyram, flutolanil, furametpyr, isopyrazam, isotianil, mepronil, oxycarboxin, pen- flufen, penthiopyrad, sedaxane, tecloftalam, thifluzamide, tiadinil, 2-amino-4 methyl-thiazole-5-carboxanilide, N-(3',4',5' trifluorobiphenyl-2 yl)-3-difluoromethyl-1 - methyl-1 H-pyrazole-4 carboxamide, N-(4'-trifluoromethylthiobiphenyl-2-yl)-3 di- fluoromethyl-1 -methyl-1 H pyrazole-4-carboxamide and N-(2-(1 ,3,3-trimethyl-butyl)- phenyl)-1 ,3-dimethyl-5 fluoro-1 H-pyrazole-4 carboxamide;

F.I-3) Inhibitors of complex III at Qi site: cyazofamid, amisulbrom;

F.I-4) Other respiration inhibitors (complex I, uncouplers)

diflumetorim; tecnazen; ferimzone; ametoctradin; silthiofam;

nitrophenyl derivates: binapacryl, dinobuton, dinocap, fluazinam, nitrthal-isopropyl, organometal compounds: fentin salts, such as fentin-acetate, fentin chloride or fen- tin hydroxide;

F.ll) Sterol biosynthesis inhibitors (SBI fungicides)

F.II-1 ) C14 demethylase inhibitors (DMI fungicides, e.g. triazoles, imidazoles) triazoles: azaconazole, bitertanol, bromuconazole, cyproconazole, difenoconazole, diniconazole, diniconazole-M, epoxiconazole, fenbuconazole, fluquinconazole, flu- silazole, flutriafol, hexaconazole, imibenconazole, ipconazole, metconazole, my- clobutanil, paclobutrazole, penconazole, propiconazole, prothioconazole, sime- conazole, tebuconazole, tetraconazole, triadimefon, triadimenol, triticonazole, uni- conazole;

imidazoles: imazalil, pefurazoate, oxpoconazole, prochloraz, triflumizole; pyrimidines, pyridines and piperazines: fenarimol, nuarimol, pyrifenox, triforine; F.I 1-2) Delta 14-reductase inhitors (Amines, e.g. morpholines, piperidines) morpholines: aldimorph, dodemorph, dodemorph-acetate, fenpropimorph, tride- morph;

piperidines: fenpropidin, piperalin;

spiroketalamines: spiroxamine;

F.II-3) Inhibitors of 3-keto reductase: hydroxyanilides: fenhexamid;

F.lll) Nucleic acid synthesis inhibitors

F.III-1 ) RNA, DNA synthesis

phenylamides or acyl amino acid fungicides: benalaxyl, benalaxyl-M, kiralaxyl, metalaxyl, metalaxyl-M (mefenoxam), ofurace, oxadixyl;

isoxazoles and iosothiazolones: hymexazole, octhilinone;

F.III-2) DNA topisomerase inhibitors: oxolinic acid;

F.III-3) Nucleotide metabolism (e.g. adenosin-deaminase)

hydroxy (2-amino)-pyrimidines: bupirimate;

F.IV) Inhibitors of cell division and or cytoskeleton

F.IV-1 ) Tubulin inhibitors: benzimidazoles and thiophanates: benomyl, carben- dazim, fuberidazole, thiabendazole, thiophanate-methyl;

triazolopyrimidines: 5-chloro-7 (4-methylpiperidin-1 -yl)-6-(2,4,6-trifluorophenyl)- [1 ,2,4]triazolo[1 ,5 a]pyrimidine

F.IV-2) Other cell division inhibitors

benzamides and phenyl acetamides: diethofencarb, ethaboxam, pencycuron, flu- opicolide, zoxamide;

F.IV-3) Actin inhibitors: benzophenones: metrafenone;

F.V) Inhibitors of amino acid and protein synthesis

F.V-1 ) Mmethionine synthesis inhibitors (anilino-pyrimidines)

anilino-pyrimidines: cyprodinil, mepanipyrim, nitrapyrin, pyrimethanil;

F.V-2) Protein synthesis inhibitors (anilino-pyrimidines)

antibiotics: blasticidin-S, kasugamycin, kasugamycin hydrochloride-hydrate, mildiomycin, streptomycin, oxytetracyclin, polyoxine, validamycin A; F.VI) Signal transduction inhibitors

F.VI-1 ) MAP / Histidine kinase inhibitors (e.g. anilino-pyrimidines)

dicarboximides: fluoroimid, iprodione, procymidone, vinclozolin;

phenylpyrroles: fenpiclonil, fludioxonil;

F.VI-2) G protein inhibitors: quinolines: quinoxyfen; F.VII) Lipid and membrane synthesis inhibitors

F.VII-1 ) Phospholipid biosynthesis inhibitors

organophosphorus compounds: edifenphos, iprobenfos, pyrazophos;

dithiolanes: isoprothiolane;

F.VII-2) Lipid peroxidation

aromatic hydrocarbons: didoran, quintozene, tecnazene, tolclofos-methyl, biphenyl, chloroneb, etridiazole;

F.VII-3) Carboxyl acid amides (CAA fungicides)

cinnamic or mandelic acid amides: dimethomorph, flumorph, mandiproamid, pyri- morph;

valinamide carbamates: benthiavalicarb, iprovalicarb, pyribencarb, valifenalate and N-(1 -(1 -(4-cyano-phenyl)ethanesulfonyl)-but-2-yl) carbamic acid-(4-fluorophenyl) ester;

F.VII-4) Compounds affecting cell membrane permeability and fatty acides carbamates: propamocarb, propamocarb-hydrochlorid

F.VII I) Inhibitors with Multi Site Action

F.VII 1-1 ) Inorganic active substances: Bordeaux mixture, copper acetate, copper hydroxide, copper oxychloride, basic copper sulfate, sulfur;

F.VIII-2) Thio- and dithiocarbamates: ferbam, mancozeb, maneb, metam, methasulphocarb, metiram, propineb, thiram, zineb, ziram;

F.VIII-3) Organochlorine compounds (e.g. phthalimides, sulfamides, chloronitriles): anilazine, chlorothalonil, captafol, captan, folpet, dichlofluanid, dichlorophen, flusul- famide, hexachlorobenzene, pentachlorphenole and its salts, phthalide, tolylfluanid, N-(4-chloro-2-nitro-phenyl)-N-ethyl-4-methyl-benzenesulfonam ide;

F.VIII-4) Guanidines: guanidine, dodine, dodine free base, guazatine, guazatine- acetate, iminoctadine, iminoctadine-triacetate, iminoctadine-tris(albesilate);

F.VIII-5) Ahtraquinones: dithianon;

F.IX) Cell wall synthesis inhibitors

F.IX-1 ) Inhibitors of glucan synthesis: validamycin, polyoxin B;

F.IX-2) Melanin synthesis inhibitors: pyroquilon, tricyclazole, carpropamide, di- cyclomet, fenoxanil;

F.X) Plant defence inducers

F.X-1 ) Salicylic acid pathway: acibenzolar-S-methyl;

F.X-2) Others: probenazole, isotianil, tiadinil, prohexadione-calcium;

phosphonates: fosetyl, fosetyl-aluminum, phosphorous acid and its salts; F.XI) Unknown mode of action:

bronopol, chinomethionat, cyflufenamid, cymoxanil, dazomet, debacarb, di- clomezine, difenzoquat, difenzoquat-methylsulfate, diphenylamin, flumetover, flusulfamide, flutianil, methasulfocarb, oxin-copper, proquinazid, tebufloquin, te- cloftalam, triazoxide, 2-butoxy-6-iodo-3-propylchromen-4-one, N- (cyclopropylmethoxyimino-(6-difluoro-methoxy-2,3-difluoro-ph enyl)-methyl)-2- phenyl acetamide, N'-(4-(4-chloro-3-trifluoromethyl-phenoxy)-2,5-dimethyl-phen yl)- N-ethyl-N methyl formamidine, N' (4-(4-fluoro-3-trifluoromethyl-phenoxy)-2,5- dimethyl-phenyl)-N-ethyl-N-methyl formamidine, N'-(2-methyl-5-trifluoromethyl-4-(3- trimethylsilanyl-propoxy)-phenyl)-N-ethyl-N-methyl formamidine, N'-(5- difluoromethyl-2 methyl-4-(3-trimethylsilanyl-propoxy)-phenyl)-N-ethyl-N-meth yl formamidine, 2-{1 -[2-(5-methyl-3-trifluoromethyl-pyrazole-1 -yl)-acetyl]-piperidin-4- yl}-thiazole-4-carboxylic acid methyl-(1 ,2,3,4-tetrahydro-naphthalen-1 -yl)-amide, 2- {1 -[2-(5-methyl-3-trifluoromethyl-pyrazole-1 -yl)-acetyl]-piperidin-4-yl}-thiazole-4- carboxylic acid methyl-(R)-1 ,2,3,4-tetrahydro-naphthalen-1 -yl-amide, methoxy- acetic acid 6-tert-butyl-8-fluoro-2,3-dimethyl-quinolin-4-yl ester and N-Methyl-2-{1 - [(5-methyl-3-trifluoromethyl-1 H-pyrazol-1 -yl)-acetyl]-piperidin-4-yl}-N-[(1 R)-1 ,2,3,4- tetrahydronaphthalen-1 -yl]-4-thiazolecarboxamide, 3-[5-(4-chloro-phenyl)-2,3- dimethyl-isoxazolidin-3 yl]-pyridine, 3-[5-(4-methyl-phenyl)-2,3-dimethyl- isoxazolidin-3-yl]-pyridine, 5-amino-2-isopropyl-3-oxo-4-ortho-tolyl-2,3-dihydro- pyrazole-1 carbothioic acid S-allyl ester, N-(6-methoxy-pyridin-3-yl) cyclopropane- carboxylic acid amide, 5-chloro-1 (4,6-dimethoxy-pyrimidin-2-yl)-2-methyl-1 H- benzoimidazole, 2-(4-chloro-phenyl)-N-[4-(3,4-dimethoxy-phenyl)-isoxazol-5-y l]-2- prop-2-ynyloxy-acetamide;

F.XI) Growth regulators:

abscisic acid, amidochlor, ancymidol, 6-benzylaminopurine, brassinolide, butralin, chlormequat (chlormequat chloride), choline chloride, cyclanilide, daminozide, dikegulac, dimethipin, 2,6-dimethylpuridine, ethephon, flumetralin, flurprimidol, flu- thiacet, forchlorfenuron, gibberellic acid, inabenfide, indole-3-acetic acid , maleic hydrazide, mefluidide, mepiquat (mepiquat chloride), naphthaleneacetic acid, N 6 benzyladenine, paclobutrazol, prohexadione (prohexadione-calcium), prohydrojas- mon, thidiazuron, triapenthenol, tributyl phosphorotrithioate, 2,3,5 tri iodobenzoic acid , trinexapac-ethyl and uniconazole;

F.XII) Biological control agents

antifungal biocontrol agents: Bacillus substilis strain with NRRL No. B-21661 (e.g. RHAPSODY®, SERENADE® MAX and SERENADE® ASO from AgraQuest, Inc., USA.), Bacillus pumilus strain with NRRL No. B-30087 (e.g. SONATA® and BALLAD® Plus from AgraQuest, Inc., USA), Ulocladium oudemansii (e.g. the product BOTRY-ZEN from BotriZen Ltd., New Zealand), Chitosan (e.g. ARMOUR-ZEN from BotriZen Ltd., New Zealand).

The invertebrate pest, i.e. arthropodes and nematodes, the plant, soil or water in which the plant is growing can be contacted with the compound(s) of formula I or the composition(s) containing them by any application method known in the art. As such, "contacting" includes both direct contact (applying the compounds/compositions directly on the invertebrate pest or plant - typically to the foliage, stem or roots of the plant) and indirect contact (applying the compounds/compositions to the locus of the invertebrate pest or plant). Moreover, invertebrate pests may be controlled by contacting the target pest, its food supply, habitat, breeding ground or its locus with a pesticidally effective amount of compounds of formula I. As such, the application may be carried out before or after the infection of the locus, growing crops, or harvested crops by the pest.

"Locus" in general means a habitat, breeding ground, cultivated plants, plant propagation material (such as seed), soil, area, material or environment in which a pest or parasite is growing or may grow. In general "pesticidally effective amount" means the amount of active ingredient needed to achieve an observable effect on growth, including the effects of necrosis, death, retardation, prevention, and removal, destruction, or otherwise diminishing the occurrence and activity of the target organism. The pesticidally effective amount can vary for the various compounds/compositions used in the invention. A pesticidally effective amount of the compositions will also vary according to the prevailing conditions such as desired pesticidal effect and duration, weather, target species, locus, mode of application, and the like.

The compounds of formula I and the compositions comprising said compounds can be used for protecting wooden materials such as trees, board fences, sleepers, etc. and buildings such as houses, outhouses, factories, but also construction materials, furniture, leathers, fibers, vinyl articles, electric wires and cables etc. from ants and/or termites, and for controlling ants and termites from doing harm to crops or human being (e.g. when the pests invade into houses and public facilities). The compounds of formula I are applied not only to the surrounding soil surface or into the under-floor soil in order to protect wooden materials but it can also be applied to lumbered articles such as surfaces of the under-floor concrete, alcove posts, beams, plywood, furniture, etc., wooden articles such as particle boards, half boards, etc. and vinyl articles such as coated electric wires, vinyl sheets, heat insulating material such as styrene foams, etc. In case of application against ants doing harm to crops or human beings, the ant controller of the present invention is ap- plied to the crops or the surrounding soil, or is directly applied to the nest of ants or the like.

The compounds of formula I can also be applied preventively to places at which occurrence of the pests is expected.

The compounds of formula I may also be used to protect growing plants from attack or infestation by pests by contacting the plant with a pesticidally effective amount of compounds of formula I. As such, "contacting the plant" includes both direct contact (applying the compounds/compositions directly on the pest and/or plant - typically to the foliage, stem or roots of the plant) and indirect contact (applying the compounds/compositions to the locus of the pest and/or plant).

In the case of soil treatment or of application to the pests dwelling place or nest, the quantity of active ingredient ranges from 0.0001 to 500 g per 100 m ² , preferably from 0.001 to 20 g per 100 m ² .

Customary application rates in the protection of materials are, for example, from 0.01 g to 1000 g of active compound per m ² treated material, desirably from 0.1 g to 50 g

per m ² .

Insecticidal compositions for use in the impregnation of materials typically contain from 0.001 to 95 % by weight, preferably from 0.1 to 45 % by weight, and more preferably from 1 to 25 % by weight of at least one repellent and/or insecticide.

For use in bait compositions, the typical content of active ingredient is from 0.001 % by weight to 15 % by weight, desirably from 0.001 % by weight to 5 % by weight of active compound.

For use in spray compositions, the content of active ingredient is from 0.001 to 80 % by weight, preferably from 0.01 to 50 % by weight and most preferably from 0.01 to 15 % by weight.

For use in treating crop plants, the rate of application of the active ingredients of this invention may be in the range of 0.1 g to 4000 g per hectare, desirably from 5 g to

600 g per hectare, more desirably from 10 g to 300 g per hectare.

In the treatment of seed, the application rates of the active ingredients are generally from 0.1 g to 10 kg per 100 kg of seed, preferably from 1 g to 1 kg per 100 kg of seed, in particular from 1 g to 250 g per 100 kg of seed, in particular from 50 g to 150 g per 100 kg of seed.

The present invention is now illustrated in further detail by the following examples which are not intended to limit the invention to them. I. Preparation Examples

Products were characterized by HPLC (High Performance Liquid Chromatography Mass Spectrometry). HPLC was carried out using an analytic RP-18 column (Chromolith Speed ROD from Merck KgaA, Germany) which was operated at 40°C. Acetonitrile with 0.1 % by volume of a trifluoroacetic acid/water mixture and 0.1 % by volume of trifluoroacetic acid served as mobile phase; flow rate: 1 .8 mL/min and injection volume: 2 μΙ.

Example 1 :

[2-(4-Chloro-phenyl)-7-trifluoromethyl-quinazolin-4-yl]et hylamine (I-99)

I-99

2-(4-Chlorophenyl)-7-trifluoromethyl-3H-quinazolin To a stirred suspension of 2-amino-4-(trifluoromethyl)benzamide (33.6 g, 0.16 mol) in water (750 mL) was added dropwise 4-chlorobenzaldehyde. Iron trichloride hexahydrate (133 g) was then added in portions. The reaction mixture was then heated at reflux for 24 h. After allowing the suspension to cool to room tempera- ture, the precipitate was isolated by vacuum filtration washing with water (3 x 500 mL) and dried under vacuum (10 mbar, 50°C). Yield = 50 g, 94%; HPLC-mass spectrometry (LC-MS): 3.7 min, 325 (M ⁺ ).

1 .2 4-Chloro-2-(4-chloro-phenyl)-7-trifluoromethylquinazoline:

To a stirred suspension of 2-(4-chlorophenyl)-7-trifluoromethyl-3H-quinazolin-4-one (50 g, 0.15 mol) in dioxane (400 mL) was added dropwise phosphorus oxychloride (43 mL, 0.46 mol). The suspension was then heated at reflux for 2 h then allowed to cool to room temperature and evaporated under reduced pressure. The remaining solid was dissolved in dioxane (1 L) and an aqueous solution of sodium hydrox- ide (50 mL, 10% weight/weight (w/w)) was added dropwise maintaining the internal temperature <10°C). Water (1 L) was then added to the resultant suspension followed by the dropwise addition of a further quantity of aqueous sodium hydroxide (90 mL, 10% w/w). The precipitate was isolated by vacuum filtration washing with water (3 x 500 mL) and dried under vacuum (10 mbar, 50°C). Yield = 49 g, 93%; LC-MS: 4.7 min, 343 (M ⁺ ); H NMR (dimethylsulfoxide (DMSO)-d ₆ ) δ 7.68 (d, 2 H, J = 8.9 Hz), 8.12 (dd, 1 H, J = 8.9, 1.8 Hz), 8.48-8.54 (m, 4 H).

1 .3 [2-(4-Chloro-phenyl)-7-trifluoromethyl-quinazolin-4-yl]ethyl amine:

To a stirred solution of 4-chloro-2-(4-chloro-phenyl)-7-trifluoromethylquinazoline (52.0 g, 0.15 mol) inTHF (400 mL) at 0°C was added dropwise a solution of ethyl- amine (0.45 mol, 230 mL, 2 M in THF. The ice-bath was then removed and the reaction mixture was allowed to stir at room temperature for 1 h. The reaction mixture was concentrated under reduced pressure then partitioned between ethyl acetate (400 mL) and water (400 mL) removing any undissolved solid by vacuum filtra- tion. The filtrate was concentrated to approximately 200 mL and the resultant precipitate was removed by vacuum filtration. The filtrate was again concentrated to approximately 100 mL volume and the resultant precipitate was removed by vacuum filtration. Finally the filtrate was cooled to 0°C upon which [2-(4-chloro-phenyl)- 7-trifluoromethyl-quinazolin-4-yl]ethylamine precipitated from solution. The precipi- tate (30 g) was isolated by vacuum filtration and dried under vacuum (10 mbar, 50°C). A second amount of the precipitate of equal purity (19.6 g) was obtained following concentration of the filtrate to approximately 50 mL volume, cooling to 0°C, filtration and drying under vacuum. Combined yield = 49.6 g, 93%; LC-MS: 2.9 min, 352 (M ⁺ ); H NMR (DMSO-d ₆ ): δ 1 .38 (t, 1 H, J = 7 Hz), 3.77-3.85 (m, 2 H), 7.46 (d, 2 H, J = 8.7 Hz), 7.64 (dd, 1 H, J = 8.3, 1 .8 Hz), 7.72-7.78 (br s, 1 H), 8.09 (s, 1 H), 8.17 (d, 1 H, J = 8.3 Hz), 8.59 (d, 2 H, J = 8.7 Hz).

Example 2:

[2-(4-Trifluoromethylphenyl)-7-trifluoromethyl-quinazolin -4-yl]ethylamine (I-209)

I-209

2.1 7-Trifluoromethyl-1 H-quinazoline-2,4-dione:

2-Amino-4-trifluoromethylbenzoic acid (25.0 g, 122 mmol) and urea (75.0 g, 1 .2 mol) were combined and heated at 200°C while stirring. After 1 h, the reaction mixture was allowed to cool to 100°C and water (100 mL) was added. The reaction mixture was then allowed to cool to room temperature and the solid was isolated by vacuum filtration washing with water (500 mL). The solid was then dried under vac- uum (10 mbar, 50°C). Yield = 24 g, 86%; LC-MS: 2.1 min, 230 (M ⁺ ); H NMR

(DMSO-de) δ 7.44 (s, 1 H) 7.47 (d, 1 H), 8.07 (d, 1 H), 1 1 .43 (br s, 1 H), 1 1.56 (br s, 1 H).

2.2 (2-Chloro-7-trifluoromethyl-quinazolin-4-yl)ethylamine:

To a stirred suspension of 7-trifluoromethyl-1 H-quinazoline-2,4-dione (25 g, 0.1 1 mol) and N,N-dimethylaniline (13.1 g, 0.1 1 mol) at 0°C was added phosphorus oxychloride (101 mL, 1.1 mol) and the reaction mixture was heated at reflux for 6 h. The reaction mixture was allowed to cool to room temperature then concentrated under reduced pressure. The resultant solid was dissolved in THF (50 mL) then cooled to 0°C and a solution of ethylamine (10 mL, 2 molar in THF) was added dropwise with stirring. After 2 h, the reaction mixture was concentrated under reduced pressure, diluted with water (250 mL) and extracted with ethyl acetate (2 x 150 mL). The combined organic layers were dried over MgS0 ₄ , filtered and concentrated under reduced pressure. Yield = 14 g, 47%; LC-MS: 3.1 min, 276 (M ⁺ ); ¹ H NMR (DMSO-de): δ 1 .26 (apparent t, 3 H, J = 7 Hz), 3.57 (ddd, 2H, J = 12.7, 7.3, 5.6 Hz), 7.84 (dd, 1 H, J = 8.7, 1 .6 Hz), 7.93 (s, 1 H), 8.49 (d, 1 H, J = 8.7 Hz), 9.05 (apparent t, 1 H, J = 5 Hz).

2.3 [2-(4-Trifluromethylphenyl)-7-trifluoromethyl-quinazolin-4-y l]ethylamine:

A solution of (2-chloro-7-trifluoromethyl-quinazolin-4-yl)ethylamine (276 mg, 1.00 mmol), p-trifluoromethylphenylboronic acid (285 mg, 1.50 mmol),

tetrakis(triphenylphosphine)palladium (1 16 mg, 0.10 mmol) and sodium carbonate (0.21 g, 2.0 mmol) in dimethoxyethane/water (3 mL, 2:1 ) was heated at 80°C for 16 h. The reaction mixture was then concentrated under reduced pressure, diluted with water (50 mL) and extracted with CH2CI2 (3 x 25 mL). The combined organic layers were dried over MgSC , filtered, and concentrated under reduced pressure. Purification by flash chromatography using cyclohexane: ethyl actetate (4:1 ) as solvent afforded [2-(4-trifluromethylphenyl)-7-trifluoromethyl-quinazolin-4- yl]ethylamine. Yield = 0.20 g, 52%; LC-MS: 3.2 min, 385 (M ⁺ ); H NMR (DMSO-de): δ 1 .34 (t, 3 H, J = 7.2 Hz), 3.68-3-78 (m, 2 H), 7.82 (dd, 1 H, J = 8.6, 1.7 Hz), 7.88 (d, 2 H, J = 8.1 Hz), 8.07 (s, 1 H), 8.50 (d, 1 H, J = 8.6 Hz), 8.67 (d, 2 H, J = 8.1 Hz), 8.70-8.76 (m, 1 H).

Example 3:

[2-(4-Chlorophenyl)-5,6,difluoro-7-trifluoromethylquinazo lin-4-yl]ethylamine (1-401 )

1-401

3.1 2,3-Difluoro-6-iodo-4-trifluoromethylbenzoic acid:

A suspension of 2,3-difluoro-4-trifluoromethylbenzoic acid (1.00 g, 4.42 mmol), palladium (II) acetate (0.199 g, 0.88 mmol) and N-iodosuccinimide (1 .19 g, 5.31 mmol) in dimethylformamide (10 mL) were heated at 100°C for 2 d. The reaction mixture was then concentrated under reduced pressure, diluted with ethyl acetate (100 mL) and washed with water (3 x 25 mL). The organic layer was dried over MgSC , fil- tered and concentrated under reduced pressure to afford a brown solid (1 .53) g which was used without further purification. LC-MS: 2.6 min, 353 (M ⁺ ).

3.2 2-(4-Chlorophenyl)-5,6-difluoro-7-trifluoromethyl-3H-quinazo lin-4-one:

A suspension of crude 2,3-difluoro-6-iodo-4-trifluoromethylbenzoic acid (1.00 g), 4- chlorobenzamide hydrochloride (0.814 g, 4.26 mmol), copper (I) iodide (0.108 g), caesium carbonate (1 .85 g, 5.68 mmol) in dimethylformamide (8 mL) were stirred under nitrogen at room temperature for 1 week. The reaction mixture was then diluted with ethyl acetate (100 mL) and washed with hydrochloric acid (1 M, 25 mL) and water (25 mL). The organic phase was dried over MgSC , filtered and concentrated under reduced pressure (0.98 g). The reaction was repeated with crude 2,3- difluoro-6-iodo-4-trifluoromethylbenzoic acid (0.50 g) to afford an additional portion (0.57 g) of the quinazolin-4-one. LC-MS: 3.6 min, 361 (M ⁺ ).

3.3 4-chloro-2-(4-chlorophenyl)-5,6-difluoro-7-trifluoromethylqu inazoline:

To a suspension of the above quinazolin-4-one (1 .50 g) in dioxane (45 mL) was added phosphorus oxychloride (3.9 mL, 41 mmol) and the resultant solution was heated at reflux for 16 h. The reaction mixture was then concentrated under re- duced pressure to afford a gummy solid which was used without further purification.

3.4 [2-(4-Trifluoromethylphenyl)-5,6,difluoro-7-trifluoromethylq uinazolin-4- yl]ethylamine:

A suspension of the above crude quinazoline and ethylamine (2 M in THF, 25 mL) was stirred at room temperature for 16 h. The reaction mixture was then concentrated under reduced pressure, diluted with ethyl acetate (75 mL) and washed with water (25 mL), aqueous sodium carbonate (25 mL) and water (25 mL). The organic phase was dried over MgSC , filtered and concentrated under reduced pressure to afford a crystalline solid. Recrystallization from hot cyclohexane: ethyl acetate (4:1 ) afforded [2-(4-chlorophenyl)-5,6,difluoro-7-trifluoromethylquinazolin -4- yl]ethylamine. Yield = 0.10 g, 6% over 4 steps. LC-MS: 4.6 min, 388 (M+); ¹ H NMR (tetrahydrofuran (THF)-d ₆ ): δ 1.38 (apparent t, J = 7 Hz, 3 H), 3.79-3.87 (m, 2 H), 7.47 (apparent d, J = 8.8 Hz, 2 H), 7.51 -7.59 (broad s, 1 H), 7.96 (dd, J = 6.2, 1 .4 Hz , 1 H), 8.54 (apparent d, J = 8.8 Hz, 2 H).

Compounds of formula I prepared according to the above mentioned method together with their physico-chemical data are compiled below

in Tables E, F and G. The corresponding physico-chemical data (LC/MS) wherein t.R is retention time in minutes and M is the mass of respective molecular ion are listed in the Tables.

In Table E, compounds are of the general formula: wherein R ^E is a mono- or dialkylamino derivative:

R

R ^fc is #-N

FT

and # denotes the binding site to the remainder

Table E:

/ t _R: : 3.755'

)

M = 407.9

In Table F, compounds are of the general formula:

wherein R ^F in the above formula is R ¹ or R ²

and R ^F is a propyl (Pr) or an ethyl (Et) and A as indicated in Table F:

Table F

1 R ^F A LC/MS I A LC/MS

Pr Pr

1-387 t _R: 3.32'

M = 391.4 I-392 t _R: 3.471 '

M = 437.5

Pr

1-388 t _R: 3.145'

M = 361.4 Pr

Pr I-393 t _R: 3.498'

1-389 t _R: 3.325'

M = 455.4 M = 395.8

Pr

1-390 t _R: 3.221 ' Pr F

M = 377.4

Pr 828'

1-391 t _R: 3.529' I-394 t _R: 3.

M = 407.4 M = 521.5

In Table 3, further examples compounds of the general formula (I)

(I) wherein R ¹ , R ² , R ³ , R ⁴ , R ^5a , R ^5b , R ^5c , R ^5d , A ¹ and A ² in each case have the meaning given in the corresponding line and wherein A ³ and A ⁴ are each CH.

Table 3

II. Evaluation of pesticidal activity:

The activity of the compounds of formula I of the present invention can be demonstrated and evaluated by the following biological test.

B.1 Southern Armyworm (Spodoptera eridania, 2 ^nd instar larvae)

The active compounds were formulated in cyclohexanone as a 10, 0000 ppm solution supplied in 1 .3 ml ABgene® tubes. These tubes were inserted into an automated elec- trostatic sprayer equipped with an atomizing nozzle and they served as stock solutions for which lower dilutions were made in 50% acetone: 50% water (v/v). A nonionic surfactant (Kinetic®) was included in the solution at a volume of 0.01 % (v/v). Lima bean plants (variety Sieva) were grown 2 plants to a pot and selected for treatment at the 1 ^st true leaf stage. Test solutions were sprayed onto the foliage by an automated electro- static plant sprayer equipped with an atomizing spray nozzle. The plants were dried in the sprayer fume hood and then removed from the sprayer. Each pot was placed into perforated plastic bags with a zip closure. Ten to 1 1 armyworm larvae were placed into the bag and the bags zipped closed. Test plants were maintained in a growth room at at 25°C and 20-40% relative humidity for 4 days, avoiding direct exposure to fluores- cent light (24 hour photoperiod) to prevent trapping of heat inside the bags. Mortality and reduced feeding were assessed 4 days after treatment, compared to untreated control plants.

In this test, compounds 1-1 , I-2, I-3, I-4, I-5, I-8, 1-10, 1-1 1 , 1-13, 1-16, 1-17, 1-21 , I-23, I- 28, I-29, I-30, 1-31 , I-37, I-38, I-40, 1-41 , I-46, I-47, I-49, I-53, I-54, I-56, I-57, I-58, I-60, 1-61 , I-63, I-64, I-67, 1-71 , I-72, I-73, I-74, I-75, I-77, I-78, I-79, I-80, I-82, I-83, I-84, I a85, I-88, 1-91 , I-94, I-99, 1-100, 1-101 , 1-102, 1-109, 1-1 10, 1-1 1 1 , 1-1 14, 1-1 17, 1-1 18, I- 1 19, -a120, 1-123, 1-124, 1-125, 1-128, 1-130, 1-132, 1-133, 1-136, 1-143, 1-151 , 1-152, I-

comparison with untreated controls. B.2 Silverleaf Whitefly (Bemisia argentifolii, adult)

The active compounds were formulated in cyclohexanone as a 10, 0000 ppm solution supplied in 1.3 ml ABgene® tubes. These tubes were inserted into an automated electrostatic sprayer equipped with an atomizing nozzle and they served as stock solutions for which lower dilutions were made in 50% acetone: 50% water (v/v). A nonionic surfactant (Kinetic®) was included in the solution at a volume of 0.01 % (v/v). Cotton plants at the cotyledon stage (one plant per pot) were sprayed by an automated electrostatic plant sprayer equipped with an atomizing spray nozzle. The plants were dried in the sprayer fume hood and then removed from the sprayer. Each pot was placed into a plastic cup and 10 to 12 whitefly adults (approximately 3-5 days old) were introduced. The insects were collected using an aspirator and 0.6 cm, nontoxic Tygon® tubing (R-3603) connected to a barrier pipette tip. The tip, containing the collected insects, was then gently inserted into the soil containing the treated plant, allowing insects to crawl out of the tip to reach the foliage for feeding. Cups were covered with a reusable screened lid (150-micron mesh polyester screen PeCap from Tetko, Inc.). Test plants were maintained in a growth room at 25°C and 20-40% relative humidity for 3 days, avoiding direct exposure to fluorescent light (24 hour photoperiod) to prevent trapping of heat inside the cup. Mortality was assessed 3 days after treatment, compared to untreated control plants.

In this test, compounds 1-1 1 , I-78, 1-120, 1-121 , 1-182, 1-195, 1-196, I-244, 1-413 and I- 442 at a test concentration of 500 ppm showed a mortality of at least 50% in comparison with untreated controls.

B.3 Colorado potato beetle (Leptinotarsa decemlineata, adult)

The active compounds were formulated in cyclohexanone as a 10, 0000 ppm solution supplied in 1.3 ml ABgene® tubes. These tubes were inserted into an automated elec- trostatic sprayer equipped with an atomizing nozzle and they served as stock solutions for which lower dilutions were made in 50% acetone:50% water (v/v). A nonionic surfactant (Kinetic®) was included in the solution at a volume of 0.01 % (v/v). Eggplants were grown 2 plants to a pot and were selected for treatment at the 1 ^st true leaf stage. Test solutions were sprayed onto the foliage by an automated electrostatic plant sprayer equipped with an atomizing spray nozzle. The plants were dried in the sprayer fume hood and then removed from the sprayer. The treated foliage was then cut and removed from the pot and placed in a 5-inch Petri dish lined with moistened filter paper. Five beetle larvae were introduced into each Petri dish and the dish was covered by a Petri dish lid. Petri dishes were maintained in a growth room at 25°C and 20-40% rela- tive humidity for 4 days, avoiding direct exposure to fluorescent light (24 hour photope- riod) to prevent trapping of heat inside the dishes. Mortality and reduced feeding were assessed 4 days after treatment, compared to untreated control plants. In this test, compound 1-201 at a test concentration of 300 ppm showed a mortality of at least 50% in comparison with untreated controls.

B.4 Diamondback moth (Plutella xylostella) The active compound was dissolved at the desired concentration in a mixture of 1 :1 (vol:vol) distilled water : acetone. The test solution was prepared at the day of use.

The activity against Plutella xylostella can be tested by the following experiments: Leaves of Chinese cabbage were dipped in test solution and air-dried. Treated leaves were placed in petri dished lined with moist filter paper. Mortality was recorded 24, 72, and 120 hours after treatment.

In this test, compounds 1-1 , I-4, I-5, I-8, 1-10, 1-1 1 , 1-13, 1-16, 1-17, I-23, I-28, I-29, I-33, I- 36, I-37, I-38, I-46, I-47, I-48, 1-51 , I-52, I-54, I-56, I-57, I-58, I-60, 1-61 , I-63, 1-71 , I-73, I-74, I-75, I-76, I-77, I-78, I-79, I-82, I-83, I-84, I-85, I-88, I-94, I-99, 1-100, 1-101 , 1-102, 1-103, 1-105, 1-109, 1-1 10, 1-1 1 1 , 1-1 14, 1-1 17, 1-1 18, 1-120, 1-121 , 1-124, 1-125, 1-131 , I- 133, 1-135, 1-136, 1-142, 1-143, 1-151 , 1-152, 1-153, 1-154, 1-157, 1-159, 1-160, 1-162, I- 163, 1-169, 1-170, 1-176, 1-177, 1-185, 1-186, 1-187, 1-191 , 1-193, 1-194, 1-195, 1-196, I- 198, 1-201 , I-202, I-204, I-205, I-206, I-207, I-209, 1-210, 1-21 1 , 1-212, 1-213, 1-215, I- 218, 1-219, 1-21 , I-223, I-224, I-225, I-227, I-228, I-229, I-230, 1-231 , I-233, I-234, I-235, I-236, I-238, 1-241 , 1-61 , I-264, I-266, I-267, I-268, I-270, I-272, I-285, I-292, I-296, I- 297, I-299, I-300, 1-301 , I-302, I-303, I-304, I-306, I-307, 1-313, I-395, I-396, I-397, I- 399, I-403 and I-404 at a test concentration of 500 ppm showed a mortality of at least 50% in comparison with untreated controls.

B.5 Orchid thrips (Dichromothrips corbetti)

Dichromothrips corbetti adults used for bioassay were obtained from a colony maintained continuously under laboratory conditions. For testing purposes, the test com- pound was diluted to a concentration of 300 ppm (wt compound: vol diluent) in a 1 : 1 mixture of acetone:water (vol:vol), plus 0.01 % vol/vol Kinetic ^® surfactant.

Thrips potency of each compound was evaluated by using a floral-immersion technique. Plastic petri dishes were used as test arenas. All petals of individual, intact orchid flowers were dipped into treatment solution and allowed to dry. Treated flowers were placed into individual petri dishes along with 10 - 15 adult thrips. The petri dishes were then covered with lids. All test arenas were held under continuous light and a temperature of about 28°C for duration of the assay. After 4 days, the numbers of live thrips were counted on each flower, and along inner walls of each petri dish. The level of thrips mortality was extrapolated from pre-treatment thrips numbers.

In this test, compounds I-5, I-8, I-29, I-56, 1-71 , 1-100, 1-101 , 1-11 1 , 1-124, 1-131 , 1-133, I- 162, 1-169, 1-170, 1-201 , I-202, I-225, I-227, 1-231 , I-235, I-242, I-243, 1-412, I-434 and I- 445 at a test concentration of 500 ppm showed a mortality of at least 50% in compari- son with untreated controls.

B.6 Vetch aphid (Megoura viciae)

For evaluating control of vetch aphid (Megoura viciae) through contact or systemic means the test unit consists of 24-well-microtiter plates containing broad bean leaf disks. The compounds were formulated using a solution containing 75% v/v water and 25%) v/v DMSO. Different concentrations of formulated compounds were sprayed onto the leaf disks at 2.5 μΙ, using a custom built micro atomizer, at two replications.

After application, the leaf disks were air-dried and 5 - 8 adult aphids placed on the leaf disks inside the microtiter plate wells. The aphids were then allowed to suck on the treated leaf disks and incubated at about 23 ± 1 °C and about 50 ± 5 % relative humidity for 5 days. Aphid mortality and fecundity was then visually assessed.

In this test, compounds 1-1 1 , I-32, I-34, I-35, I-47, I-66, I-78, I-84, I-86, I-87, 1-122, I- 162, 1-164, 1-165, 1-169, 1-170, 1-197, I-205, 1-217, I-220, I-232, I-233, I-235, I-240, I-

241 , I-264, I-282, I-330, 1-413, 1-415, 1-418 and I-425 at a test concentration of 800 ppm showed a mortality of at least 50%.

B.7 Green Peach Aphid (Myzus persicae, mixed life stages)

The active compounds were formulated in cyclohexanone as a 10,000 ppm solution supplied in tubes. The tubes were inserted into an automated electrostatic sprayer equipped with an atomizing nozzle and they served as stock solutions for which lower dilutions were made in 50% acetone:50% water (v/v). A nonionic surfactant (Kinetic®) was included in the solution at a volume of 0.01 % (v/v).

Bell pepper plants at the first true-leaf stage were infested prior to treatment by placing heavily infested leaves from the main colony on top of the treatment plants. Aphids were allowed to transfer overnight to accomplish an infestation of 30-50 aphids per plant and the host leaves were removed. The infested plants were then sprayed by an automated electrostatic plant sprayer equipped with an atomizing spray nozzle. The plants were dried in the sprayer fume hood, removed, and then maintained in a growth room under fluorescent lighting in a 24-hr photoperiod at about 25°C and about 20-40% relative humidity. Aphid mortality on the treated plants, relative to mortality on untreated control plants, was determined after 5 days.

In this test, compounds 1-29, 1-32, 1-33, 1-35, 1-57, 1-60, 1-77, 1-100, 1-101 , 1-102, 1-105, I- 109, 1-1 14, 1-1 18, 1-1 19, 1-120, 1-150, 1-162, 1-165, 1-169, 1-191 , 1-195, 1-217, 1-218, I- 221 , I-223, I-225, I-227, I-228, I-235, I-239, I-240, 1-241 , I-270, 1-271 , I-272, I-273, I- 274, I-279, I-280, I-283, I-284, I-286, I-288, I-289, I-290, 1-291 , I-292, I-296, I-332, I- 335, I-402, 1-415, 1-418, I-425, I-436 and I-448 at a test concentration of 800 ppm showed a mortality of at least 50%.

B.8 Boll weevil (Anthonomus grandis)

For evaluating control of boll weevil (Anthonomus grandis) the test unit consists of 24- well-microtiter plates containing an insect diet and 20-30 A. grandis eggs.

The compounds were formulated using a solution containing 75% v/v water and 25% v/v DMSO. Different concentrations of formulated compounds were sprayed onto the insect diet at 20 μΙ, using a custom built micro atomizer, at two replications.

After application, microtiter plates were incubated at about 23 ± 1 °C and about 50 ± 5 % relative humidity for 5 days. Egg and larval mortality was then visually assessed.

In this test, compounds 1-10, 1-1 1 , 1-13, 1-17, I-28, I-29, 1-31 , I-34, I-37, I-38, I-40, 1-41 , I- 46, I-58, I-60, 1-61 , I-64, 1-71 , I-73, I-77, I-78, I-79, I-80, I-82, I-83, 1-100, 1-101 , 1-102, I- 108, 1-109, 1-1 1 1 , 1-1 13, 1-1 14, 1-1 16, 1-1 19, 1-120, 1-121 , 1-124, 1-132, 1-133, 1-152, I- 153, 1-154, 1-157, 1-159, 1-162, 1-163, 1-169, 1-182, 1-191 , 1-193, 1-194, 1-195, 1-199, I- 201 , I-202, I-205, I-207, I-208, 1-21 1 , 1-218, 1-219, 1-221 , I-222, I-223, I-25, I-227, I-229, I-230, 1-231 , I-232, I-233, I-234, I-235, I-236, I-240, I-243, I-255, 1-261 , I-264, I-267, I- 269, 1-271 , I-272, I-273, I-277, I-280, 1-281 , I-282, I-283, I-284, I-285, I-289, I-290, I-

291 , I-92, I-295, I-330, I-335, I-336, I-395, I-396, I-397, I-399, I-403, I-406, 1-412, 1-415, 1-416, I-420, I-24, I-425, I-427, I-428, I-430, 1-431 , I-435, I-438 and I-449 at a test concentration of 800 ppm showed a mortality of at least 50%. B.9 Mediterranean fruitfly (Ceratitis capitata)

For evaluating control of Mediterranean fruitfly (Ceratitis capitata) the test unit consisted of microtiter plates containing an insect diet and 50-80 C. capitata eggs. The compounds were formulated using a solution containing 75% v/v water and 25% v/v DMSO. Different concentrations of formulated compounds were sprayed onto the insect diet at 5 μΙ, using a custom built micro atomizer, at two replications.

After application, microtiter plates were incubated at about 28 ± 1 °C and about 80 ± 5 % relative humidity for 5 days. Egg and larval mortality was then visually assessed.

In this test, compounds 1-10, 1-1 1 , 1-12, 1-13, 1-14, 1-16, 1-17, 1-19, I-28, I-29, I-34, I-37, I- 38, I-45, I-46, I-47, I-49, I-56, I-57, 1-61 , I-64, 1-71 , I-72, I-73, I-74, I-75, I-77, I-78, I-79, I-80, 1-81 , I-82, I-83, I-87, I-98, I-99, 1-100, 1-101 , 1-102, 1-105, 1-107, 1-109, 1-1 1 1 , 1-1 14, 1-1 15, 1-1 17, 1-1 18, 1-1 19, 1-120, 1-121 , 1-125, 1-133, 1-151 , 1-152, 1-153, 1-154, 1-155, I- 157, 1-159, 1-162, 1-163, 1-169, 1-182, 1-191 , 1-193, 1-195, 1-196, 1-199, 1-201 , I-202, I- 205, I-206, I-207, I-208, I-209, 1-210, 1-213, 1-215, 1-218, 1-219, 1-221 , I-222, I-223, I- 224, I-225, I-226, I-227, I-228, I-229, I-230, 1-231 , I-233, I-234, I-235, I-236, I-237, I- 239, 1-241 , I-255, I-257, I-264, I-267, I-269, I-270, I-272, I-276, I-295, I-330, 1-331 , I- 332, I-335, I-395, I-396, I-397, I-399, I-400, I-403, I-404, I-406, I-407, I-408, I-409, I- 412, 1-414, 1-415, 1-416, 1-417, 1-418, I-420, I-424, I-427, 1-431 , I-434, I-437, I-438, I- 440, 1-441 , I-445, I-446, I-447, I-448 and I-449 at a test concentration of 800 ppm showed a mortality of at least 50%. B.10 Tobacco budworm (Heliothis virescens)

For evaluating control of tobacco budworm (Heliothis virescens) the test unit consists of 96-well-microtiter plates containing an insect diet and 15-25 H. virescens eggs.

The compounds were formulated using a solution containing 75% v/v water and 25% v/v DMSO. Different concentrations of formulated compounds were sprayed onto the insect diet at 10 μΙ, using a custom built micro atomizer, at two replications.

After application, microtiter plates were incubated at about 28 ± 1 °C and about 80 ± 5 % relative humidity for 5 days. Egg and larval mortality was then visually assessed. In this test, compounds I-8, 1-10, 1-1 1 , 1-12, 1-13, 1-16, 1-17, 1-19, I-28, I-29, I-32, I-34, I- 37, I-38, I-39, I-40, 1-41 , I-46, I-47, I-49, I-56, I-57, I-60, 1-61 , I-63, I-64, 1-71 , I-72, I-73, I-74, I-75, I-76, I-77, I-78, I-79, I-80, I-82, I-83, I-84, I-85, I-99, 1-100, 1-101 , 1-102, 1-109, 1-1 1 1 , 1-1 14, 1-1 15, 1-1 16, 1-1 17, 1-1 18, 1-1 19, 1-120, 1-121 , 1-122, 1-124, 1-125, 1-126, I-

130, 1-132, 1-133, 1-151 , 1-152, 1-153, 1-154, 1-157, 1-158, 1-159, 1-160, 1-161 , 1-162, I-

163, 1-168, 1-169, 1-182, 1-191 , 1-193, 1-194, 1-195, 1-196, 1-197, 1-199, I-200, 1-201 , I-

202, I-204, I-205, I-206, I-207, I-208, I-209, 1-210, 1-212, 1-215, 1-216, 1-218, 1-219, I-

221 , I-222, I-223, I-224, I-225, I-226, I-227, I-228, I-229, I-230, 1-231 , I-232, I-233, I-

234, I-235, I-236, I-237, I-238, I-239, 1-241 , I-255, I-256, I-257, 1-261 , I-264, I-266, I-

267, I-269, I-270, 1-271 , I-272, I-273, I-280, I-282, I-283, I-284, I-287, I-290, 1-291 , I- 292, 1-295, 1-329, 1-330, 1-331 , 1-332, 1-335, 1-395, 1-396, 1-397, 1-399, 1-400, 1-403, I- 404, 1-405, 1-406, 1-407, 1-408, 1-409, 1-412, 1-413, 1-414, 1-415, 1-416, I-420, I-424, I- 425, I-427, I-430, 1-431 , I-433, I-435, I-436, I-437, I-438, I-439, I-440, I-445, I-446, I- 447, I-448, I-449 at a test concentration of 800 ppm showed a mortality of at least 50%.